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ABSTRACT 
Alzheimer's disease (AD) is a progressive neurodegenerative disease with 
an insidious onset that makes it difficult to distinguish from normal aging. It 
begins with an impairment of memory that develops into amnestic mild cognitive 
impairment (aMCI) and later to dementia as deficits become apparent in other 
cognitive domains. Effective biomarkers that differentiate normal aging, MCI, and 
AD and predict future cognitive decline are needed. Potential biomarkers have 
been studied in isolation, but their impact when combined is not understood. The 
goal of this project is to determine the optimal combination of CSF biomarkers, 
MRI morphometry, FOG PET metabolism, and neuropsychological test scores to 
differentiate between normal aging subjects and those with MCI and AD. This 
study addresses: 1) the optimal normalization region and partial volume 
correction method to quantify FOG PET analysis, 2) the effects of adjusting MRI-
v 
based cortical thickness measures for differences in gray/white matter tissue 
contrast in normal aging and disease, 3) whether multimodal multivariate 
stepwise logistic regression models can predict group membership, and 4) 
whether multimodal multivariate stepwise linear regression models can 
determine which imaging and CSF biomarker variables best predict future 
cognitive decline. The results indicate that normalizing FOG PET to the 
cerebellum along with using a gray matter mask for partial volume correction 
provides optimal prediction. In contrast, age-associated changes in gray/white 
matter intensity ratio did not differentiate between the groups and only slightly 
improved the efficacy of cortical thickness as a biomarker. MRI morphometry of 
the gray matter and neuropsychological test scores were better able to 
discriminate between the groups than FOG PET or CSF biomarker 
concentrations. Combining all modalities significantly improved the index of 
discrimination, especially at the earliest stages of the disease. MRI gray matter 
morphometry variables were more highly associated with baseline cognitive 
function and best predicted future cognitive decline compared to other variables. 
Overall these findings demonstrate that a multimodal approach using MRI 
morphometry, FOG PET metabolism, neuropsychological test scores, and CSF 
biomarkers provides significantly better discrimination than any modality alone. 
Hence, the variables important for discriminating between the groups may be 
candidates for biomarkers in human clinical interventional trials. 
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Chapter 1 -General introduction 
1 
INTRODUCTION 
Alzheimer's disease (AD) is the most common form of dementia. At the 
present time it is affecting approximately 5.4 million Americans and the incidence 
is expected to nearly double within the next few decades as the population ages 
(Anon 2012). The rate of development of AD is heightened in individuals with 
amnestic mild cognitive impairment (MCI). Amnestic MCI is characterized by 
cognitive deficits primarily affecting memory, preserved overall cognitive and 
functional abilities, and the absence of dementia (R. C. Petersen 2001 ). 
Individuals with MCI convert to AD at a rate of 10 to 15% per year in comparison 
to approximately 1% per year in "normal aging" individuals (R. C. Petersen 
2001), making it imperative to generate effective methods for identifying the early 
signs in individuals with MCI who go on to develop AD. The clinical presentation 
of MCI is heterogeneous, making it difficult to determine at what stage in the 
normal aging, MCI, AD spectrum an individual may be in. There are a number of 
factors that may contribute to diagnosis, including performance on 
neuropsychological tests, brain morphometric measurements, brain glucose 
uptake, and concentrations of biomarkers in cerebrospinal fluid (CSF) . 
Pathologically, AD and MCI are characterized by the presence of 
intracellular neurofibrillary tangles (NFTs) and extracellular amyloid plaques. The 
NFTs are composed of insoluble hyperphosphorylated tau protein. Normal tau 
protein, the non-hyperphosphorylated type, is involved in microtubule 
stabilization of the axonal cytoskeleton. In the presence of NFTs, however, the 
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integrity of the cytoskeleton is impaired, such that neurons are dysfunctional and 
there is synaptic and neuronal loss (G6mez-lsla et al. 1997; Mosconi 2005). In 
AD and MCI, NFTs accumulate in the hippocampus, entorhinal cortex, amygdala, 
and other limbic areas that are important memory structures. As the disease 
progresses, the NFTs affect more neocortical areas, resulting in a deficit in other 
cognitive domains (Mosconi 2005) . While NFTs have a predilection for medial 
temporal lobe and limbic structures, amyloid plaques tend to accumulate more in 
the association cortices and, as the disease progresses, affect more 
hippocampal structures (H Braak & E. Braak 1991; D. R. Thai et al. 2002). The 
extent of amyloid distribution is less closely related to the severity of impairment 
on cognition than the NFTs (Mosconi 2005). Amyloid plaques are extracellular, 
are composed of insoluble fibrils of amyloid-beta (Ap), and may be related to the 
hypometabolism that is observed using FOG PET (Mosconi 2005). The 
underlying pathology is difficult to monitor in vivo, however, using imaging 
techniques, CSF sampling, and neuropsychological testing, it is possible to 
monitor the state of the disease progression. But, which method provides the 
best differentiation between normal aging, MCI, and AD? CSF levels of ABeta 1-
42 (AP-42), total tau, and phosphorylated tau, structural brain changes as 
measured with MRI morphometry, and functional brain changes as measured 
with FOG PET may all be useful. 
There is evidence that there is free exchange of molecules between the 
brain and CSF (Reiber & Peter 2001), which makes CSF a likely candidate for 
3 
biomarker for MCI and AD. There are three major markers of AD that are present 
in CSF, namely total tau (tTau), hyperphosphorylated tau (pTau), and A~-42 
(Zetterberg et al. 2003). It has been suggested that these markers are able to 
identify AD in its early stages with fairly high accuracy (Hansson et al. 2006), with 
increases in pTau and tTau have been observed in AD compared to normal 
aging (K Blennow et al. 1995; M. Ewers et al. 2007). However, there is overlap 
between AD and other forms of dementia in this measure, making it potentially 
difficult to rule out differential diagnoses. CSF of both MCI and AD subjects 
shows decreased concentrations of A~-42 (M. Ewers et al. 2007), which may 
reflect an increased deposition of A~ in aggregated plaques in the brain (Cedazo-
Minguez & Winblad 201 0). Although the increase in A~-42 and decreases in both 
pTau and tTau in CSF have been observed in MCI and AD, to what extent they 
can differentiate between normal aging , MCI, and AD and to what degree this 
can be improved upon by the addition of imaging data is not fully understood. 
Once of the consequences of AD pathology is a disruption of synaptic 
function. This may be indirectly measured via changes in glucose metabolism. 
FOG PET, a glucose analogue, is typically used as a marker of synaptic function, 
as metabolic changes are closely tied to glucose consumption. There is a 
relatively consistent pattern of decreased metabolism that occurs in AD. The 
regions that tend to show hypometabolism are the posterior 
cingulate/retrosplenial cortex and the cortical structures in the parieto-temporal 
junction, such as the angular gyrus and the precuneus. Some studies also 
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indicate a decrease in hippocampal metabolism (De Santi S. et al. 2001; Y. Li et 
al. 2008; Mosconi et al. 2009), although this is not consistently observed 
(Kawachi et al. 2006; Matsunari et al. 2007; K. Ishii et al. 2005). There is not a 
consistent pattern for MCI (Mosconi et al. 2008). Glucose metabolism changes 
mirror the Braak and Braak staging of NFTs (Mosconi et al. 2009) , thus FOG 
PET may be able to differentiate between normal aging, MCI, and AD groups 
with a high degree of discrimination. 
As previously mentioned, one of the consequences of AD pathology is 
neuronal loss. This loss is indirectly visible in vivo through imaging techniques, 
such as MRI. MRI is particularly useful for this, as it is a 3-dimensional imaging 
method. This enables researchers to examine the various ways in which atrophy 
can present itself, namely through changes in cortical surface area, thickness, or 
volume, of the cortical structures. Cortical thickness has been shown to be a 
particularly useful metric for tracking disease progression ; however, cortical 
surface area has not been examined to its full extent. Volumetric and cortical 
thickness changes have been observed consistently in MCI and AD, with the 
earliest detectable changes occurring in the entorhinal cortex and hippocampus, 
spreading outward to other cortical and subcortical structures (Michael Ewers et 
al. 2011; R J Killiany et al. 2002; P. M. Thompson et al. 2003). The combination 
of structures that best differentiates normal aging, MCI, and AD from one another 
has not been fully examined in a ROI-based data-driven approach. Many studies 
have limited their search to only cortical thickness in a set of ten or so 
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predetermined ROis. This may be detrimental to the ability to identify the MRI 
features that best characterize and differentiate between groups. 
Ultimately the accumulation of NFTS and A~, and the resultant changes 
in synaptic function and neuronal loss, manifests as cognitive deficits. The first 
round of testing when a patient presents with a memory complaint to the clinic is 
typically a battery of neuropsychological tests. Each of the tests in the battery is 
meant to measure performance on different types of cognitive skills (e.g. 
executive function, visuospatial abilities, etc.) or forms of memory (e.g. long-term 
memory, recall, recognition) . The Mini-mental status examination (MMSE) is 
often used as a metric of dementia severity, but because it covers a range of 
general cognitive abilities, it is often insensitive to early stage AD (Devanand et 
al. 1997; Galasko et al. 1990; Herlitz et al. 1997), in which memory is the primary 
complaint. The clinical dementia rating (CDR) is another commonly utilized 
metric for determining dementia severity. Using the CDR, normal aging would be 
a score of 0, MCI receives a value of 0.5, and once the scores run above 1, the 
individual likely has dementia. The test examines six domains: memory, 
orientation, judgment and problem solving, function in community affairs, home 
and hobbies, and personal care. The difficulty is that the test scoring is geared 
more for determining the more severe stages of dementia. Thus, the question 
arises, is there a better set of tests for examining changes in cognition that occur 
between normal aging and MCI, and then between MCI and AD and differentiate 
between these groups? 
6 
Each of the four modalities we discussed above has been implicated to be 
useful for discriminating normal aging, MCI, and AD. There is evidence that a 
combination of these methods may be better than the individual methods on their 
own (Kawachi et al. 2006). However, there are some additional factors that may 
attribute to the efficacy of FOG PET or cortical thickness measures for 
differentiating between subject groups. 
PET imaging has innately poor spatial resolution, which can pose 
problems when it is used in neurodegenerative diseases where progressive 
atrophy is a defining feature of the disease, such as AD. What happens is that in 
atrophic regions, signal from neighboring tissues, such as CSF in which there is 
no metabolism, the metabolic values can be artificially low. This is particularly a 
problem in structures that are already small. Thus, in regions such as the medial 
temporal lobes, the already small volume combined with atrophy can easily result 
in artificially low metabolic values. To eliminate this problem, partial volume 
correction (PVC) strategies in post-processing can be used. This is not done 
consistently and few studies directly compare the ability of different PVC 
methods to differentiate accurately between normal aging, MCI, and AD. Thus, 
this study will address the issue of partial volume correction across the AD 
spectrum. 
FOG PET data utilized in this study is non-quantitative because venous 
blood was not sampled during the data acquisition. Thus, in order to directly 
compare the FOG metabolism between subjects, we need to normalize the data 
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to a reference region that does not change with the disease. The best region to 
normalize with for differentiating between normal aging, MCI , and AD is under 
contention. Thus, the second chapter will address the choice of reference region 
for normalization of FOG PET data. 
Cortical thickness values are determined in part by the gray/white matter 
boundary. This boundary is often elusive, as the tissue contrast is often subtle, 
particularly when the tissue is affected by pathology. Thus, it has been suggested 
that adjusting cortical thickness for changes in gray/white matter intensity ratio 
(GWIR) may improve cortical thickness accuracy (Grydeland et al. 2012; D H 
Salat et al. 2009) , which may in turn result in its being a better predictor of MCI 
and AD (Grydeland et al. 2012). In this light, the third chapter will address the 
issues of GWIR in normal aging , the abil ity of GWIR to predict group membership 
on its own and as an adjustment factor for cortical thickness, and finally the 
potential change in cortical thickness effect size after adjusting for GWIR will be 
examined . 
The third study addresses the ability to differentiate between normal 
aging, MCI , and AD with different modalities, namely MRI morphometry (e.g. 
cortical thickness, surface area, and volume) , FOG metabolism, CSF biomarker 
concentration , and neuropsychological test scores. The discriminability of each 
modality on its own was determined, followed by an examination of the change in 
discriminability after combining modalities. 
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The fourth study addresses the use of CSF biomarkers, MRI 
morphometry, and FOG PET to predict baseline cognitive performance on a 
number of tasks and also to predict future cognitive decline in these tasks. We 
chose the tasks that had been shown in the third study to best differentiate 
between all three subject groups, namely clock draw, Trails A and B, digit span 
forward and backward, and 30 minute recall, recognition, and number of 
recognition errors. Stepwise linear regression models were used to predict 
baseline and follow-up change from baseline MRI morphometric and FOG 
metabolic data. Both imaging modalities were first tested on their own and then 
together, for those tests in which both modalities contributed. 
There are a number of statistical techniques that are common to all four 
studies, including residuals and regression. The regression used in the fourth 
study is stepwise linear, whereas the type used for the first three studies is 
stepwise logistic. I will briefly describe these techniques here and the importance 
of them for what information they can divulge. Residuals are used to control for 
the effects of a nuisance variable on a variable(s) of interest. Another common 
way to do this is to use ratios and divide the variable of interest by the nuisance 
variable. The problem with ratios is that it is unclear whether the resulting value is 
mostly driven by the numerator or denominator, and there are also no units. This 
can cause problems when we want to know how the variable of interest on its 
own, independent of the nuisance variable, affects MCI or AD because when we 
use a ratio, the final value is still influenced by the nuisance variable . Residuals 
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remove the variance of the nuisance variable from the variable of interest while 
maintaining the units. 
Stepwise logistic regression is used consistently throughout the first three 
studies to determine the ability of a set of variables to discriminate between 
diagnostic groups. In almost all cases, with the exception of when examining all 
three groups together, the outcome variable (e.g. the diagnostic group) is 
dichotomous (e.g. normal aging or MCI). Thus, the models assess which 
variables are indicative of normal aging, MCI, or AD. Whether or not a variable is 
determined to be a predictor of disease group is determined based on the odds 
ratio, which is a measure of the amount of influence a variable has on the 
outcome variable (e.g. how much the odds of MCI increases or decreases based 
on hippocampal volume). The odds ratio is calculated for each variable and if the 
odds ratio meets a predetermined cutoff value, it is entered as a variable in the 
model. For every variable that is entered into the model, each variable already 
present in the model is reassessed and if it no longer meets the cutoff value, it 
leaves the model. Thus, the end result is a set of variables that contribute 
independent variance to the determination of diagnostic group. The ability of the 
overall model to differentiate between groups is determined with the c-statistic, 
which is a measure of discrimination with values between 0.5 and 1, whereby 1 is 
perfect discrimination and 0.5 is random discrimination. 
Stepwise linear regression is similar to stepwise logistic regression, with 
the exception that the outcome variable is not categorical, but is linear. Thus, 
10 
goal is to determine the set of variables that best fits the slope of the outcome 
variable (e.g. digit span backward score). The variables that contribute variance 
to the model is determined in a stepwise manner, although rather than an odds 
ratio, the variance is measures by standardized betas. The ability of the overall 
model to predict the outcome variable is determined with the adjusted R-square, 
which is a measure of the total variance in the outcome variable that the model 
accounts for. It ranges from 0 to 1, with 1 representing 100% of the variation in 
the outcome variable. 
Using these statistical techniques, the overall goal of this dissertation is to 
use a data-driven approach to examine the relationships between imaging 
measures, CSF biomarkers, and neuropsychological tests in normal aging, MCI, 
and AD in depth in order to identify the factors that are most associated with 
each stage of the disease as well as predictive of future decline. 
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Chapter 2 - Differentiating between normal aging, mild cognitive 
impairment, and Alzheimer's disease with FOG PET: Effects of 
normalization region and partial volume correction method 
15 
INTRODUCTION 
Individuals with mild cognitive impairment (MCI) and Alzheimer's disease 
(AD) show disease-related decreases in 18F-flurodeoxyglucose (FOG) PET 
metabolism, which correlate with changes in memory function (Desgranges et al. 
2002). This hypometabolism tends to follow the pattern of pathology observed in 
AD, first affecting the medial temporal lobes and spreading outwards to involve 
the temporal, parietal, and frontal cortices while sparing the primary sensory 
areas. These changes are less severe in MCI, as it is a precursor of AD and 
individuals tend to not have the same degree of clinical impairments. Despite 
many studies outlining FOG uptake in MCI and AD, there is a lack of consistency 
in two key components to PET data processing; namely, choice of reference 
region for normalization and partial volume correction. 
Normalization allows for the direct comparison of non-quantitative PET 
data between subjects and may decrease variance within the dataset. In order to 
qualify for a candidate reference region for normalization, the brain region must 
fulfill a number of criteria: it must not be affected by the disease or condition 
being studied , it must be easily and reliably identifiable, and it ought to provide 
the most accurate differentiation of subject groups (Dukart et al. 2010; Yakushev 
et al. 2008). The optimal choice of reference region for normalization has been 
debated in the field, with the pons (Minoshima et al. 1995), cerebellum (Dukart et 
al. 2010), and primary somatosensory cortices (Yakushev et al. 2008) all being 
suggested to be the best region. In addition, many studies utilize the whole brain 
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and a proportional mean scaling factor (Dukart et al. 201 0; Samuraki et al. 2007), 
which, in the case of AD, likely does not fulfill the first criteria for a reference 
region, as widespread global changes in metabolism are often observed. Studies 
that compare normalization regions tend to be relatively small and utilize only 
one research site, thus the results may not be applicable to other studies. Large-
scale studies, such as the Alzheimer's disease neuroimaging initiative (ADNI) are 
prime candidates for examining which reference region is optimal for 
differentiating normal aging, MCI, and AD from one another, as the sample size 
is large and multiple research sites are used. 
The other critical PET image analysis step often ignored in MCI and AD 
research is partial volume correction. When it is used, there are numerous 
methods, few of which address the region-of-interest (ROI) based analysis. PET 
images have innately limited spatial resolution. This becomes a problem when 
the disease of interest is characterized by regional atrophy, such as hippocampal 
and entorhinal atrophy in AD and MCI. Because of the progressive AD-related 
atrophy, small brain regions, which are more sensitive to partial volume effects, 
tend to display artificially low FOG uptake values, thereby falsely enhancing 
difference between the disease and control groups (Rousset & H. Zaidi 2006). 
Essentially then, if partial volume correction is not used, then the disease-related 
hypometabolism may not be true changes in metabolism, but are likely 
metabolism changes contaminated by tissue atrophy. To eliminate this problem, 
some FOG PET studies use partial volume correction (PVC) that is based on 
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voxel-wise analysis (Meltzer et al. 1999; Meltzer et al. 1996; Park et al. 2006; 
Rousset et al. 1998; Rousset & H. Zaidi 2006; Samuraki et al. 2007; Daisuke 
Yanase et al. 2005). One group has also published a study using a region of 
interest (ROI)-based FOG PET partial volume correction (K B Walhovd, AM Fjell, 
A M Dale, et al. 201 0). The present study will examine the effects of partial 
volume correction on FOG uptake in MCI and AD using two methods: the use of 
gray matter mask (GMM) (Daisuke Yanase et al. 2005; Matsuda et al. 2003), 
typically a voxel-based approach, to remove non-gray matter voxels adapted for 
use with FreeSurfer, a semi-automated image analysis software program, and 
the statistical approach of Walhovd and colleagues (K B Walhovd, AM Fjell, AM 
Dale, et al. 201 0). In the second approach, cortical thickness and subcortical 
volume residuals are used to correct for partial volume effects. 
The main aims of this study were to first examine which ROI provides the 
most sensitive normalization when differentiating between normal aging, MCI, 
and AD in a large sample collected at multiple research centers. The second aim 
of this study was to examine the effects of PVC on normal aging, MCI, and AD 
using two techniques: 1) applying a grey matter mask (GMM) (Matsuda et al. 
2003; Daisuke Yanase et al. 2005), and 2) taking residuals of uptake after 
removing the effects of cortical thickness plus subcortical volume (K B Walhovd, 
A M Fjell, A M Dale, et al. 201 0). These aims were tested by building statistical 
models of discrimination to identify the best set of anatomically-based FOG PET 
measures to differentiate between normal aging, MCI, and AD. 
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MATERIALS AND METHODS 
Subjects 
The data for use in this study were chosen from the larger pool of data 
that has been made publically available by the Alzheimer's Disease 
Neuroimaging Initiative. Data was screened to include all subjects who had both 
PET and MRI scans available for use on the ADNI/LONI website 
(www.loni.ucla.edu/ADNI) at the time this study began. From this screened 
dataset, PET data from 21 subjects was of poor contrast and quality and had to 
be omitted from the analyses for this study. Three subjects were omitted due to 
missing information. This left us with data from 403 subjects. They had an age 
range of 55-89 years with an overall average age of 75.47 years. Of this group, 
146 were female and 257 were male. In terms of subgroups, 105 were identified 
as health control subjects, 204 fell into the category of MCI and 94 fell into the 
category of having AD as determined by the ADNI (Table 2.1). 
All subjects completed a battery of neuropsychological tests, including the 
mini-mental state examination (MMSE) (M. F. Folstein et al. 1975), the CDR-Sum 
of Boxes(J C Morris 1993), and the Global dementia scale (Auer & B Reisberg 
1997; B Reisberg et al. 1988). On the basis of their cognitive status the subjects 
were classified by the ADNI clinical core as: (a) normal controls with normal 
cognition and memory, CDR 0, and MMSE between 24-30; (b) amnestic MCI 
with memory complaint verified by a study partner, memory loss measured by 
education-adjusted performance on the Logical Memory II subscale of the 
19 
Wechsler Memory Scale-Revised (Wechsler 1987), preserved activities of daily 
living, CDR 0.5, MMSE between 24 and 30, and absence of dementia at time of 
baseline MRI scan; or (c) probable AD with memory complaint validated by an 
informant, abnormal memory function for age and education level, absence of 
depression, impaired activities of daily living, diminished cognition, CDR > 0.5, 
and MMSE between 20 - 26. 
Alzheimer's Disease Neuroimaging Initiative 
The ADNI was a 5-year non-randomized natural history non-treatment 
study utilizing data from multiple study centers across the United States and 
Canada. One of the main goals of the ADNI was to develop optimized methods 
and uniform standards for the acquisition of multicenter MRI and PET data on 
normal control subjects and patients with MCI and AD in drug/treatment trials. 
For more information about the ADNI please refer to http://www.adni-info.org. 
MRI scans 
For this study, we chose MRI scans from those acquired by the ADNI on 
1.5T scanners from General Electric (GE), Philips Medical Systems (Philips), and 
Siemens Medical Solutions (Siemens). Specific pulse sequence guidelines can 
be found at http://www.loni.ucla.edu/ADNI/Research/Cores/index.shtml. In this 
study we used the two MPRAGE scan acquired at baseline for each participant. 
The data from the LONI website was downloaded for use in it's original format 
since the Freesurfer processing pipeline has its own normalizing procedures. 
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FOG PET scans 
For this study, we chose FOG PET scans from those acquired by the 
AONI on GE, Philips, or Siemens scanners. Specific protocols for each scanner 
are available from the AONI website 
(http://adni.loni.ucla.edu/research/protocols/pet-protocols/). These data were 
corrected for radiation attenuation and scatter using scanner-specific algorithms 
and each image was visually assessed for potential artifacts by the AONI PET 
core at the University of Michigan. For this study we used the original PET data 
that was not pre-processed by the AONI PET core so that we could have local 
control of all the processing steps as with the MRI scans. 
Freesurfer Analysis 
All MRI and PET scans were processed with the Freesurfer 4.4.1 image 
analysis suite, which is documented and freely available for download from 
http://surfer.nmr.mgh.harvard.edu/. The FOG PET scans were re-processed in 
version 5.1.0 in order to do GMM partial volume correction. For each subject, the 
2 OICOM T1-weighted MRI datasets were motion corrected , averaged, 
segmented into gray matter, white matter, and cerebral spinal fluid (CSF), and 
intensity normalized. The cortex was parcellated into regions of interest based on 
gyral and sulcal structure. For each of the cortical regions volume, surface area, 
and cortical thickness were determined . Volume was calculated for each of the 
subcortical structures. Please refer to the FreeSurfer wiki page for more detailed 
information (http://surfer.nmr.mgh.harvard.edu/fswiki) . 
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PET Processing 
Once the T1-weighted MRI images were processed, the PET images were 
affine spatial transformed into "anatomical space" 1x1x1 , 256x256x256, which 
was the same resolution as the transformed MRI images. The PET and MRI 
images were then co-registered using an automated Freesurfer boundary based 
application using 6 degrees of freedom, such that no skewing or twisting of the 
data occurred (Figure 2.1 ). The resulting coregistration was visually assessed for 
accuracy and adjusted if necessary (approximately 25% of the datasets). After 
the two datasets were co-registered, the PET data was applied as a mask to the 
MRI images and analyses performed. FOG uptake was measured in specific 
ROis according to the cerebral cortex parcellations generated on the 
representative MRI images (Desikan et al. 2006). A total of 41 cortical and 
subcortical areas were examined for changes in MRI morphometry and FOG 
uptake related to MCI and AD relative to normal aging (Figures 2 and 3) . 
PET reference region for normalization 
To control for individual global variations and to increase sensitivity of the 
method for differentiating between subject groups (Yakushev et al. 2008), a 
number of reference regions for normalization were tested, namely the 
brainstem, precentral gyrus, postcentral gyrus, cerebellum, and thalamus. These 
regions were chosen because they have been reported by others to be good 
candidates for normalization (Minoshima et al. 1995; Dukart et al. 201 0). The 
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reference regions were first tested for disease effects before and after PVC and if 
there were no disease-related differences found using ANOVA, they were 
assessed as normalization regions. Normalization was done using residuals. 
PET Gray matter mask partial volume correction 
Each participant's MRI was segmented into gray matter (GM), white 
matter (WM) and cerebrospinal fluid space (CSF). The MRI WM segment was 
made binary and, after registration, served as a WM mask for the PET images. 
The WM PET mask was then made binary and multiplied by the original PET 
image to obtain a WM-only PET image. The GM PET image with partial volume 
correction (PVC) was obtained by subtracting the WM PET image from the 
original PET image and then multiplying this image by a binary GM MRI mask. 
The Freesurfer parcel lations were then applied to the GM PET. 
PET residuals partial volume correction 
The second PVC method was a statistical-based approach in which the 
effects of cortical thickness and subcortical volume were removed from the FOG 
PET metabolic values via residuals. This approach has been used in the past 
with FOG PET data processed in FreeSurfer (K B Walhovd, AM Fjell, AM Dale, 
et al. 201 0). 
Statistical Analysis 
In order to assess the equity of the male-female distribution in the three 
diagnostic groups, l tests were performed. AN OVA was used in order to assess 
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the age distribution in the three diagnostic groups. T-tests showed no significant 
lefUright differences, thus the data from the two hemispheres was averaged. 
Logistic regression Analyses 
For each candidate normalization region we created a logistic stepwise 
regression model for diagnostic group, controlling for age, gender, and education 
by forcing them into the model. This was accomplished by running linear 
regressions for MCI vs. normal, AD vs. MCI, and all three groups together with 
each FOG PET regional uptake variable individually in order to identify their 
predictor values. If the point estimate was below 0.75 or above 1.25 the FOG 
PET regional uptake variable was determined to be an adequate predictor on its 
own and was entered as a variable in the overall model. 
Separate models were created for differentiating between AD and MCI, 
MCI and normal aging, and all three groups together based upon data 
normalized to each of the candidate normalization regions. The c-statistic and 
AIC for each model were used to assess its utility. Hosmer-Lemeshow goodness 
of fit Chi square tests were used to assess the models' calibration. 
RESULTS 
Chi-square tests revealed no significant differences for distribution of 
males and females between groups (df=2, p=0.3517). Age was not significantly 
different between control , MCI, and AD groups, as indicated with ANOVA 
(p=0.6684). 
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Normalization region 
We tested the pre- and post-central gyri, thalamus, brainstem (as a 
surrogate for the pons), and cerebellum both before and after partial volume 
correction for significant differences between groups in order to assess if disease 
state has an effect on them. After these initial tests, only uptake in the brainstem 
and cerebellum was preserved as normalization candidates. ANOVA indicated 
that in the non-partial volume corrected PET data, the pre- and post-central gyri 
showed significantly decreased FOG uptake (p < 0.05) with disease progression 
eliminating them as potential normalization candidates. After partial volume 
correction, the thalamus showed significantly decreased uptake with disease (p < 
0.05) and was eliminated as a potential candidate for normalization. Conversely, 
the brainstem and cerebellum did not show significant disease-related 
differences (p > 0.05) making them good candidates for normalizing the FOG 
PET uptake data. To determine which region was better, we created logistic 
regression models for differentiating between all three subject groups normalizing 
to brainstem and cerebellum individually and in combination, which resulted in 
three separate models. To compare the models directly we took only the 
common regions to all three models and forced them into separate final models. 
These final models showed that the cerebellum slightly outperformed the 
brainstem, with c-statistics of 0.826 and 0.823, respectively. Thus, for the 
remainder of the study, the cerebellum was used as the normalization region. 
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Partial Volume Correction 
ANOVAs for the effects of partial volume correction 
To assess the effects of PVC, we examined the differences in between-
group relationships as determined by Tukey's post-hoc ANOVA tests. Prior to 
PVC, the majority of regions showed significant differences between normal 
aging, MCI, and AD (Table 2.2), with the exception of some cingulate, frontal, 
visual, and mid-brain regions. The highest degrees of change were observed in 
the medial temporal lobe, frontal , temporal, and parietal regions. After PVC using 
residuals, nearly all previously significant regions of hypometabolism were no 
longer significant, with the exception of the postcentral gyrus. Three regions 
showed an increase in significance, namely the amygdala, thalamus, and 
temporal pole. After PVC using the GMM method, there were again mixed 
effects, with some regions decreasing in significance and other regions 
increasing in significance. Table 2.2 outlines the specific details. 
Stepwise logistic regression models 
To examine the effects of partial volume correction, we created a series of 
models that differentiated normal aging from MCI, normal aging from AD, MCI 
from AD, and all three groups from one another before partial volume correction , 
after correction using a statistically-based residuals approach , and after 
correction using the GMM. Here we present the results from differentiating 
normal aging from MCI and normal aging from AD. In all models, age, gender, 
26 
and education were forced in to control for the variance they may have had on 
the model. Similar results were found for all four model conditions, thus the other 
two groups of models for differentiating AD from MCI and all three groups are 
presented in the supplementary material. 
Models normal aging from MCI 
Partial volume correction significantly decreased the ability to predict 
group membership using FOG PET data, regardless of which method of PVC 
was used. The GMM method provided a better model than cortical thickness 
residuals, both in terms of c-statistic (ROC) and AIC. Prior to partial volume 
correction, models differentiating between normal aging and MCI provided a c-
statistic of 0.810 and AIC of 310 (Table 2.3). Hosmer-Lemeshow goodness of fit 
shows that this model is well calibrated (chi-square = 11.82, p = 0.16). The 
regions that contributed significant amounts of variance to the model included the 
entorhinal cortex and the hippocampus. Age was the only other significant 
predictor. Banks of the superior temporal sulcus, caudal middle frontal, inferior 
temporal, and superior temporal all contributed variance to the model, but these 
failed to reach statistical significance. 
After correcting using cortical thickness and subcortical volume residuals, 
the c-statistic was 0.678 and AIC was 361. Hosmer-Lemeshow goodness of fit 
shows that this model is well calibrated (chi-square = 7.33, p = 0.50). The 
difference in c-statistics between non-PVC and residuals-PVC models was 
statistically significant (p = 0.0008). The regions that were significant predictors 
27 
were the amygdala and temporal pole. The paracentral gyrus contributed but 
failed to reach statistical significance. 
After correcting using the GMM method, the c-statistic was 0.688 and AIC 
was 355. Hosmer-Lemeshow goodness of fit shows that this model is well 
calibrated (chi-square = 4.29, p = 0.83). The difference in c-statistics between 
non-PVC and GMM-PVC models was also statistically significant (p = 0.0015). 
The regions that contributed significantly to the model were the entorhinal, 
fusiform, inferior temporal, and the isthmus of the cingulate. The c-statistic and 
AIC both indicate that the GMM method of PVC provides the best model for 
discriminating MCI from normal aging . 
Models differentiating normal aging from AD 
Again, partial volume correction significantly decreased the ability to 
discriminate group and the GMM method provided a better model, both in terms 
of c-statistic and AIC, than the residuals method of PVC (Table 2.4). Prior to 
PVC, differentiating between normal aging and AD subject groups provided a 
model with a c-statistic of 0.972 and AIC of 110. However, Hosmer-Lemeshow 
goodness of fit test shows that this model is not well calibrated and may not 
provide consistent results (chi-square = 50.86, p < 0.0001). The variables that 
contributed significantly to the model include precuneus, rostral anterior 
cingulate, isthmus of the cingulate, insula, parahippocampal gyrus, hippocampus, 
and superior parietal. Age was also a significant predictor. 
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After correcting using cortical thickness and subcortical volume residuals, 
the c-statistic was 0.864 and AIC was 195. Hosmer-Lemeshow goodness of fit 
shows that this model is well calibrated (chi-square= 6.57, p = 0.58). The regions 
that contributed significantly to the model were the entorhinal, amygdala, 
parahippocampus, thalamus, paracentral gyrus, and the inferior temporal lobe. 
Education was a significant predictor, as well. 
After correcting using GMM, the c-statistic was 0.879 and AIC was 185. 
Hosmer-Lemeshow goodness of fit shows that this model is well calibrated (chi-
square = 3.89, p = 0.87). The regions that contributed significantly to the model 
were the entorhinal, parahippocampus, middle temporal, temporal pole, and the 
paracentral and post-central gyri . Education was also a significant predictor. 
Other regions that contributed, although not significantly, to the model were the 
isthmus of the cingulate and the precuneus. 
Direct comparison of models 
Because different regions, only some of which are previously attributed to 
MCI and AD, contributed to each of the models of different correction types, we 
wanted to verify the efficacy of one correction method over another by allowing 
only specific brain regions that are consistently affected in MCI and AD into the 
models. Thus, we re-created models using only the measures of the entorhinal 
cortex, age, gender, and education in order to directly compare the non-partial 
volume corrected model and the two PVC models. When comparing MCI and 
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normal aging, c = 0.726 for non-PVC, c = 0.655 for GMM, and c = 0.594 for 
cortical thickness residuals. When comparing AD and normal aging, c = 0.865 for 
non-PVC, c = 0.713 for GMM, and c = 0.653 for cortical thickness residuals. 
Similar results were found for comparing MCI and AD and for differentiating all 
three groups. The results of these analyses confirm that GMM provides higher c-
statistics than cortical thickness residuals, but lower than non-PVC values. 
Correlations with Age 
Correlations between FOG uptake and age were only tested on the normal 
aging subjects to avoid contamination from AD-related effects, thus na9e= 105 
and nFDG uptake= 98. GMM-type PVC removed most of the age-related changes in 
FOG uptake compared to both non-PVC uptake and residual-PVC uptake (data 
not shown). Prior to partial volume correction, there were significant negative 
correlations between age and FOG uptake in a number of regions. After PVC 
using cortical thickness and subcortical volume residuals, a number of significant 
negative correlations between age and FOG uptake remained. There was also a 
significant positive correlation in the caudate. After PVC using the GMM method, 
there was a significant positive correlation between age and FOG uptake in the 
pallidum (R = 0.24613, p = 0.0146). No other regions showed significant age-
related correlations. 
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DISCUSSION 
FOG PET can provide vital information in the study of degenerative 
diseases such as Alzheimer's disease. In the raw, unprocessed form, FOG PET 
data is difficult to interpret quantitatively particularly when making comparisons 
between groups. In order to make these comparisons more meaningful, the 
uptake in each scan must be normalized to a control region within the scan and 
corrected for the influence of factors that could adversely impact the data. In this 
study we first examined which anatomically based ROI could serve as an 
appropriate region for normalizing FOG uptake across subjects ranging from 
normal aging, MCI and Alzheimer's disease. Next we looked into a means for 
addressing partial volume effects, a morphometric feature which can become 
more pronounced with atrophy in disease states such as Alzheimer's disease. 
We assessed two methods, one using a gray matter mask to remove the 
potential confounding effects of the white matter, and the second using a 
statistical correction based upon using the residuals derived from cortical 
thickness or subcortical volume depending upon the structure. Specifically we 
sought to identify the best correction factors for partial volume errors and 
normalization to obtain the statistical model which best differentiates between 
FOG uptake in normal aging, MCI , and AD. The influence of partial volume 
correction on age-related effects was also examined in healthy control subjects. 
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Normalization region ANOVA 
Our results suggest that the cerebellum is the best region to use for 
normalizing scans when using FOG PET data to differentiate between normal 
aging , MCI, and early stage AD. Of the other regions that we assess, the pre-
and post-central gyri showed significant hypometabolism in the AD group which 
is consistent with previous studies (Minoshima et al. 1995), thereby affirming that 
they are not appropriate normalization regions when AD subjects are being used. 
Interestingly, others have found that the somatosensory cortex (the pre- and 
post-central gyri combined) provided the best normalized data for discriminating 
between normal aging and MCI subject groups (Yakushev et al. 2008) though 
since they did not use partial volume correction their data and findings may be 
based on a mixture of metabolic and morphometric changes. 
We also found that after PVC the thalamus showed significant 
hypometabolism in the AD group. Similarly, Minoshima et al. (1995) found 
significant disease-related differences in the thalamus; however, this was without 
any partial volume correction making it difficult to discern whether this was due to 
changes in metabolism, volume, or both. In this study we only found thalamus 
differences after correcting for partial volume effects suggesting that this 
difference is the result of a true reduction in metabolism and not a change in 
volume. 
Taken together, our findings on the pre- and post-central gyrus and 
thalamus affirm the importance of correcting for partial volume effects. It also 
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underscores the importance of testing the reference region for disease-related 
effects in the subject sample to ensure its validity as a reference region. 
Partial Volume Correction 
Many studies that have looked at choosing a normalization region have 
not corrected for partial volume effects and those which have looked at PVC 
have not examined which brain region was best for normalization in their sample. 
Since these two factors can interact, it was important to look at both factors 
simultaneously in a sample that included not only normal aging and AD subjects, 
but also MCI subjects, which have been neglected in these types of study. 
We found that the adapted GMM method, which corrects the data at the 
image level, provided a higher index of discriminability in all group comparisons 
than using a statistical correction with cortical thickness or subcortical volume 
residuals. In addition, the regions that were chosen by the analysis for inclusion 
into the final models with the GMM method also are more consistent with those 
typically impacted by Alzheimer's disease. 
The changes in Tukey's post-hoc analysis indicate that there is an 
interaction between partial volume correction and FOG metabolism amongst the 
three groups. The decrease in significance observed throughout the cortex would 
indicate that the FOG data prior to correcting for partial volume was likely 
contaminated by atrophy, particularly in the AD group, as reflected by the low 
uptake values. We would like to point out that in a number of instances, regions 
I 
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typically associated with AD, (e.g. the hippocampus) were in the non-PVC model , 
but not in the PVC model. This does not necessarily imply that the regions no 
longer showed significant hypometabolism with disease. The logistic models 
indicate which variables contribute unique amounts of variance to the 
discrimination of two or more subject groups. Thus, there can still be significant 
disease-associated hypometabolism in a region that is not in the logistic model. 
Thus, the hippocampus may contribute variance to differentiating normal aging 
from MCI, but if the variance overlaps with a region that contributes more 
variance, such as the entorhinal cortex, then the hippocampus would not be 
included in the model, but the entorhinal cortex would be. 
Correlations with age 
We examined age-related correlations with FOG uptake before and after 
partial volume correction with the GMM and residual methods. We found that the 
efficacy for removing age-related changes in FOG uptake varied depending on 
which PVC method was used. Residuals failed to remove most of the 
correlations, while the GMM-PVC method removed most of the age-related 
changes. Previous studies on FOG changes in normal aging have shown 
reductions in the frontal and temporal lobes, particularly the dorsolateral frontal 
cortex (S De Santi et al. 1995); superior frontal cortex( Kuhl et al. 1982); and in 
the cingulate, parahippocampal, superior temporal, medial frontal , and posterior 
parietal cortices (Martinet al. 1991). On the contrary, a number of studies have 
observed no correlations between age and FOG uptake (M J de Leon, Ferris , 
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George, Christman , et al. 1983; M J de Leon, Ferris, George, B Reisberg, et al. 
1983; M J de Leon et al. 1984; Rapoport 1986). There are limited studies 
specifically looking at the change in age correlations with FOG uptake after 
correcting for partial volume effects (Cidis Meltzer et al. 2000). Consistent with 
their results, we found that correcting PET values for partial volume removes the 
majority of age-related effects, but only when using the GMM method. For 
instance, after PVC, the medial orbitofrontal cortex still showed age correlations 
in their study, while in ours the age-related decline in the medial orbitofrontal 
cortex remained after cortical thickness residual PVC, but was removed with 
GMM-PVC. Along the same lines, cortical thickness residuals actually increased 
the significance of many of the age/FOG uptake correlations. GMM PVC 
removed all age-related decline with the exception of the pallidum. 
CONCLUSION 
We sought to determine which choice of reference region for normalization 
provided the best model for discriminating between normal aging , MCI, and AD 
subject groups and also to determine the effects of partial volume correction on 
the statistical models. Partial volume correction is necessary for identifying which 
brain regions show true changes in FOG uptake with disease progression 
independent of any changes in MRI morphometry. Our results indicate that for 
this study sample, the cerebellum was the best region for normalization. The best 
models were those in which there was no partial volume correction, but by 
correcting for partial volume effects we can be certain that the FOG changes are 
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from decreased metabolism and not influenced by atrophy. Out of the two PVC 
methods tested (cortical thickness and subcortical volume residuals and GMM), 
we found that the GMM provides a higher index of discriminability, as measured 
with the c-statistic. Not only that, but the regions that were predictors in the GMM 
model better concurred with the literature on which regions are involved at the 
MCI and early AD disease stages. In addition, we can conclude that partial 
volume correction with the GMM diminished the age-related changes observed in 
the normal aging population. These results together suggest that perhaps the 
GMM is better than using residuals for FOG PET data processed in Freesurfer. 
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Figure 2. 
Coronal view 
of parcellated 
cortical and 
subcortical 
regions. 
Female MCI 
subject age 79 
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Figure 1. Co registration of FDG 
PET and Tl-weighted MPRAGE 
MRI scans shown in coronal, 
sagittal, and axial sections. The 
green line indicates the gray/ 
white matter boundary. The 
FDG PET scans are on the top 
and the MRI scans are on the 
bottom . The images are from a 
normal aging 83 year old male. 
Figure 3. Lateral and medial views of raw 
FOG uptake mapped onto inflated brain. 
Parcellated cortical regions are outlined. 
Table 2.1 Demographic information 
Subjects Age mean Education MMSE 
(male/female) years (std Mean (std dev) 
dev) 
Normal 105 (64/41) 75.81 (4.75) 15.90 (3.12) 28.98 (1 .12) 
Aging 
MCI 204 (137/67) 75.44 (7.22) 15.80 (2.88) 27.15 (1.71)8 
AD 94 (56/38) 74.91 (7.37) 14.61 (3.21)8 '0 23.48 
(2.14)a,b 
a significant difference from normal aging (p < 0.05), 0 significant difference 
from MCI (p < 0.05). 
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Table 2.2 ANOVA results for FOG uptake changes between nonnal aging, MCI, and AD subject groups. 
The first three columns show p-values from ANOVAs comparing uptake in normal aging, MCI, and AD 
before partial volume correction (PVC) and after PVC using residuals and gray matter mask (GMM) 
methods. The MCI vs. nonnal, AD, vs. MCI, and AD vs. nonnal columns show the specific relationships 
between groups, whereby '<' indicates a decrease in MCI compared to nonnal in the first column, AD < 
MCI, and AD < normal in the three columns, respectively (p > 0.05). Similarly, '>' indicates a sgnificant 
increase in one group compared to the other, i.e. MCI > nonnal, AD > MCI, and AD > nonnal. '=' 
indicates no significant change in uptake between groups. 
P-value P-value P-value MCivs. ADvs. ADvs. 
non-PVC residuals GMM nonnal MCI nonnal 
banks sts <.0001 0.63 0.001 <,=,= -,-,- <, =, < 
caudal anterior cingulate 0.60 0.33 "0:42 
' ' ' . ' . 
caudal middle frontal 0.73 0.32 0.05 
. ' 
-,-,- - -
' 
= 
' 
cuneus <.0001 0.40 0.25 <,=,= 
' ' 
<, =, = 
entorhinal 0.0007 0.07 <.0001 =, =,< 
' . 
<, <, < 
frontal pole <.0001 0.12 0.28 < - -. , < - -
' . 
<, =, = 
fusifonn <.0001 0.18 0.03 <,=,< <,=, = <, =, = 
inferior parietal <.0001 0.07 0.0006 <,=, < <, =,= <, <, < 
inferior temporal 0.04 0.007 <.0001 = = < 
' ' 
=,<,= <,<, < 
insula 0.007 0.72 0.24 
. ' ' ' 
<, =, = 
isthmus of the cingulate 0.09 0.07 <.0001 =, =,< -,-,- =,<, < 
lateral occipital 0.14 0.05 0.29 
' ' ' ' ' ' 
= 
lateral orbitofrontal 0.007 0.39 0.11 
' ' ' ' ' 
<, =. = 
lingual 0.001 0.20 0.28 
' ' ' ' ' 
<, =, = 
medial orbitofrontal <.0001 0.83 0.11 
' ' ' 
<,=, = <,=, = 
middle temporal 0.0009 0.21 <.0001 =,=, < <, =, = <, =, < 
paracentral 0.0001 0.02 0.02 =,>,= <,=, > <, >, > 
parahippocampal gyrus 0.03 0.008 6.005 =,=,< 
' ' 
<, <, < 
pars opercularis 0.003 0.34 0.17 
' ' 
< - -
' ' 
<,=,= 
pars orbitalis 0.002 0.39 0.25 
' ' 
<,=, = < - -
' . 
pars triangularis <.0001 0.52 0.28 <,=, = <,=, = <,=,= 
pericalcarine 0.82 0.14 0.13 
' ' 
-.-. -
' ' 
postcentral gyrus <.0001 0.04 0.0004 <,=,= <,=, > <, =, > 
posterior cingulate 0.13 0.11 0.06 
' . ' ' 
=,=, < 
precentral gyrus 0.007 0.61 0.005 
' ' 
= = > 
' ' · 
<, =, = 
precuneus 0.03 0.08 0.008 =,=,< - ,-, - <, =,< 
rostral anterior cingulate <.0001 0.31 0.24 
' . 
<, =, = < - -
' ' 
rostral middle frontal <.0001 0.29 0.17 
' . 
<,=, = <, =, = 
superior frontal 0.001 0.58 0.06 
' . 
<,=,= < - -
' ' 
superior parietal <.0001 0.77 0.13 <,=.= <,=, = <, =, = 
superior temporal 0.04 0.36 0.03 =,=, < .. >, =, = 
supramarginal <.0001 0.25 0.13 <,=, = <,=,= <,=, = 
temporal pole 0.37 0.003 0.01 =,>, < - - -
' ' ' ' 
transverse temporal <.0001 0.24 0.41 <,=, = <,=, = <,=, = 
amygdala 0.47 <.0001 0.004 =, <,< =, <,= =,<, < 
caudate 0.50 0.44 0.07 . ' 
' ' ' ' 
hippocampus 0.002 0.16 0.002 =,=,< <,=, = <,=, < 
pallidum 0.01 0.74 0.03 
' ' ' ' 
<,=, > 
putamen 0.1 3 0.89 0.002 = = < 
' ' ' ' ' ' 
thalamus 0.04 0.001 0.19 
' . ' ' 
<,<, = 
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Table 2.3 Stepwise logistic regression models for differentiating between MCI 
and normal aging groups before and after partial volume correction. The top 
model shows the non-pvc model (c = 0.81 0), followed by the cortical thickness + 
subcortical volume residuals (c = 0.678), and the GMM on the bottom (c = 0.688). 
MCI versus normal aging Unit Odds Ratio (95%CI) p-value 
Non-PVC model 
_gender 1 1.855 (0.~~5 - 3.462) 0.05 
education 2.9586 O.f!~1 (0.655- 1.185) 0.40 
age 6.5536 
-
0.597 (0.439- 0.812) 0.001 
entorhinal 337.3 0.681 (0.478- 0.970) 0.03 
banks STS 341.8 0.773 (9_:558- 1.071) 0.12 
-
caudal middle frontal 876.3 0.742 (0.5_38 -1 .023) 0.07 
inferior temp<?ral 1279 0.741 (Q._520- 1.0§_4) 0.11 
·-
superior temporal 1166.3 1.418 (0.948- 2.1 ?2) 0.09 
---
hipp~campus 532.6 0.~4~ (0.~2 - 0.537) <0.0001 
Cortical thickness+ 
subcortical volume residuals 
gender 1 1.131 (0.645- 1.985) 0.67 
education 2.9586 0.907 (0.703- 1.171) 0.45 
age 6.5536 0.815 (0.6~5 -1.064) 0.13 
paracentral gyrus 371 .1 1.261 (0.949- 1.674) 0.11 
temporal pole 225.5 1.478 ( 1 .1~ -1.927) 0.004 
amygdala 21.0682 0.667 (0.499- 0.890) 0.006 
Gray matter mask 
gender 1 1.507 (0.869- 2.612) 0.14 
education 2.9574 
-
0.857 (0.658 - 1.117) 0.25 
age 6.4782 0.79~ (0.611- 1.041) 0.10 
entorhinal 1349.3 0.549 (0.361 - 0.835) 0.005 
fusiform 1235.9 ~-4~9 (1 .342 - 4.434) 0.004 
-
inferior temporal 1301 0.576 (0.341 - 0.975) 0.04 
isthmus of the cingulate 2007.9 0.588 (0.386- 0.895) 0.01 
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Table 2.4 Stepwise logistic regression models for differentiating between AD and 
normal aging groups before and after partial volume correction. The top model 
shows the non-pvc model (c = 0.972), followed by the cortical thickness + 
subcortical volume residuals (c = 0.864), and the GMM on the bottom (c = 0.879). 
AD versus nonnal aging Unit Odds Ratio (95%Ci) p.value 
Non-PVC model 
gf!nder 1 2.~9? (0:_~- 8.639) 0.18 
education 3.2426 0.5~1 (0.295 - 1.068) 0.08 
age 6.0469 o:~03 (q.o~9- o.523) 0.001 
frontal pole 131.3 0.6~1 (0.3_2~ - 1.~0~ ) 0.16 
fusiform 1171 .9 0.483 (0.22~- 1.019) 0.06 
precuneus 1003.1 0.13~ (0.044- 0.393) 0.0003 
rostral anterior cingulate 276.6 2.0:40 (1.Q02- 4.156) 0.05 
isthmus of the cingulate 272.3 2.72? (1.090- 6.808) 0.03 
insula 660.4 2.997 (1.271- 7.067) 0.01 
earahippocampal gyrus 305.3 0.441 (0.214- 0.~09) 0.03 
superior parietal 1458.7 3.~18 (1.2~5- 8.318) 0.02 
hippocampus 621.4 0.012 (0.002 - 0.067) <0.0001 
Cortical thickness + 
subcortical volume residuals 
gender 1 1:408 (0.575 - 3.45) 0.45 
education 3.2426 0.526 (0.344 - 0.802) 0.003 
-
age 6.0469 0.703 (0.470 -1.051) 0.09 
entorhinal 246.9 0.597 (0.391 - 0.912) 0.02 
inferior temporal 1297.9 0.595 (0.368 - 0.961) 0.03 
paracentral gyrus 328.2 2.671 (1.640- 4.351) <0.0001 
parahippocampal gyrus 183.3 0.505 (0.~07- 0.833) 0.007 
amygdala 23.6388 0.32~ (0.195- Q.530) <0.0001 
thalamus 52.2657 0.612 (0.411- 0.911) 0.02 
Gray matter mask 
gender 1 1.072 (0.450- 2.551) 0.88 
education 3.2507 0.574 (0.3~9 - 0.869) 0.009 
age 5.9331 1.051 (0. 705- 1.567) 0.81 
entorhinal 1508.9 0.103 (0.033- 0.325) 0.0001 
istl]mus of the cingulate 2183.6 0.423 (0.120- 1.495) 0.18 
middle temporal 1686 0.231 (0.106- 0.501) 0.0002 
paracentral gyrus 2075.2 2.471 (1_:q2o- 5.987) 0.05 
parahippocampal gyrus 1576.2 4.218 (1.220- 14.579) 0.02 
postcentral gyrus 1575.6 3.685 (1.463 - 9.279) 0.006 
precur:'eus 2083.1 0.333 (0.102- 1.087) 0.07 
temporal pole 1264.5 3.130 (1.132- 8.655) 0.03 
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Table 2.5 Stepwise logistic regression models for differentiating between all three 
groups before and after partial volume correction. The top model shows the non-
pvc model (c = 0.831 ), followed by the cortical thickness+ subcortical volume 
residuals (c = 0.693), and the GMM on the bottom (c = 0.735). 
All three groups Unit Odds Ratio {95%CI) p..value 
Non-PVC model 
gender 1 0.?38 (0.466 -1.170) 0.20 
education 3.0693 0.768 (0.6!5- q.960) 0.02 
age 6.6897 0.656 (0.520 - 0.827) 0.0004 
entorhinal 363.1 0.~60 (0.493 - 0.882) 0.005 
caudal middle frontal 865.2 0.71~ (Q.?39- 0.939) 0.02 
frontal pole 132.3 0.772 (0.~_90- 0.994) 0.04 
inferior temporal 1387.9 0.532 (0.395- 0.716) <0.0001 
-
medial orbitofrontal 405.5 1.266 (0.~9- 1.656) 0.08 
precuneus · 921.5 0.714 (0.~39- 0.944) 0.02 
superior frontal 1986.8 1.691 (1.217- 2.348) 0.002 
temporal pole 307.2 1.449 (1.1~6- 1.866) 0.004 
hippocampus 575.6 0.336 (0.242 - 0.466) <0.0001 
caudate 562.4 1.337 (1.069 - 1.672) 0.01 
Cortical thickness+ 
subcortical volume residuals 
gender 1 1.196 (0.763 -1.874) 0.43 
education 3.0693 0.729 (q.595- 0.893) 0.002 
~ 
age 6.6897 0.781 (0.638- 0.959) 0.02 
inferior temporal 1299.2 0.657 (0.525 - 0.822) 0.0002 
amygdala 23.057 0.~61 (0.453- 0.695) <0.0001 
thalamus 51.4717 0.741 (0.604- 0.909) 0.004 
Gray matter mask 
gender 1 1.04? (0.~90- 1.589) 0.830 
education 3.0711 0.68~ (0.?5~ - 0.845) 0.0004 
age 6.586 0.998 (0.808 - 1.232) 0.98 
entorhinal 1405.3 0.718 (0.566- 0.912) 0.007 
inferior parietal 1761.9 0.59~ ~Q.436 - 0.822) 0.002 
isthmus of the cingulate 1974.2 0.588 (0.43_1 - 0.803) 0.0008 
postcentral gyrus 1517.7 2.675 0.988- 3.601) <0.0001 
lpallidum 710.9 1.231 (0.989- 1.531) 0.06 
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Table 2.6 Stepwise logistic regression models for differentiating between AD and 
MCI groups before and after partial volume correction. The top model shows the 
non-pvc model (c = 0.774), followed by the cortical thickness+ subcortical 
volume residuals (c = 0.714), and the GMM on the bottom (c = 0.726). 
AD versus MCI Unit Odds Ratio (95%CI) p-value 
Non-PVC model 
gender 1 0.904 (0:§01 - 1_:632) 0.74 
education 3.0409 0.6~ _(~.50~ - 0.8J 7) 0.004 
age 7.2123 0.908 (0.~2 - 1.228) 0.53 
inferior temporal 1366.6 <?..628 (()_.436- 0.906) 0.01 
precuneus 927 
.. 
0.69~ (0.48_6 - 0.98?) 0.04 
rostral middle frontal 1573.9 1.?67 (q.896 -1.793) 0.18 
hippoca~pus 552.8 0.4~ (0.3_51 - 0 .6~) <0.0001 
. -
Cortical thickness + 
subcortical volume residuals 
gender 0.902 0.902 (0.476 -1 .711) 0.75 
education 0.63 0.63 (0.4?6- 9.834) 0.001 
age 0.899 0.899 (0.675-1.196) 0.46 
inferior temporal 0.787 0. 787 (0.564 - 1.099) 0.16 
parahippocampal gyrus 0.75 0.75 (0.537- 1.049) 0.09 
amygdala 0.616 0.61~ (0.460- 0.824) 0.001 
thalamus 0.75 0.75 (0.567- 0.992) 0.04 
Gray matter mask 
gender 1 0.716 (0.406 -1 .265) 0.25 
education 3.0423 0.61 (0.461 - 0.8_(l8) 0.0006 
age 7.0892 1.0~5 (0.811 - 1.452) 0.58 
inferior temporal 1337.9 0.55~ (0.407- 0.749) 0.0001 
postcentral gyrus 1564 1.779 (1.285- 2.463) 0.0005 
!putamen 2407.4 1.425 (1.043- 1.946) 0.03 
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Chapter 3 - Does the gray/white intensity ratio matter when 
discriminating between normal aging, mild cognitive 
impairment, and Alzheimer's disease? 
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INTRODUCTION 
Alzheimer's disease (AD) is the leading form of dementia today. It is 
characterized by an insidious onset of progressive decline in cognition 
associated with the accumulation of amyloid plaques and neurofibrillary tangles 
throughout the cortex. Mild cognitive impairment (MCI), particularly the amnestic 
form, is thought to be a precursor to AD and is characterized by the same 
pathology, though in lesser amounts. The accumulation of neurofibrillary tangles 
in the cortex has been associated with neuronal loss and atrophy (G6mez-lsla et 
al. 1997; Grignon et al. 1998). This atrophy can be visualized using MRI 
measures, such as cortical thickness. 
With MRI, two boundaries can be identified that are critical for calculating 
cortical thickness: the gray matter-pial surface and the gray/white matter 
boundary. The accurate identification of both these boundaries is critical for 
calculating cortical thickness (Bruce Fischl & Anders M. Dale 2000). Alterations 
in the brain due to processes such as aging or disease may impact the MRI 
signal, such that the gray/white matter boundary becomes blurred . Indeed, age-
(D H Salat et al. 2009; Westlye et al. 2009) and AD-related (Grydeland et al. 
2012; D H Salat et al. 2011; Westlye et al. 2009) changes in gray/white matter 
intensity ratio (GWIR)s have been observed. Adjusting cortical thickness values 
for the age-related gray/white matter intensity changes may improve the ability to 
observe age-related cortical thickness changes (D H Salat et al. 2009). Similarly 
adjusting for changes in the GWIR in AD may add to the ability to differentiate 
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between normal aging and AD subjects (Grydeland et al. 2012); however, this 
has yet to be tested in an independent sample in subjects diagnosed with MCI 
and AD. 
The main goal of this study is to examine the effects of GWIR on cortical 
thickness in normal aging , MCI, and AD subjects using data from the Alzheimer's 
Disease Neuroimaging Initiative (ADNI). Specifically, we tested the following 
hypotheses: 1) GWIR correlates positively with age in normal aging subjects, 2) 
GWIR decreases progressively between normal aging, MCI , and AD subject 
groups, 3) adjusting cortical thickness measurements for GWIR improves the 
ability to differentiate between normal aging , MCI, and AD subjects using 
statistical models, and 4) the effect size of cortical thickness increases after 
adjusting for GWIR. 
METHODS 
Subjects 
The data for use in this study were obtained from the Alzheimer's Disease 
Neuroimaging Initiative. Data were screened to include all subjects who had both 
PET and MRI scans available for use on the ADNI/LONI website at the time this 
study began because this project evolved off of a larger project looking at both 
PET and MRI. Demographic information can be found in Table 3.1. 
As part of the ADNI, all subjects completed a battery of 
neuropsychological tests. On the basis of their cognitive status the subjects were 
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classified by the ADNI clinical core as: (a) normal controls with normal cognition 
and memory, (b) amnestic MCI with memory complaint verified by a study 
partner, or (c) probable AD with memory complaint validated by an informant. 
Alzheimer's Disease Neuroimaging Initiative 
The ADNI was a 5-year non-randomized natural history non-treatment 
study utilizing data from multiple study centers across the United States and 
Canada. One of the main goals of the ADNI was to develop optimized methods 
and uniform standards for the acquisition of multicenter MRI and PET data on 
normal control subjects and patients with MCI and AD in drug/treatment trials. 
For more information about the ADNI please refer to http://www.adni-info.org. 
MRI acquisition and analysi!» 
For this study, we analyzed the baseline T1-weighted MPRAGE MRI 
scans from those acquired by the ADNI on 1.5T scanners from General Electric, 
Philips Medical Systems, and Siemens Medical Solutions. Specific pulse 
sequence guidelines can be found at 
http://www.loni.ucla.edu/ADNI!Research/Cores/index.shtml. All MRI scans were 
processed with the Freesurfer 5.1.0 (Dale A.M. et al. 1999; B. Fischl et al. 1999), 
which is documented and freely available. The processing pipeline has been 
described in detail elsewhere (Dale A.M . et al. 1999; B. Fischl et al. 1999; Bruce 
Fischl et al. 2002; Bruce Fischl, Andre van der Kouwe, et al. 2004; Bruce Fischl, 
David H Salat, et al. 2004; Bruce Fischl & Anders M. Dale 2000). Briefly, for each 
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subject, the 2 DICOM T1-weighted MRI datasets were motion corrected, 
averaged, segmented into gray matter, white matter, and cerebr.al spinal fluid, 
and intensity normalized. As outlined in Salat (D H Salat et al. 2009), gray matter 
tissue intensities were measured 35% through the thickness of the cortical 
ribbon. White matter tissue intensities were measured 1 mm below the gray/white 
matter boundary, into the white matter. The GWIR was calculated by dividing the 
white matter by the gray matter intensity values. The ratios were then projected 
onto the cortical surface and smoothed with a Gaussian kernel with a full width at 
half maximum of 30mm. The cortex was parcellated into ROis based on gyral 
and sulcal structure using the Desikan/Killiany atlas (Desikan et al. 2006) . 
Cortical thickness and GWIR were calculated for each of the 68 cortical 
parcellations. 
Statistical Analysis 
Equality of the male-female distribution in the three diagnostic groups was 
examined with x2 tests. Age, education, and MMSE distributions in the three 
diagnostic groups were examined with ANOVA. 
Residuals were used to adjust for GWIR on cortical thickness values 
within each parcellated brain region . Paired t-tests showed significant left/right 
differences, thus the data from the two hemispheres were not averaged. 
To examine whether adjusting cortical thickness for GWIR improved 
predictability we created logistic stepwise regression models. To identify the most 
salient brain regions for differentiating our three subject groups, each cortical 
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thickness (adjusted and non-adjusted) variable and each GWIR variable was 
entered into a separate logistic regression. The variables with a point estimate 
below 0.75 or above 1.25 cutoff values were entered into stepwise logistic 
regressions to differentiate AD vs. normal aging, MCI vs. normal aging, AD vs. 
MCI, and all three groups. Age, gender, and education were forced into the 
models, effectively controlling for any influence they may have on the variables 
on interest. The entry and exit criteria for the stepwise models were based on a 
significance level of 0.20. The c-statistic for each model was used to compare 
goodness-of-fit between models. C-statistics of the raw and GWIR adjusted 
models were compared using the Delong test (E. R. Delong et al. 1988). The 
efficacy of the adjustment factor was examined based on changes in the c-
statistic of the final logistic regression model. 
The estimated effect sizes of the adjustment factor on cortical thickness 
were calculated, whereby F-ratio = (F-adjusted thickness/F-non-adjusted 
thicknessf Pearson correlation was used to examine the relationship between 
aging and GWIR and the relationship between raw cortical thickness and GWIR 
adjusted cortical thickness values. 
RESULTS 
Chi-square tests revealed no significant differences for distribution of 
males and females between groups (df=2, p=0.35). Age was not significantly 
different between control, MCI, and AD groups, as indicated by ANOVA (p=0.52). 
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The AD subject group had on average a year less education than normal and AD 
groups (p < 0.05). MMSE also showed significant decreases in both the MCI and 
AD subject groups (p < 0.05) (Table 3.1). 
Age-related changes in GWIR: 
We examined the correlations between age and GWIR and found only two 
regions that were significantly correlated : left pars orbitalis (r = 0.1 0, p = 0.04) 
and the right temporal pole (r = 0.14, p = 0.004). We did not correct for multiple 
comparisons, but it is not likely that the left pars orbitalis would remain significant 
after adjusting for multiple correlations. None of the other regions showed 
significant age-related changes (p > 0.05) (Data not shown). 
Gray/white intensity ratio does not differ between diagnostic groups: 
Differences in GWIR between normal aging, MCI, and AD for each of the 
cortical brain regions was examined using ANOVA followed by Tukey's honestly 
significant difference test. None of the brain regions showed significant 
differences in GWIR between any of the groups (p > 0.05) (Data not shown). 
Gray/white matter intensity ratio is not effective at discriminating between 
normal aging, MCI, and AD 
The ability of GWIR to discriminate between normal aging, MCI, and AD 
was examined with stepwise logistic regression. None of the cortical regions 
tested made the initial cutoff for comparing AD vs. MCI or for comparing all three 
groups. Three regions made the initial cutoff for comparing MCI vs. normal aging 
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and one region made the initial cutoff for AD vs. normal aging. The final model for 
MCI vs. normal aging had a c-statistic of 0.601 and aside from age, gender, and 
education, included only the right lateral orbitofrontal gyrus. The final model for 
AD vs. normal aging had a c-statistic of 0.638 and included only the right 
parahippocampal gyrus (Data not shown). 
Improved discrimination of diagnostic groups after adjusting cortical 
thickness for gray/white intensity ratio 
We examined if adjusting for GWIR could increase the ability of cortical 
thickness to differentiate between the three diagnostic groups. Small differences 
in the c-statistic after adjusting for GWIR were observed. After adjustment, the c-
statistic increased across all diagnostic groupings except for AD vs. normal 
aging , in which the c-statistic decreased. None of the changes in c-statistic 
reached statistical significance. For differentiating between normal aging and AD, 
cortical thickness provided a c-statistic of 0.978 (confidence interval = 0.963, 
0.993) and GWIR adjusted cortical thickness provided a c-statistic of 0.965 
(confidence interval = 0.945, 0.986) (Tables 3.2a, 3.2b) . The difference between 
the c-statistics was not statistically significant (p = 0.1 0). The cortical thickness 
models before and after adjustment for differentiating MCI vs . normal aging 
provided c-statistics of 0.796 (confidence interval = 0.739, 0.839) and 0.810 
(confidence interval = 0.747, 0.846), respectively (Tables 3.3a, 3.3b) . The 
difference between the c-statistics was not statistically significant (p = 0.39) . The 
models for differentiating AD vs. MCI before and after adjustment provided c 
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statistics of 0.834 (confidence interval = 0.778, 0.873) and 0.837 (confidence 
interval = 0.784, 0.878), respectively (Tables 3.4a, 3.4b). The difference between 
the c-statistics was not statistically significant (p = 0.40). The non-adjusted and 
adjusted cortical thickness models for differentiating between all three groups 
provided c statistics of 0.829 and 0.830, respectively (Tables 3.5a, 3.5b). 
Because the outcome variable had three levels, the c-statistics could not be 
directly compared. These results indicate that although the GWIR on its own 
does not show diagnostic changes, adjusting for GWIR slightly improves 
discriminability between most diagnostic groups. 
Effects of adjusting cortical thickness for GWIR: 
We next examined the relationship between groups in cortical thickness 
before and after GWIR adjustment. After adjusting the cortical thickness 
measures for GWIR, the difference between diagnostic groups changed in only 
six regions, namely the left isthmus of the cingulate, left pericalcarine, left 
postcentral, right pericalcarine, right postcentral, and right posterior cingulate 
(Tables 3.6a and 3.6b). The squared F-raties indicate that there was an increase 
in power in of 34 of 68 regions throughout the frontal, temporal and cingulate 
cortices after adjusting cortical thickness for GWIR, as indicated by F-ratios 
greater than 1 (Table 3.2a and 3.2b). The highest effects were observed in the 
left posterior cingulate (F-ratio = 1.59), left temporal pole (F = 1.16), left 
pericalcarine (F-ratio = 6.24), right cuneus (F-ratio = 1.13), right insula (F-ratio = 
1.12), and the right pericalcarine (F-ratio = 42.76). Correlations between adjusted 
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and unadjusted cortical thickness measures were significant in all regions (r > 
0.99, p < 0.0001) (data not shown). 
DISCUSSION 
Recent studies indicate that there is an age-related change in the 
gray/white matter intensity ratio, which changes disproportionately in Alzheimer's 
subjects (D H Salat et al. 2009; D.H . Salat et al. 2011; Westlye et al. 2009). The 
Alzheimer's-related changes have only been tested in one sample thus far. We 
expanded these studies by applying them to the ADNI sample and including MCI 
subjects. By including MCI subjects we apply the results to a wider spectrum of 
the disease progression. 
Age-associated changes in GWIR 
In this study we found isolated positive correlations with age only in the left 
pars orbitalis and the right temporal pole. This indicates an increase in GWIR 
with age and a reduction in tissue contrast in these regions with increasing age. 
Previous studies have indicated a widespread reduction in gray/white matter 
contrast with age (D H Salat et al. 2009; Westlye et al. 2009); however, the age 
range in both of these other studies was larger, encompassing more young 
subjects than are included in the ADNI dataset. It is plausible that the limited age-
related changes we observed may have been a product of the age range 
included in our study. 
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GWIR in MCI and AD 
The GWIR did not differ between normal aging, MCI, and AD in any of the 
cortical brain regions. This was rather surprising as we were expecting to 
observe increases in the ratio in temporal regions, as has previously been 
observed (D.H. Salat et al. 2011). While it is not entirely clear why this 
discrepancy exists, there are a number of factors that will need further 
investigation in future studies. These include differences in the scanners used, 
differences in pulse sequenoe, and differences in subject sampling. The data 
analyzed in this study was drawn from General Electric, Philips and Siemens 
1.5T scanners located at multiple research sites, rather than the one scanner and 
site used in previous works (D .H. Salat et al. 2011; D H Salat et al. 2009). Also, 
since the ADNI worked to develop pulse sequence parameters that could be 
used to produce equivalent T1 weighted images at all sites (Jack Jr. et al. 2008) 
it should come as no surprise that the OASIS and ADNI study sequences differ in 
a number of ways which could impact the signal obtained from the different 
tissue types. Our finding of no significant differences in GWIR between normal 
aging, MCI, and AD suggest that for th is measurement to be a good candidate 
biomarker for MCI or AD, MRI sequence optimalization would need to take place 
to ensure differences can be found in the marker in the dataset of interest. 
GWIR is not able to differentiate between normal aging, MCI, and AD 
Stepwise logistic models for differentiating between normal aging, MCI, 
and AD using only the GWIR values did not provide good indices of 
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discrimination. This provides further evidence that although gray/white matter 
intensity has previously been shown to differ between AD and normal aging 
(Westlye et al. 2009), it cannot differentiate between these two groups 
meaningfully as an independent measure in the ADNI dataset. 
Adjusting cortical thickness for GWIR increased the ability to differentiate 
between normal aging, MCI, and AD 
We examined if adjusting cortical thickness for GWIR increased the 
overall ability to differentiate between normal aging, MCI, and AD. We observed 
that in nearly all cases, with the exception of AD vs. normal aging, the c-statistic 
increased after adjustment, albeit not significantly, indicating that adjusting 
cortical thickness for GWIR can improve the ability to predict MCI and AD. In 
general the finding of improved discrimination is in agreement with the results 
found in a recent study in which GWIR was added to a logistic regression model 
predicting disease group (Grydeland et al. 2012). 
It appears that our results, obtained with data from ADNI, differ in a 
number of ways from those obtained from studies using OASIS data. First, we 
did not observe widespread age-related correlations, as was found in Salat's 
study (D H Salat et al. 2009). Second, we did not observe significant changes in 
GWIR between normal aging, MCI, and AD. This is contrary to the results found 
by Salat and Westyle (D H Salat et al. 2009; D.H. Salat et al. 2011; Westlye et al. 
2009). Third, we did not find as widespread increase in power in cortical 
thickness after adjusting for GWIR as Westyle did (Westlye et al. 2009). And 
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finally, we did not find the same increase in predictability of AD compared to 
normal aging after adjustment as Grydeland found (Grydeland et al. 2012). This 
suggests that when using GWIR in MCI and AD subjects, it must be done with 
caution , as results have yet to be consistently obtained across samples that use 
different parameters for acquiring T1-weighted MPRAGE scans. 
Effects of GWIR adjustment on cortical thickness 
Although there were no significant differences in GWIR between the 
normal aging , MCI , and AD groups, we did observe an increase in effect size 
based on the square ratios of the F-values after adjustment, although these did 
not reach statistical significance. In addition , we observed more pronounced 
cortical thickness changes in the AD group in a few regions. The majority of 
these regions have not typically been reported to be impacted by disease 
pathology in the early stages of the disease. Less pronounced AD-related 
differences in cortical thickness were also observed throughout the cortex. Taken 
together, this suggests that adjusting for GWIR does influence the cortical 
thickness measurements to some degree, which is in agreement with a previous 
study that found an increase in power after adjusting cortical thickness for 
intensity ratio when comparing AD to normal aging (Westlye et al. 2009). We 
have extended these findings to include MCI, indicating that adjusting cortical 
thickness for GWIR may increase the effect sizes between MCI and normal aging 
or AD groups. Further work needs to be done to better understand if this 
adjustment factor is truly working to remove a disease-related artifact or if the 
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process of adjusting the data is simply reducing the variance in the data with a 
mathematical function. 
CONCLUSIONS 
Overall our results provide weak support for adjusting cortical thickness for 
gray/white intensity ratio based on improvements in c-statistics for differentiating 
normal aging, MCI, and AD. We were unable to use GWIR as an independent 
predictor of MCI or AD as it was not able to differentiate between subject groups, 
nor did it show any significant differences between normal aging, MCI, or AD 
throughout the cortex. 
Cortical thickness is becoming an important biomarker for potentially 
identifying those at risk for, or in the earliest stages of, Alzheimer's disease. For 
this tool to become optimized, it is critical that sources of errant variance in this 
measure be identified and removed. However, the present study reminds us that 
it is vital to confirm that the errant source of variance is actually present in the 
data before trying to remove it. This will become more important as imaging 
studies embrace higher field strengths and more sophisticated coils. 
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Table 3.1 Demographic information 
Subjects Age mean Education MMSE 
(male/female) years (std Mean (std dev) 
dev) 
Normal 105 (64/41) 75.81 (4.75) 15.90(3.12) 28.98 (1.12) 
Aging 
MCI 204 (137/67) 75.44 (7.22) 15.80 (2.88) 27.15 (1 .71)a 
AD 94 (56/38) 74.91 (7.37) 14.61 (3.21)a,o 23.48 
(2.14)a,b 
a significant difference from normal aging (p < 0.05) , 0 significant difference 
from MCI (p < 0.05). 
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Table 3.2a Cortical thickness model for predicting AD vs. normal 
aging. The c-statistic indicates the ability of the model to discriminate 
between the subject groups. Point estimates with 95% confidence 
intervals are presented. STS = superior temporal sulcus. 
A9~ ­
Gender 
Education 
-·-·-·-
Rig_tlt ~O!_ltal p9le 
Left rostral middle frontal 
·- -Left medial orbitofrontal 
Left ~~~-t_ri~_~gl!laris 
Le~ superior frontal 
R!g~t caudal anteri~>r cingulatE!_ 
Left lllid~le ten:tporal 
Left banks STS 
-
RJght entorhinal 
L~ft parahippocampus 
Right ~uperior parietal 
R~ght precuneus 
Rig~t ~uneus 
Right lingual 
Left insula 
c= 0.978 
unit ; Point Estimate (C.I) 
6.11 ' . ..9:.?.?J 0.09 - Q. 7_2) 
1.0_9 .?. .. 6~JQ.59 ~ 1 ~. !6) 
-~.22 0_:40 (Q.21 - 0.7~) 
0.28 I _ ! .82_ (9_·~~ -3. 72) 
0.19 Q.O~ (Q.O_? - 0.~9) 
.9·? ~- .9..:. ~_1! (!!:05- 0~59) 
0.20 2.~~ (Q.8?- 8.33) 
p-value 
0.01 
0.2 
0.007 
0.1 
0.005 
0.005 
0.09 
0.?1 ~0:.9~ (9.7_9- 852.65) <.0001 
f 
0.29 4. 1~(1 .. ~9-1_9.9~) 0.004 
0.26 ' 
_9.Q2 ~Q._902- 0.15) 0.0003 
·-
0.25 0.4:_3 (0.15 - 1.25) 0.12 
0 .5_~ : O.Of (O.QO? - 0.11) <.0001 
0.39 0.13 (0.04 - 0.46) 0.001 
0.20 ; 4.48 (1.00- 20.05) 0.05 
0.19 0:95 .(!).0_07- 0.31) 0.002 
0.14 0.~5 (Q.19- 1.10) 0.08 
-
0.13 2.39 (0.88- 6.51) 0.09 
0.23 3.7_9 (1.~0- 10 .5~) 0.01 
-- -·-
-
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Table 3.2b GWIR-corrected cortical thickness models for predicting 
AD vs. normal aging. The c-statistics indicate the ability of the model 
to discriminate between the subject groups. Point estimates with 95% 
confidence intervals are presented. STS =superior temporal sulcus. 
unit 1 Point Estimate {C.I) p-value 
Age 6.11 0.84 (0.41 - 1.69) 0.62 
Gender 1.00 9·7~ ~~.22 ~ ?.56) 0.65 
-
Education 3.22 0.36 (0.19 - 0.66) 0.001 
Left rostral middle frontal 0.19 0.16 (0.05 - 0.49) 0.001 
Left pars opercularis 0.20 ~.6 (1.02 - 6.65) 0.05 
Left precentral gyrus 0.23 4.86 (1.87- 12.63) 0.001 
Left posterior cingulate 0.20 2.64 (1 .08 ~ 6.45) 0.03 
Left middle temporal 0.26 0.23 (0.06 - 0.83) 0.03 
Left infe~~r te"!poral 0.26 0.38 (0.12 -1.21) 0.1 
Left te~poral ~ole 0.43 · 1.75 (0_.77 - 3.99) 0.18 
Left banks STS 0.25 q.30 (0.11 - 0. ?9) 0.01 
-
Right entorhinal 0.55 0.15 (0.06 - 0.36) <.0001 
Left parahippo~mpus 0.39 0.2? .(0.1_9 - 0.47) <.0001 
Right precuneus 0.19 ; 0.3~ (0.1 4- 0.80) 0.01 
Left insula 0.23 2.58 (1.12 - 5.95)_ 0.03 
-
-
c = 0.965 
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Table 3.3a Cortical thickness model for predicting MCI vs. normal 
aging. The c-statistic indicates the ability of the model to discriminate 
between the subject groups. Point estimates with 95% confidence 
intervals are presented. 
unit I Point Estimate (C.I) p-value 
Age 6.49 . 0.§~ (0.4~ - 0. 78) 0.0004 
Gender 1.00 . 1. 7~(0 .. ~~ - 3.18) 0.06 
Education 2.96 0_:8_§ {0_:_6~- 1.13) 0.28 
-
... 
-
Left rostral middle frontal 0.17 0.69 _(0.~~ - 1.15) 0.15 
Left caudal middle frontal 0.21 0.~4 (0.39 - 1.07) 0.09 
-
Left medial orbitofrontal 0.21 0.77 (0.55 -1.06) 0.11 
-
Left superior frontal 0.20 2.11_ (1.1~- 3.76) 0.01 
L~ft middle t~mp~~al 0.22 0.39 (0.23- 0.64) 0.0002 
Right ento~!_linal 0.49 0.~ (0.~8 - 0. 78) 0.0008 
Left parahippocampus 0.38 · 0.70 (0.52- 0.94) 0.02 
Left inferior parietal 0.19 1.~7 (1.11- 3.16) 0.02 
Right fu~iform 0.21 1.51 (1.02- 2.24) 0.04 
Right precuneus 0.17 0.67 (0.42 - 1.06) 0.09 
c = 0.791 ' 
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Table 3.3b GWIR-corrected cortical thickness models for predicting 
MCI vs. normal aging. The c-statistics indicate the ability of the model 
to discriminate between the subject groups. Point estimates with 95% 
confidence intervals are presented. STS = superior temporal sulcus. 
unit Point Estimate (C.I) p.value 
Age 6.50 0.~~ (0.45 - 0.83) 0.001 
Gender 1.00 1 .5~ (0.~_§ - 2.88) 0.14 
Education 2.96 0.88 (0.66_- 1.17) 0.38 
Left rostral middle frontal 0.17 0.6_2 (0.~7- 1.05) 0.08 
-
Left caudal middle frontal 0.21 0.57 <9·34- 0.95) 0.03 
- -
Left medial orbitofrontal 0.21 0.7_5 (9.54- 1.04) 0.09 
Left pars opercularis 0.20 1.54 (1.00- 2.36) 0.05 
Left superior frontal 0.20 2.16(1.20-3.89) 0.01 
Left middle teml?<?ral 0.22 0.37 (~.22 - 0.63) 0.0002 
Right banks STS 0.22 0} 8 (0.54 - 1.13) 0.19 
Right entorhinal 0.49 0.60 (0.-42 - 0.86) 0.006 
Left parahippocampus 0.38 0.70 (0.51 - 0.95) 0.02 
Left inferior parietal 0.19 2.15 (1.25- 3.70) 0.006 
Right fusiform 0.21 1.40 (0.92 - 2.12) 0.12 
Right precuneus 0.17 _0:6_~ (O.i O- 1.03) 0.07 
c= 0.797 
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Table 3.4a Cortical thickness model for predicting AD vs. MCI. The c-
statistic indicates the ability of the model to discriminate between the 
subject groups. Point estimates with 95% confidence intervals are 
presented. STS = superior temporal sulcus. 
unit 1 Point Estimate (C. I) • p-value 
Age 7.26 : 
- -
0.:~~ (Q:60 - 1.16) 0.28 
Gender 1.00 .9.·I~JQ .. ~.9 -1 .~~) 0.0004 
---
···~~ --
Education 3.03 0.57 (0 :.~2 - 0. 78) 0.37 
Left isthmus of the cingulate 0.26 0.53 _(0.~- 0.82) 0.005 
Left ~~te_ri~r Eingulate 0.19 1.47 (!>.~6 :-~-2.~) - 0.08 
·- ·~ 
~~ft il)!erio_r: t~m~ral 0.24 0.41 (Q..26 - 0._66 0.0003 
~eft temp~ral p~_le 0.44 . 1.?~ (1.0~ - ~- ~_5) 0.04 
Rig~t ban~s _ST~ 0.23 -· Q.61.JQ.~1 - Q .~2)_ 0.02 
.. 
-l3ig_~t entorhinal 0.54 Q-~~(0.3~ - Q_._71) 0.0001 
Left parahipp~~mpus 0.39 . Q.78 (0..:~?- 1.11) 0.17 
Right supramarginal 0.20 1.~~ (0.8_9 - 2.15) 0.15 
-
Left insula 0.22 1.~8 (Q.92 - 1.07) 0.12 
-
-
c= 0.822 
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Table 3.4b GWIR-corrected cortical thickness models for predicting 
AD vs. MCI. The c-statistics indicate the ability of the model to 
discriminate between tile subject groups. Point estimates with 95% 
confidence intervals are presented. STS =superior temporal sulcus. 
unit , Point Estimate (C.I) p-value 
Age 7.27 0.8?(Q.~~-1.14) _ 0.23 
-
Gender 1.00 · 
-0.~~ <0.·¥- 1.~0- . 0.6 
Education 3.04 _9.5~ (0.40 - 9· 76) . 0.0002 
..- ----. 
Left isthmus of t~e ci!]9.ulate 0.26 0.~~ (0.31 - 0.76) 0.002 
-· 
L~ft ~st~or c~gulate 0.19 1 :?~ (1.09- ~.39) 0.05 
Right middle temporal 0.23 0.59 (0.34- 1.03) 0.07 
Le_ft inferior temporal 0.24 0.~~ (0._27 - 0. 72) 0.001 
Left temporal pole 0.43 1.5? (1._01 - 2.28) 0.04 
R_!ght banks STS 0.23 · 0.6~ _(0.45 -1.07) 0.09 
Ri_ght entorhinal 0.53 Q.50 (0.33 - 0. 75) 0.001 
Left parahippocampus 0.39 0.7'_~ (9.5?- 1.06) 0.1 
Right supramarginal 0.20 1.38 (0.85- 2.24) 0.2 
Right fusiform 0.22 1_.5~ (0.94- ?·~7) 0.09 
----
Left insula 0.22 1.~2 (0.~~ - 2. ~_5) 0.09 
--
c= 0.831 i 
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Table 3.5a Cortical thickness model for predicting all three groups. 
The c-statistic indicates the ability of the model to discriminate 
between the subject groups. Point estimates with 95% confidence 
intervals are presented. STS = superior temporal sulcus. 
unit 1 Point Estimate (C.I) p-value 
Age 6.70 
-
0.67 (0._5_3- q_.84) 0.0005 
Gender 1.00 . 1_.~9 (0:.~8 - ?..21) 0.16 
-- --
Education 3.06 0:§5 (0:52- 0.81) <.0001 
Left rostral middle frontal 0.18 .9..:_60 (0.4_9 : Q.8_9) 0.01 
-· -· 0.22 ' Left caudal middle frontal 0.7_5 (~._5_9- 1.14) 0.18 
Left medial orbitofrontal 0.21 0.75 (0:57- 0.9~) 0.03 
Left pars opercularis 0.20 1.45 ( 1.04 - 2.03) 0.03 
Left ~ars ~rbitalis 0.28 1.?.~ <9-~_?.- 1.64) 0.16 
Left superior frontal 0.20 1.61 (1.03-2.53) 0.04 
Right Isthmus of the cingulate 0.26 ~ .24 (0.95- ! .63) 0.12 
Left middle temporal 0.24 0.5?. (9.=!_4 - 0. 79) 0.003 
Left inf~rior temporal 0.24 0:53 (0.35- 0.81) 0.003 
~eft temporal pole 0.42 1: 37 ( 1._02 - 1 . 8~) 0.04 
Righ! bank~ STS 0.23 ' 0,70 (0:53- 0.94) 0.02 
Right entorhinal 0.53 0.46 (0.35 - 0.62) <.0001 
Left par~hippocampal 0.39 0.64 (0.51 - 0.82) 0.0004 
Left s~perior parietal 0.20 1.52 (~ .01 - ?.30) 0.05 
Ri_gh~ fi:Jsifor~ 0.22 1.42 (1.02 -1.9~) 0.04 
Right precuneus 0.18 0.55 (0.38 - 0.80) 0.002 
Left_ la.teral_ occipital 0.16 1.2} (0.9~- - 1. 78) 0.16 
Left insula 0.22 , 1.30 (0.~6 - 1. 7~) 0.09 
c= 0.829 
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Table 3.5b GWIR-corrected cortical thickness models for predicting 
all three groups. The c-statistics indicate the ability of the model to 
discriminate between the subject groups. Point estimates with 95% 
confidence intervals are presented. STS = superior temporal sulcus. 
Age 
Gender 
Education 
Left rostral middle frontal 
Right ~-~~-al ~i~d!e f!._ontal 
Left medial orbitofrontal 
L! ft pars oper~ularis 
f3lght pars orp i~l!s 
!:.~~~~p_erior tJ:.o~~ 
~ght isthmus _£>f the cingulate 
Left mi~dle_te.!!_lp'!_~l 
Le~ inf_!rior tempor~l 
Left t~mporal pole 
f3ight ~~nks -~T~ 
~i9_ht entorhi!l<!!_ 
Left pa~hipp_o~mpal 
Rig~t superior parietal 
Right inferior pari~tal 
Right fu~iform 
Rig~t pr~cun~l!S 
L~ft lateral occipital 
Left insula 
c= 0.830 
unit 
6.70 
1.00 
3.06 
0.18 
0.22 
0.21 
0.20 
0.27 
0.20 
0.26 
0.24 
0.24 
0.42 
0.23 
0.53 1 
0.39 · 
0.20 
0.21 
0.22 
0.18 
0.16 
0.22 
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Point Estimate (C.I) 
0.71 (0.56- 0.89) 
_!.29 _(0.82 - 2.06) 
0.:._6~ (0.5_2- ~81) 
0.6~ (0.40 - 0.88) 
~]'~(0.~0-1.94) 
_0.75 (0.57- 0.98) 
1 .~3 ( 1.1 Q - 2.12) 
1_.3q (0.9~ - 1. 73) 
) ._5! (1.00- 2.45) 
1.30 (0.~9 - 1. 70) 
0.5~(0.~? - 0.~~) 
0.~~(9;~7 - 0.8~J 
! .31 (0~~-1 .76) 
0.74 i0-?4- ~ .00) 
.i>-~_7 (9.35 - 0.6_3)_ 
..Q.:68 (0.53 :- 0.86) 
_2~0 (1 .~0- 3.46) 
_Q.68 (0.:42- 1.11) 
1.30 <9 ·9~ - 1.82) 
0__.5_~ _(Q:~ - 0. ?6) 
1.32 (0.95 - 1.83) 
~ .29 (0.96 - 1. 75) 
p-value 
0.003 
0.27 
0.0001 
0.01 
0.08 
0.03 
0.01 
0.07 
0.05 
0.06 
0.008 
0.006 
0.07 
0.05 
<.0001 
0.002 
0.0006 
0.12 
0.13 
0.001 
0.10 
0.09 
Table 3.6a Results from ANOVA and Tukey's post-hoc analysis for differences in cortical thickness in 
the left hemisphere before and after GWIR correction in normal aging, MCI, and AD subject groups. 
The change in effect size after correctio is reflected in the F-ratio, whereby a value greater than 1 
indicates an increased effect size. Degrees of freedom for each ANOVA is 2. For Tukey's columns, the 
letters represent the groupings for normal aging, MCI, and AD, respectively. 
Cortical region 
Left hemisphere 
Fr~ntal eo~e 
Rostral middle frontal 
-- - - - --Caudal middle frontal 
I atercii cibitofrOntcif-
Medial orbitofrontal 
~rs ~rcularis 
Pars orbitalis 
Pars trian~u~a~~ 
Supef!or frontal 
Precentral 
Postcentral 
Paracentral 
Rostral anl_!rior cingu._la!~ 
Cauda_! a_r:lt~rio~ c_ing~ate 
lsthmu~ o! the cir:_l_Q~Iate 
Posterior ~ingul~~e 
S~perior ~emporal 
Middl~ tempo!~l 
ln!erior ter_nporal 
Tell_lp_oral ~~~ _ 
Tral)sverse temporal 
Banks sts 
Entorhinal 
~a~hippocampu~ 
Su~rior pa~etal 
Inferior parietal 
Supramargil!~l 
Fusiform 
Precuneus 
Cuneus 
Pericalcarine 
-- -Lateral occipital 
L!_~gual 
Insula 
Cortical Thickness 
r-
GWIR Corrected Cortical 
Thickness 
r-
square F P Tukey square F P Tukey F-ratio 
0.03 5.25 
0.11 
0.08 
0.06 
0.08 
0.03 
0.03 
0.06 
0.06 
0.03 
0.05 
0.01 
0.03 
0.004 
0.09 
0.04 
0.11 
0.18 
0.18 
0.06 
0.02 
0.11 
0.14 
0.08 
0.03 
0.10 
0.09 
0.13 
0.07 
0.004 
0.01 
0.04 
0.05 
0.05 
25.2 
16.8 
12.4 
16.9 
6.28 
5.96 
12.3 
13.8 
6.75 
9.7 
1.n 
6.24 
0.8 
18.7 
7.28 
24.6 
42.4 
44.7 
111.8 
4.75 
24.1 
33 
H .2 
6.57 
21 .3 
19.5 
29.8 
15.4 
0.71 
2.91 
7.74 
10.5 
9.n 
<.0001 
<.0001 
<.0001 
<.0001 
0.002 
0.003 
<.0001 
<.0001 
0.001 
~~!>~~ 
a,a,b 
- a~!~ 
~·!!_~?..~ 
a,ab,b 
a,b,b 
~.~.c 
a,ab,b 
<.0001 a,a,b 
.. 
0.17 a,a,a 
0.00~ a,ab~b 
q.~ ~~~ 
<.0001 a! b·~ 
O.QO_q~ ~ab,b 
<.0001 
<.0001 
<.0001 
a,b,c 
a,b.~ 
~.b,c 
<.0001 .. a,b,c 
0.009 a,ab,b 
<.0001 a,b,c 
<.0001 a,b,c 
<.0001 a.~.c 
0.002 a,ab.~ 
<.0001 a,b,c 
<.0001 '!l·b·~ 
-:.OOQ1 a,b,c 
<.0001 a,b,c 
0.49 a,a,a 
0.06 a,ab,b 
0.0005 a,a,b 
-
<.0001 a,a,b 
<.0001 a,a,b 
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0.11 25.14 
0.08 16.75 
0.06 12.48 
0.08 16.86 
0.03 6.30 
0.03 6.10 
-- - --0.06 12.20 
0.06 13.75 
0.03 6.49 
0.04 9.17 
0.01 1.74 
0.03 6.02 
0.004 0.79 
-----0.09 19.06 
0.04 7.27 
0.1 1 24.66 
0.18 42.43 
0.18 44.61 
-0.06 12.70 
0.02 4.80 
0.11 23.84 
0.14 33.46 
.. - . 
0.08 17.03 
0.03 6.43 
0.10 21.37 
--
0.09 19.51 
0.13 29.79 
--0.07 15.29 
0.003 0.54 
0.01 2.72 
0.04 7.43 
0.05 10.12 
0.05 9.58 
0.005 a,ab,b 1.03 
<.0001 a,b,c 0.99 
<.0001 a,b,c 0.99 
<.0001 
<.0001 
0.002 
0.003 
<.0001 
<.0001 
0.0017 
0.0001 
0.18 
0.003 
0.45 
<.0001 
0.0008 
<.0001 
<.0001 
<.0001 
a,a,b 
a,b,c 
a,ab,b 
a,ab,b 
a,b,b 
a,b,c 
a,ab,b 
a,a,b 
a,a,a 
a,ab,b 
a,a,a 
a,a,b 
a,ab,b 
a,b,c 
a,b,c 
a,b,c 
1.02 
0.99 
1.01 
1.05 
0.98 
0.96 
0.92 
0.08 
0.97 
0.93 
0.98 
1.04 
1.59 
1.00 
1.00 
1.00 
<.0001 a,b,c 1.16 
0.009 a,ab,b 1.02 
<.0001 a,b,c 0.98 
<.0001 a,b,c 1.03 
<.0001 a,b,c 0.98 
0.002 a,ab,b 1.00 
<.0001 a,b,c 1.01 
<.0001 a,b,c 1.00 
<.0001 a,b,c 1.00 
<.0001 a,b,c 0.99 
0.58 a,a,a 0.58 
0.07 a,ab,b 6.24 
0.0007 a,a,b 0.92 
<.0001 a,a,b 0.94 
.-
<.0001 a,a,b 0.96 
Table 3.6b Results from ANOVA and Tukey's post-hoc analysis for differences in cortical thickness in 
the right hemisphere before and afte1r GWIR correction in normal aging, MCI, and AD subject groups. 
The change in effect size after correctio is reflected in the F-ratio, whereby a value greater than 1 
indicates an increased effect size. Degrees of freedom for each AN OVA is 2. For Tukey's columns. the 
letters represent the groupings for normal aging, MCI, and AD, respectively. 
Right hemisphere 
~rontal po~e 0.04 7.26 · 0.0008 ~!b.~ - 0.03 7.15 0.0009 a,b,b 0.97 
----
Rostral middle frontal 0.10 21.3 <.0001 a, b.~ 0.10 21.50 <.0001 a,b,c 1.02 
---- --~- ·- ·-
Caudal middle frontal 0.07 15.8 <.0001 a,b,c 0.08 16.20 <.0001 a,b,c 1.06 
--- ... _ 
- ---Lateral orbitofrontal 0.06 11.6 <.0001 a,a,b 0.06 12.06 <.0001 a,a,b 1.07 
Medial orbitofrontal 0.06 13 <.0001 a,b,c 0.06 13.04 <.0001 a,b,c 1.00 
.. 
- - - -
Pars opercula~s 0.05 10.7 <.0001 ~.~.b 0.05 10.84 <.0001 a,a,b 1.02 
Pars orbitalis 0.04 7.51 0.0006 a,a~.~ 0.04 7.50 0.0006 a,ab,b 1.00 
~ars tri~ngularis 0.04 9.38 0.0001 a,b.~ 0.05 9.57 <.0001 a,b,b 1.04 
Superi~r ~ntal 0.08 18.3 <.0001 _ a,b!~ 0.09 18.87 <.0001 a,b,c 1.06 
---
Precentral 0.02 4.21 0.02 a,ab,b 0.02 4.26 0.01 a,ab,b 1.02 
--
Postcentral 0.02 5.01 0.007 a,ab,b_ 0.02 4.97 0.007 a,ab,b 0.08 
Paracentral 0.02 4.42 0.01 a.~~b 0.02 4.39 0.01 a,ab,b 0.99 
- -
Rostral anterior cing~:~~t~. 0.01 2.39 0.09 a,ab,b 0.01 2.37 0.10 a,ab,b 0.98 
-
Cau~al anterior cingulate 0.01 1.21 0.30 a,a,a 0.01 1.22 0.30 a,a,a 1.02 
-
Isthmus of the cing_~l~te 0.06 12.5 <.0001 a,a,b 0.06 12.68 <.0001 a,a,b 1.04 
Posterior cingulate 0.04 9.04 0.0001 a.?.c 0.04 9.22 0.0001 a,a,b 0.30 
Superior temporal 0.09 20.2 <.0001 a,b,c 0.09 20.55 <.0001 a,b,c 1.03 
Middle temporal 0.15 36 <.0001 a,b,c 0.16 36.54 <.0001 a,b,c 1.03 
Inferior te~poral 0.13 28.9 <.0001 a,b,c 0.13 29.40 <.0001 a,b,c 1.03 
Temporal pole 0.08 18.3 <.0001 a,a,b 0.08 17.81 <.0001 a,a,b 0.95 
-
"Transverse temporal 0.003 0.51 0.60 a.~.a_ 0.003 0.52 0.59 a,a,a 1.04 
Banks sts 0.13 29 <.0001 a,b,c 0.13 28.97 <.0001 a,b,c 1.00 
Entorhinal 0.19 46.8 <.0001 a,b,c 0.1 9 46.38 <.0001 a,b,c 0.98 
Para hippocampus 0.09 19.5 <.0001 a,b,c 0.09 19.19 <.0001 a,b,c 0.97 
Superior parietal 0.02 4.48 0.01 a,ab,b 0.02 4.61 0.01 a,ab,b 1.06 
-
Inferior parietal 0.11 24 <.0001 a,b,c 0.11 23.85 <.0001 a,b,c 0.99 
Supramarginal 0.08 116.9 <.0001 a,b,c 0.08 17.09 <.0001 a,b,c 1.03 
Fusiform 0.10 21.6 <.0001 a,b,c 0.10 22.37 <.0001 a,b,c 1.07 
Precuneus 0.09 118.8 <.0001 a,b,c 0.09 19.02 <.0001 a,b,c 1.02 
Cuneus 0.01 2.26 0.1 1 a,a,a 0.01 2.40 0.09 a,a,a 1.13 
Pericalcarine 0.01 1.41 0.24 a,a,a 0.01 1.39 0.25 a,a,a 42.76 
Lateral occipital 0.05 9.62 <.0001 a,a,b 0.05 9.39 0.0001 a,a,b 0.95 
Lingual 0.04 7.94 0.0004 a,a.~ 0.04 7.85 0.0005 a,a,b 0.98 
Insula 0.05 '10.9 <.0001 a,a,b 0.05 11.49 <.0001 a,a,b 1.12 
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Chapter 4 - Multimodal discrimination between normal aging, 
mild cognitive impairment, and Alzheimer's disease 
74 
INTRODUCTION 
Alzheimer's disease (AD) is the most common form of dementia in our 
society today. It is a disorder that is found across the world and is currently 
affecting approximately 5.4 million Americans. Since age is the best known risk 
factor for AD, the incidence rate of AD is expected to nearly double within the 
next few decades as the American population ages (Anon 2012). The rate of 
development of AD is heightened in individuals with the amnestic form of mild 
cognitive impairment (MCI). Amnestic MCI is characterized by cognitive deficits 
primarily affecting memory, preserved overall cognitive and functional abilities, 
and the absence of a dementia (R. C. Petersen 2001 ). Individuals with MCI 
convert to AD at a rate of about 10 to 15% per year in comparison to 
approximately 1% per year in normal aging (R. C. Petersen 2001), making it 
imperative to generate effective methods for identifying individuals with MCI. This 
can be a challenge because the clinical presentation of MCI is heterogeneous, 
making it difficult to determine at what stage in the normal aging, MCI, AD 
spectrum an individual may be in. There are a number of factors that have been 
discussed as contributing to the differential diagnosis, including performance on 
neuropsychological tests, brain morphometric measurements, brain glucose 
uptake, and concentrations of biomarkers in cerebrospinal fluid (CSF). 
Pathologically, AD and, to a lesser extent, MCI are characterized by the 
presence of intracellular neurofibrillary tangles (NFTs) and extracellular amyloid 
plaques. The NFTs are composed of insoluble hyperphosphorylated tau protein. 
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Normal tau protein, the non-hyperphosphorylated type, is involved in microtubule 
stabilization of the axonal cytoskeleton (Trojanowski et al. 1993). In the presence 
of NFTs, however, the integrity of the cytoskeleton is impaired , such that neurons 
are dysfunctional and there is synaptic and neuronal loss (G6mez-lsla et al. 
1997; Mosconi 2005). In AD and MCI, NFTs accumulate in the locus coeruleus 
(Heiko Braak & Del Tredici 2011a; Heiko Braak & Del Tredici 2011 b) 
hippocampus, entorhinal cortex, amygdala, and other limbic areas that are 
important for memory. As the disease progresses, the NFTs affect more 
neocortical areas, resulting in a deficit in other cognitive domains (H Braak & E. 
Braak 1991; H Braak & E. Braak 1995; Heiko Braak & Del Tredici 2011 a; St 
George-Hyslop 2000). While NFTs have a predilection for medial temporal lobe 
and limbic structures, amyloid plaques tend to accumulate more in the 
association cortices and , as the disease progresses, affect more hippocampal 
structures (H Braak & E. Braak 1991; D. R. Thai et al. 2002). The extent of 
amyloid distribution is related to the severity of impairment on cognition (Hulette 
et al. 1998). Amyloid plaques are extracellular, are composed of insoluble fibrils 
of amyloid-beta (A~) , and may be related to the hypometabolism that is observed 
using FOG PET (Mosconi 2005). The underlying pathology is nearly impossible 
to monitor in vivo, however., using imaging techniques, CSF sampling, and 
neuropsychological testing as biomarkers of the disease, it is possible to monitor 
disease progression. What remains unclear is which individual or combination of 
biomarkers provides the best differentiation between normal aging , MCI , and 
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AD? CSF levels of ABeta '1-42 (AI3-42), total tau, and phosphorylated tau, 
structural brain changes as measured with MRI morphometry, and functional 
brain changes as measured with FOG PET have all been shown to be of some 
value. 
There is evidence that there is free exchange of molecules between the 
brain and the CSF (Reiber & Peter 2001 ), which is the basis for the use for 
molecular analysis of CSF samples for biomarker of MCI and AD. In particular 
there are three major compounds that have been identified as being present in 
the CSF of AD patients, namely total tau (tTau), hyperphosphorylated tau (pTau), 
and Al3-42 (Zetterberg et al. 2003). It has been reported that these markers are 
able to identify AD in its early stages with fairly high accuracy (Hansson et al. 
2006) as increased levels of pTau and tTau have been observed in AD 
compared to normal aging (K Blennow et al. 1995; M. Ewers et al. 2007). CSF 
samples from both MCI and AD subjects shows decreased concentrations of Al3-
42 (M. Ewers et al. 2007), which may reflect an increased deposition of Al3 in 
aggregated plaques in the brain (Cedazo-Minguez & Winblad 201 0). 
One of the consequences of AD pathology is a disruptio~ of synaptic 
function that may be indirectly measured via changes in glucose metabolism. 
FOG PET, a glucose analogue, is typically used as a marker of synaptic function , 
as metabolic changes are closely tied to glucose consumption. There is a 
relatively consistent pattern of decreased metabolism that occurs in AD. The 
regions that tend to show hypometabolism are the posterior 
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cingulate/retrosplenial cortex and the cortical structures in the parieto-temporal 
junction, such as the angular gyrus and precuneus. Some studies also indicate a 
decrease in hippocampal and entorhinal metabolism, although this is not 
consistently observed. There is not a consistent pattern for MCI (Mosconi et al. 
2008). 
As previously mentioned, one of the consequences of AD pathology is 
neuronal loss. This loss is visible in vivo through indirect methods, such as MRI. 
MRI enables researchers to examine the various ways in which atrophy can 
present itself, namely through changes in cortical surface area, thickness, or 
volume, of the cortical structures. Cortical thickness has been shown to be a 
particularly useful metric for tracking disease progression. Volumetric and cortical 
thickness changes have been observed consistently in MCI and AD, with the 
earliest detecTable 4.changes occurring in the entorhinal cortex hippocampus, 
spreading outward to other cortical and subcortical structures (Michael Ewers et 
al. 2011; R J Killiany et al. 2002; P. M. Thompson et al. 2003). 
Ultimately the accumulation of NFTS and Al3, and the resultant changes 
in synaptic function and neuronal loss, manifests as cognitive deficits that are 
quantified through the use of neuropsychological tests. Each test in a typical 
battery is meant to measure performance on different types of cognitive skills 
(e.g. executive function, visuospatial abilities, etc.) or forms of memory (e.g. long-
term memory, recall, recognition). Neuropsychological measures, especially 
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those of memory function tend to readily identify individuals with AD but have 
more variability to them than the other measures discussed. 
Each of the four modalities we discussed above has been implicated to be 
useful for discriminating normal aging, MCI, and AD. Since each of the modalities 
is to an extent independent of the other, it is conceivable that a combination of 
them would provide better discrimination than any individual method on its own. 
In the current study we explored this concept using a data-driven approach. 
Because each of these factors can provide independent information that can 
influence diagnosis as a whole, we also examined if we can increase the ability 
to differentiate groups by combining modalities. 
Thus, the main aims were: 1) to determine the independent value of MRI, 
FOG PET, CSF sampling, and neuropsychological test scores in differentiating 
between normal aging, MCI, and AD groups, and 2) to determine the best 
combination of modalities to differentiate between normal aging, MCI and AD 
groups. 
MATERIALS AND METHODS 
Subjects 
The data for use in this study were chosen from the larger pool of data 
that has been made publically available by the Alzheimer's Disease 
Neuroimaging Initiative. Data was screened to include all subjects who had both 
PET and MRI scans available for use on the ADNI/LONI website 
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(www.loni.ucla.edu/ADNI) at the time this study began. From this screened 
dataset, PET data from 21 subjects was of poor contrast and quality and had to 
be omitted from the analyses undertaken in this study. Three subjects were 
omitted due to missing information . This left us with data from 403 subjects. We 
present demographic information on this sample in Table 4.1. 
As part of the ADN I, all subjects completed a battery of 
neuropsychological tests , On the basis of their cognitive status the subjects were 
classified by the ADNI clinical core as: (a) normal controls with normal cognition 
and memory, Clinical Dementia Rating (CDR) 0, and Mini Mental Status Exam 
(MMSE) between 24-30; (b) amnestic MCI with memory complaint verified by a 
study partner, memory loss measured by education-adjusted performance on the 
Logical Memory II subscale of the Wechsler Memory Scale-Revised (Wechsler 
1987), preserved activities of daily living, CDR 0.5, MMSE between 24 and 30, 
and absence of dementia at time of baseline MRI scan; or (c) probable AD with 
memory complaint validated by an informant, abnormal memory function for age 
and education level, absence of depression, impaired activities of daily living, 
diminished cognition, CDR> 0.5, and MMSE between 20- 26. 
Alzheimer's Disease Neuroimaging Initiative 
The ADNI was a 5-year non-randomized natural history non-treatment 
study utilizing data from multiple study centers across the United States and 
Canada. One of the main goals of the ADNI was to develop optimized methods 
and uniform standards for the acquisition of multicenter MRI and PET data on 
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normal control subjects and patients with MCI and AD in drug/treatment trials. 
For more information about the ADNI please refer to http://www.adni-info.org. 
CSF Sampling 
Detailed CSF collection and processing methods can be found in 
elsewhere (Shaw et al. 2011). Briefly, CSF samples obtained by lumbar puncture 
were examined for tTau. pTau, and Al3-42 using an immunoassay method. These 
measures were performed by the ADNI Biomarker Core at the University of 
Pennsylvania School of Medicine. 
Neuropsychological testing 
For this study we analyzed the cognitive scores from the cognitive and 
neuropsychological tests taken at the first visit. CDR memory, CDR problem 
solving and judgment, Trails A, Trails B, Clock draw, Clock copy, digit span 
forward and backward, and the Rey's Auditory verbal 30 minute delay 
recognition, 30 minute recognition errors, and 30 minute recall were examined for 
their ability to differentiate between subject groups in this study. 
MRI scans 
For this study, we analyzed the T1-weighted MPRAGE baseline MRI 
scans from those acquired by the ADNI on 1.5T scanners from General Electric 
(GE), Philips Medical Systems (Philips), and Siemens Medical Solutions 
(Siemens). Specific pulse sequence guidelines can be found at 
http://www.loni.ucla.edu/ADNI/Research/Cores/index.shtml. 
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FOG-PET scans 
For this study, we analyzed baseline FOG-PET scans from those acquired 
by the ADNI on GE, Philips, or Siemens scanners. Specific protocols for each 
scanner are available from the ADNI website 
(http://adni.loni.ucla.edu/research/protocols/pet-protocols/) . These data were 
corrected for radiation attenuation and scatter using scanner-specific algorithms 
and each image was visually assessed for potential artifacts by the ADNI PET 
core at the University of Michigan. For this study we used the original PET data 
that was not pre-processed by the ADNI PET core so that we could have local 
control of all the processing steps as with the MRI scans. 
Freesurfer Analysis 
All MRI and FOG PET scans were processed with the Freesurfer 5.1.0 
(Dale A.M. et al. 1999; B. Fischl et al. 1999), which is documented and freely 
available. The processing pipeline has been described in detail elsewhere (Dale 
A.M. et al. 1999; B. Fischl et al. 1999; Bruce Fischl et al. 2002; Bruce Fischl, 
Andre van der Kouwe, et al. 2004; Bruce Fischl, David H Salat, et al. 2004; Bruce 
Fischl & Anders M. Dale 2000). Briefly, for each subject, the 2 DICOM T1-
weighted MRI datasets were motion corrected, averaged, segmented into gray 
matter, white matter, and cerebral spinal fluid (CSF), and intensity normalized. 
Cortical thickness measures were corrected for gray/white matter intensity ratio 
using residuals, as it was previously determined to increase the predictive ability 
of cortical thickness in our sample (Chapter 3). The gray/white matter intensity 
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ratio was calculated as previously described, but will be briefly outlined here (D H 
Salat et al. 2009; D.H. Salat et al. 2011). Gray matter tissue intensities were 
measured 35% through the thickness of the cortical ribbon. White matter tissue 
intensities were measured 1 mm below the gray/white matter boundary, into the 
white matter. The GWIR was calculated by dividing the white matter by the gray 
matter intensity values. The ratios were then projected onto the cortical surface 
and smoothed with a Gaussian kernel with a full width at half maximum of 30mm. 
The cortex was parcellated into regions of interest (ROis) based on gyral and 
sulcal structure using the Desikan/Killiany atlas(Desikan et al. 2006). In this 
study, the isthmus of the cingulate is the portion of the cingulate posterior to the 
marginal ramus. Many studies refer to this region as the posterior cingulate. For 
consistency we will refer to this region as the isthmus throughout and specify 
posterior cingulate when the hypometabolism extended anterior to the marginal 
ramus. 
PET Processing 
Once the T1-weighted MRI images were processed, the PET images were 
affine spatial transformed into "anatomical space" 1 x1 x1, 256x256x256, which 
was the same resolution as the transformed MRI images. The PET and MRI 
images were then co-registered using an automated Freesurfer boundary based 
application using 6 degrees of freedom (Douglas N Greve & Bruce Fischl 2009), 
such that no skewing or twisting of the data occurred (Figure 4.1 ). The resulting 
coregistration was visually assessed for accuracy and adjusted if necessary 
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(approximately 25% of the datasets). After the two datasets were co-registered, 
FOG uptake was measured in specific ROis according to the cerebral cortex 
parcellations generated on the representative MRI images (Desikan et al. 2006). 
A total of 82 cortical and subcortical areas were examined for changes in MRI 
morphometry and FOG uptake related to MCI and AD relative to normal aging 
(Figures 2 and 3). 
To control for individual global variations and to increase sensitivity of the 
method for differentiating between subject groups (Yakushev et al. 2008) , the 
FOG uptake was normalized to regional activity in the cerebellum using 
residuals. The choice of reference region was based on the results from a 
previous study in which we tested which region was best suited for as a 
reference region for normalization in our subjects. Partial volume effects were 
also corrected for using an adapted gray matter mask (Daisuke Yanase et al. 
2005). 
Statistical Analysis 
In order to assess the equality of the male-female distribution in the three 
diagnostic groups, x2 tests were performed. AN OVA was used in order to assess 
the age, education, and MMSE distributions in the three diagnostic groups. 
Hemisphere differences for both MRI and PET data were examined with paired t-
tests and correlation analysis. If the t-tests showed no significant differences the 
two hemispheres they were averaged together. Age was correlated with each of 
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the morphometric and uptake variables, including cortical surface area, volume, 
cortical thickness, gray/white matter intensity ratio, and FOG uptake. 
Logistic regression Analyses 
In order to determine which ROis and neuropsychological tests should be 
entered into the models for diagnostic group, we first performed step-wise logistic 
regression on each variable individually with entry and exit criteria of 0.20. If the 
odds ratio was below 0.75 or above 1.25 it was determined to be an adequate 
predictor on its own and was entered as a variable in the model for that modality. 
For each modality (e.g. cortical thickness, volume, cortical surface area, FOG 
uptake, CSF profile, and neuropsychological tests), all the variables that met 
criterion were placed into a second step-wise logistic regression with entry and 
exit criteria of 0.20 and diagnostic group as the dependent variable. Age, gender, 
and education were forced into the model, thus any variance that they 
contributed to diagnostic group was controlled for. To generate multi-modal 
models, the variables from modality specific model with the highest c-score were 
entered into another step-wise logistic regression using the same parameters as 
before. To examine the added effects of CSF biomarker concentrations on the 
multimodal model , we forced all the variables from the multimodal model into the 
CSF-multimodal model. In this way we could ensure that the variables 
contributing variance in the first multimodal model were repeated in the CSF-
multimodal model in order to limit the changes in c-statistic to just the CSF 
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biomarker concentrations. In instances where a ROI was represented by more 
than one modality in the model (e.g. cortical thickness and FOG uptake), the 
modality accounting for the most variance in the model was included and the 
other was excluded. The same process was used to control for models in which 
both hemispheres were represented from the same modality. Pearson's 
correlation was used to assess collinearity amongst the predictor variables of the 
multimodal models. 
RESULTS 
Chi-square tests revealed no significant differences for distribution of 
males and females between groups (df = 2, p = 0.3517). Age was not 
significantly different between control, MCI, and AD groups, as indicated by 
ANOVA (p = 0.6684). The AD group had on average a year less education than 
normal and MCI groups, which, although small, was significant (p < 0.05). As 
expected, the MMSE scored also showed significant decreases in both the MCI 
and AD subject groups (p < 0.05). 
LeftlRight Hemisphere differences: 
Volume, cortical thickness, and cortical surface area were significantly 
different between left and right hemispheres in the vast majority of regions (data 
not shown). There were also significant correlations between the hemispheres in 
all regions for volume, cortical thickness, and cortical surface area (p < 0.05). 
Although we observed significant correlations, we also observed widespread 
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significant hemisphere differences and decided to keep the hemispheres 
separate for all MRI measures. FOG PET showed no significant differences 
between hemispheres, so the data from the two hemispheres were averaged . 
Models for predicting diagnostic group 
MRI 
Separate volume, cortical thickness, and cortical surface area models 
were generated and the variables contributing unique variance from each of 
these models were entered into a separate stepwise logistic regression model to 
generate a total MRI model. 
AD vs. MCI 
The MRI variables which contributed significant amounts of variance (p < 
0.05) to the model discriminating AD from MCI included volume of the left 
hippocampus; cortical surface area of the left postcentral gyrus and right middle 
temporal; and cortical thickness of the left isthmus of the cingulate, left insula, left 
inferior temporal, right entorhinal, and of the right banks of the superior temporal 
sulcus. In addition, education was a significant predictor (p = 0.0005). Overall, 
the MRI model for AD vs. MCI generated a c-statistic of 0.861 (Hosmer-
Lemeshow goodness of fit Chi-square = 4.86, p = 0.77, Cox and Snell 
generalized R2 = 0.33, Nagelkerke R2 = 0.46) (Table 4.2). 
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MCI vs. normal aging 
The MRI variables which contributed significant amounts ofvariance (p < 
0.05) to the model discriminating MCI from normal aging included volume of the 
left entorhinal, right hippocampus, right caudal anterior cingulate, and left caudal 
middle frontal; cortical surface area of the right inferior temporal and right 
paracentral gyri; and cortical thickness of the left middle temporal, left rostral 
middle frontal, right banks of the superior temporal sulcus, right inferior parietal, 
and left superior frontal regions. In addition, age (p < 0.0001) and gender (p = 
0.029) were significant predictors. The MCI vs. normal aging model gave a c-
statistic of 0.870 (Hosmer-Lemeshow goodness of fit Chi-square = 7.54, p = 
0.48, Cox and Snell generalized R2 = 0.36, Nagelkerke R2 = 0.50) (Table 4.3). 
AD vs. normal aging 
The MRI variables that contributed significant amounts of variance (p < 
0.05) to the model discriminating AD from normal aging included volume of the 
left entorhinal, left hippocampus, right caudal anterior cingulate, left rostral 
anterior cingulate, and right banks of the superior temporal sulcus; cortical 
surface area of the left caudal middle frontal and left inferior temporal; and 
cortical thickness of the right cuneus, left middle temporal, and left lateral 
occipital regions. In addition, age (p - 0.0027) and education (p = 0.0023) were 
significant predictors. Overall, the MRI model for normal control vs. AD gave a c-
statistic of 0.986 (Hosmer-Lemeshow goodness of fit Chi-square = 0.68, p = 1.0, 
Cox and Snell generalized R2 = 0.70, Nagelkerke R2 = 0.94) (Table 4.4). 
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All three groups 
The MRI variables which contributed significant amounts of variance (p < 
0.05) to the model discriminating all three groups included volume of the left 
hippocampus and left caudal middle frontal; cortical surface area of the right 
fusiform; and cortical thickness of the right entorhinal, right superior parietal, left 
inferior temporal, left middle temporal, left temporal pole, right banks of the 
superior temporal sulcus, right rostral middle frontal, left medial orbitofrontal, left 
pars opercularis, left lateral occipital, and right precuneus regions. In addition, 
age (p < 0.0001), gender (p = 0.011), and education (p = 0.0006) all contributed 
significantly to the model. Overall, the MRI model for differentiating all three 
groups gave a c-statistic of 0.879 (Cox and Snell generalized R2 = 0.53, 
Nagelkerke R2 = 0.60) (Table 4.5). 
FOG PET 
AD vs. MCI 
FOG metabolism in a number of regions significantly contributed to the 
model differentiating AD from MCI. These regions, along with education (p = 
0.0006), were the inferior temporal, postcentral, and putamen. Overall, the FOG 
PET model provided a c-statistic of 0.726 (Hosmer-Lemeshow goodness of fit 
Chi-square= 9.47, p = 0.30, Cox and Snell generalized R2 = 0.15, Nagelkerke R2 
= 0.22) (Table 4.6). 
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MCI vs. normal aging 
FOG metabolism in a number of regions significantly contributed to the 
model differentiating MCI from normal aging. These regions were the entorhinal, 
fusiform, inferior temporal, and isthmus of the cingulate. Overall, the model 
provided a c-statistic of 0.688 (Hosmer-Lemeshow goodness of fit Chi-square = 
4.29, p = 0.83, Cox and Snell generalized R2 = 0.11, Nagelkerke R2 = 0.15) 
(Table 4.7). 
AD vs. normal aging 
FOG metabolism in a number of regions significantly contributed to the 
model differentiating AD from normal ag ing. These regions, along with education 
(p = 0.0087), were the entorhinal, middle temporal, paracentral, postcentral, 
parahippocampus, and the temporal pole. Overall, the model provided a c-
statistic of 0.879 (Hosmer-Lemeshow goodness of fit Chi-square = 3.89, p = 
0.87, Cox and Snell generalized R2 = 0.41, Nagelkerke R2 = 0.55) (Table 4.8). 
All three groups 
FOG metabolism in a number of regions significantly contributed to the 
model differentiating all three groups. These regions, along with education (p = 
0.0004), were the entorhinal, inferior parietal, isthmus of the cingulate, and the 
postcentral gyrus. The model provided a c-statistic of 0. 735 (Cox and Snell 
generalized R2 = 0.22, Nagelkerke R2 = 0.25), respectively (Table 4.9). 
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Neuropsychological tests 
AD vs. MCI 
The neuropsychological tests which contributed significant variance to the 
model differentiating AD from MCI were the digit span backwards, trails A, and 
the RAVL T 30 minute delay and delay errors. Education was also significant. 
Overall, the neuropsychological test model for AD vs. MCI gave a c-statistic of 
0.876 (Hosmer-Lemeshow goodness of fit Chi-square= 1 0.55, p = 0.23, Cox and 
Snell generalized R2 = 0.44, Nagelkerke R2 = 0.62) (Table 4.1 0). 
MCI vs. normal aging 
The neuropsychological tests which contributed significant variance to the 
model differentiating MCI from normal aging were the clock score, digit span 
backwards, trails B, and the RA VL T 30 minute delay and delay errors. Age was 
also significant. The model provided a c-statistic of 0.841 (Hosmer-Lemeshow 
goodness of fit Chi-square = 8. 79, p = 0.36, Cox and Snell generalized R2 = 0.29, 
Nagelkerke R2 = 0.41) (Table 4.11 ). 
AD vs. normal aging 
The neuropsychological tests which contributed significant variance to the 
model differentiating AD from normal aging were the clock score, digit span 
forward , and the RA VL T 30 minute delay and delay errors. The model provided a 
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c-statistic of 0.9692 (Hosmer-Lemeshow goodness of fit Chi-square = 1 0.50, p = 
0.23, Cox and Snell generalized R2 = 0.69, Nagelkerke R2 = 0.92) (Table 4.12). 
All three groups 
The neuropsychological tests which contributed significant variance to the 
model differentiating all three groups were the clock score, digit span backward , 
trails A and B, and the RA VL Y 30 minute delay and delay errors. This model 
provided a c-statistic of 0.878 (Cox and Snell generalized R2 = 0.63, Nagelkerke 
R2 = 0.73) (Table 4.13). 
CSF measures 
AD vs. MCI 
In the CSF model for differentiating AD from MCI , education was the only 
significant predictor (p = 0.01). There were trends for both A~-1-42 and pTau (p = 
0.069 and 0.063, respectively) . The c-statistic for this model was 0.685 and 
accounted for 11% of the variance, according to Nagelkerke R2 (Hosmer-
Lemeshow goodness of fit Chi-square = 6.55, p = 0.59, Cox and Snell 
generalized R2 = 0.08, Nagelkerke R2 = 0.11) (Table 4.14). 
AD vs. normal 
The CSF model for differentiating AD from normal aging included A~-1-42 
and tTau along with age, gender, and education. Both of the CSF measures of 
pathology were significant (p < 0.0001 and p = 0.0004, respectively) , along with 
education (p < 0.05). The overall model was able to discriminate well between 
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the groups with a c-statistic of 0.904. This accounted for approximately 60% of 
the variance, with a Nagelkerke R-square of 0.604 (Hosmer-Lemeshow 
goodness of fit Chi-square = 8.55, p = 0.38, Cox and Snell generalized R2 = 0.45) 
(Table 4.15) . 
MCI vs. normal 
The CSF model for differentiating MCI from normal aging included A~-1-
42 and tTau, both of which were significant predictors (p = 0.0005 and 0.0025, 
respectively). The model had a c-statistic of 0.775 (Hosmer-Lemeshow goodness 
of fit Chi-square = 0.775, p = 0.51, Cox and Snell generalized R2 = 0.20, 
Nagelkerke R2 = 0·28) . Neither age, gender, nor education were significant 
predictors (Table 4.16). 
All three groups 
For differentiating all three groups with CSF measures of pathology, A~-1-
42 and tTau were both significant predictors, along with education (p = <0.0001 , 
0.0011 , and 0.03, respectively). Neither age nor gender were significant. Overall 
the model had a c-statistic of 0. 753 and accounted for approximately 28% of the 
variance (Cox and Snell generalized R2 = 0.24, Nagelkerke R2 = 0.28) (Table 
4.17). 
Multi-modal 
Once a final model for each modality was completed , they were combined 
into a multi-modal model with the main goal of obtaining a model that better 
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discriminated between groups. Because fewer subjects had a CSF sample, and 
because lumbar puncture is a fairly invasive procedure, we first examined the 
imaging and cognitive test modalities together without CSF measures and then 
we made new multimodal models with added CSF to see if this improved the 
discriminability. 
AD vs. MCI 
When differentiating between AD and MCI the c-statistic was 0.918 
(Hosmer-Lemeshow goodness of fit Chi-square = 1 0.55, p = 0.23, Cox and Snell 
generalized R2 = 0.44, Nagelkerke R2 = 0.62) in the final multi-modal model, 
which included neuropsychological tests and MRI. FOG PET variables did not 
contribute any additional variance to the model (Table 4.18). The model after the 
addition of both A~-1-42 and pTau had a c-statistic of 0.943 (Hosmer-Lemeshow 
goodness of fit Chi-square= 8.85, p = 0.36, Cox and Snell generalized R2 = 0.51, 
Nagelkerke R2 = 0.70) (Table 4.19). 
MCI vs. normal aging 
For differentiating between MCI and normal aging subjects the c-statistic 
was 0.925 (Hosmer-Lemeshow goodness of fit Chi-square= 6.77, p = 0.56, Cox 
and Snell generalized R2 = 0.46, Nagelkerke R2 = 0.64) using MRI, FOG PET, 
and neuropsychological test variables (Table 4.20). The second model including 
CSF variables to the model was better able to discriminate with a c-statistic of 
0.972 (Hosmer-Lemeshow goodness of fit Chi-square = 3.20, p = 0.92, Cox and 
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Snell generalized R2 = 0.59, Nagelkerke R2 = 0.81). Of the CSF variables, both 
total tau and A~-1-42 were added (Table 4.21). 
AD vs. normal aging 
When differentiating between AD and normal aging the c-statistic was 
0.939 (Hosmer-Lemeshow goodness of fit Chi-square = 0.66, p = 0.72, Cox and 
Snell generalized R2 = 0.74, Nagelkerke R2 = 0.99) in the final multi-modal 
model, which included only neuropsychological tests and MRI. FOG PET again 
did not contribute any additional variance to the model. The difficulty here is that 
when gender is forced into the model, it becomes unreliable, with a number of 
extreme odds ratios for the predictor variables, although the c-statistic here was 
1.00. In order to address this issue, each variable was examined with respect to 
the other variables and, it was determined that not forcing gender into the model 
resolved the reliability issue. Thus, the final model for differentiating normal aging 
vs. AD does not include gender. Age and education along with left hippocampal 
volume and AVLT 30 minute delay scores composed the model, which had an 
overall c-statistic of 0.996 (Hosmer-Lemeshow goodness of fit Chi-square= 0.49, 
p = 1.0, Cox and Snell generalized R2 = 0.70, Nagelkerke R2 = 0.94). All the 
variables were significant except for education (Table 4.22). With the addition of 
CSF, the c-statistic increased to 0.998 (Hosmer-Lemeshow goodness of fit Chi-
square = 0.33, p = 1.0, Cox and Snell generalized R2 = 0.33, Nagelkerke R2 = 
0.95). CSF concentrations of a~-1-42 were in the model, although did not make a 
significant contribution (p = 0.07) (Table 4.23). 
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All three groups 
When differentiating between all three groups the c-statistic was 0.928 
(Cox and Snell generalized R2 = 0.6334, Nagelkerke R2 = 0.7248) in the final 
multi-modal model (Table 4.24) . The model for differentiating all three groups 
included neuropsychological tests, MRI , and FOG PET variables. After the 
addition of CSF samples to the candidate variables of the model, the c-statistic 
increased to 0.946 (Cox and Snell generalized R2 = 0.68, Nagelkerke R2 = 0.78). 
The CSF variable included was Af:3-1-42, which was a significant predictor (Table 
4.25). 
DISCUSSION 
In this study we created a set of models that characterize the MRI 
morphometric, FOG PET, CSF, and neuropsychological test variables that are 
best able to discriminate between normal aging , MCI, and AD. We addressed 
two main hypotheses: 1) MRI, FOG PET, CSF, and neuropsychological test 
scores on their own can distinguish between normal aging , MCI, or AD subject 
groups, and 2) combining modalities increases the predictability of the model. 
MRI, FOG PET, CSF, and neuropsychological testing models for predicting 
normal aging, MCI, and AD 
Each modality on its own was able to distinguish between the groups to 
some degree; however, MRI provided a better discrimination than FOG PET, 
CSF biomarker concentraion , or neuropsychological tests. FOG PET and CSF 
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biomarker concentration providing the least discrimination depending on which 
groups were being compared. To our knowledge only a limited number of studies 
have compared these four modalities, there are a number of studies that have 
examined discrimination between normal aging and MCI or AD in MRI and FOG 
PET. We will discuss how our results for both individual and multimodal models 
relate to the literature below. 
MRI 
Our combined MRI model was the result of a stepwise logistic regression 
whereby the pool of variables available for the model were those that were 
independent predictors from three separate models, each examining a different 
aspect of three-dimensional MRI-derived structures, namely volume, cortical 
thickness, and cortical surface area. This was necessary as a data-limiting step 
but has the added benefit of not limiting the model to only one morphometric 
measurement. In each of our MRI models, there were variables from each type of 
measurement that contributed independent variance to the model. This indicates 
that it may be counter productive to limit MCI and AD studies to only cortical 
thickness, but that volume and cortical surface area may also be important 
indicators of disease. It has previously been suggested that cortical thickness 
changes more in AD than cortical surface area when the effects of age are 
removed (Dickerson, Feczko, et al. 2009). Dickerson et al. (Dickerson, Feczko, et 
al. 2009) failed to observe an effect of AD on cortical surface area in the 
perirhinal cortex or the parahippocampal gyrus. Our study, on the other hand 
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showed that there were a number of regions in which cortical surface area was 
affected by both MCI and AD even after the effects of age were accounted for, 
suggesting that this measure may have been unduly overlooked in the past even 
though it is not able to discriminate between groups as well as cortical thickness. 
Cortical surface area may be linked to brain volume in that it may represent 
cortical columns, whereas cortical thickness may represent the number of cells 
within a column (Courchesne et al. 2000; Rakic 1988), however, the underlying 
cellular mechanism of cortical surface area is not well understood. It has also 
been suggested that cortical surface area may be influenced by a variety of 
factors such as synaptogenesis, dendritic arborization, intracortical myelination, 
and connectivity (Eyler et al. 2011 ). Changes in MRI volume are highly correlated 
with post-mortem measures of tissue volume, which suggests that the volume 
loss observed in this study likely reflects neuronal loss. Cortical thickness 
changes are thought to reflect loss of neurons and neuropil. Studies that examine 
ante-mortem cortical thickness with post-mortem neuron counts show high levels 
of agreement. 
In our MRI models for differentiating normal aging from MCI, volumes of 
both the right hippocampus and the left entorhinal cortex were significant 
predictors, while the left hippocampal volume and right entorhinal cortical 
thickness were significant predictors for AD vs. MCI, suggesting that there is not 
only hemisphere effects, whereby one hemisphere is affected before the other, 
98 
but also that different types of geometry are more effective than others at 
differentiating different stages of the disease. 
Previous studies suggest the entorhinal volume, hippocampus volume (De 
Santi S. et al. 2001; Kawachi et al. 2006; K B Walhovd, A M Fjell, Brewer, et al. 
201 0) , amygdala (Kawachi et al. 2006), and inferior temporal lobe volume to be 
predictive of AD (Schmand et al. 2011 ). Other studies also suggest that 
retrosplenial thickness is able to predict AD (K B Walhovd, A M Fjell, Brewer, et 
al. 201 0), while other still rely on what is known as the "cortical signature of AD", 
which is a set of 10 cortical thicknesses that have been shown to change 
consistently in AD (Dickerson, Bakkour, et al. 2009). One benefit of the current 
study to previous studies is that we did not examine only a few preselected 
regions, but rather included the entire cortical and subcortical gray matter. To 
directly test the benefit of not limiting our data to regions that change most with 
AD, we created a model that included only the "cortical signature regions", along 
with age, and education, to see which model differentiated normal aging from AD 
best. We found that our data-driven approach was better able to differentiate 
groups, with a significantly larger c-statistic (c = 0.90 for signature and R = 0.98 
for our model, p = 0.0002). In addition, regions typically associated with the 
signature of Alzheimer's disease were not all in the models differentiating 
disease group, suggesting that although the "Alzheimer's signature" regions may 
change most in the disease that they are not optimal for differentiating disease 
states. Thus, this paper indicates additional brain regions that might be targeted 
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for future studies and perhaps for assisted in clinical diagnosis. Although 
significant changes were observed throughout the cortex, not all these regions 
were able to contribute unique and independent variance to the models. 
FOG PET 
Not surprisingly, FOG PET did not perform as well as MRI or 
neuropsychological test scores for distinguishing between diagnostic groups. 
This finding is in agreement with a number of previous studies (Schmand et al. 
2011; K B Walhovd et al. 2009; K B Walhovd, AM Fjell, Brewer, et al. 201 0) and 
at odds with others that have found evidence for better prediction with FOG PET 
than with MRI (De Santi S. et al. 2001; Kawachi et al. 2006; Matsunari et al. 
2007). While some of these discrepancies may be accounted for by sample, 
scanner, and scanning protocol, a portion of the difference may be accounted for 
by differences in post-processing methods. While here we present data from a 
data-driven ROI-based approach that re-sampled the PET data into MRI space, 
many of the other studies use a-priori ROis or else use a voxel-based approach 
using relatively large voxels, which may be less sensitive to group changes, 
particularly in small structures or those that may show more anatomical 
variability. Another post-processing difference lies in the treatment of partial 
volume effects and normalization region. We controlled for partial volume effects, 
which diminished some of the group differences (Chapter 2) and may have 
contributed to its relatively poor performance compared to MRI morphometric 
variables. Most of the studies citing an increased ability of FOG PET to detect AD 
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compared to normal aging do not adjust for partial volume errors that occur in 
PET imaging in atrophic structures, which likely artificially inflates the ability of 
FOG PET to predict group (Kawachi et al. 2006; Matsunari et al. 2007; D. Zhang . 
et al. 2011). We also normalized to the cerebellum, rather than the pons or whole 
brain based on results of one of our previous studies (Chapter 2). 
In the individual FOG PET model , a number of regions contributed 
independent variance to the models. Surprisingly some cortical regions typically 
preserved in the disease contributed variance to the models differentiating AD 
from both MCI and normal ag ing, such as the para- and post-central gyri. Closer 
examination of the odds ratios and ANOVA results from these regions indicate 
for both regions , AD showed increased metabolism and the odds ratios were 
greater than one, indicating that increased metabolism in these two regions is 
suggestive of AD. It is not clear at this point whether this is protective for these 
AD subjects, as the subjects enrolled in the ADNI had relatively mild AD . 
Regions common to all four models were the amygdala and inferior 
temporal cortex. The entorhinal cortex was in models predicting either MCI or AD 
from normal aging, but not when comparing MCI to AD. This supports the notion 
of early involvement of the entorhinal cortex. Previous studies have indicated that 
although it changes early in the disease, FOG uptake in the entorhinal cortex 
contributes to models classifying normal aging and AD (K 8 Walhovd, A M Fjell, 
Brewer, et al. 201 0) and that it may in fact be an important area for classifying 
MCI and normal aging (De Santi S. et al. 2001) . The isthmus of the cingulate 
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was also affected when comparing MCI to normal aging, which suggests that the 
region changes early in the disease and that, while the decrease in activity may 
also be present in AD, that by then it no longer contributed unique variance to the 
model, likely because other regions contribute more or overlapping variance to 
the model. Previous studies have suggested that glucose metabolism in the 
temporal neocortex is a predictor for differentiating MCI from AD. Our results also 
indicate that the inferior temporal cortex, as well as the postcentral gyrus and 
putamen are significant predictors to the model differentiating MCI from AD. 
Neuropsychological tests 
There are a number of benefits to using neuropsychological tests for 
determining diagnostic group, including its low cost relative to MRI, PET, and 
CSF sampling. There is also no risk to the patient. On the other hand, these tests 
may not be as specific to differential diagnoses, they can take a long time to 
administered, and have the most variability of any of the variables being 
discussed in this study. That being said, what do these tests contribute on their 
own and which tests are most effective at distinguishing normal aging, MCI , and 
AD from one another? Our results indicate that for this sample of normal aging, 
MCI, and mild AD, there were a number of tests common to all models. 
Among the common tests were clock drawing test score, RA VL T 30 
minute delay, and RAVL T delay errors. For differentiating normal aging from 
MCI, the earliest stage in the progression, Trails B and digit span backwards 
were also predictors. As the disease progresses to AD, Trails B has a higher 
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odds ratio, indicating that poorer performance is more highly related to AD than it 
was to MCI. In addition, Trails A and digit span forward, were predictors in the 
normal aging vs. AD model. In the model differentiating MCI from AD, a mix of 
visuospatial ability, executive function, and memory were in the model, as 
indicated by the presence of Trail A and digit span backward tests. Taken 
together, these results show that different combinations of tests were better at 
differentiating normal aging from MCI than differentiating MCI from AD, and 
normal aging from AD. This is not surprising given the progression of the disease 
and the basement effects that may be observed in tasks that require more 
memory and executive function, such as Trails B. 
CSF models 
We examined which of three biomarkers found in CSF contributed to 
models differentiating between normal aging, MCI, and AD. Afl-1-42 contributed 
variance to each of the models, which reached statistical significance in all 
models except for the MCI vs. AD model. The type of tau, total or 181-p, was not 
consistent between models. Total tau contributed to each of the models with the 
exception of differentiating AD from MCI. In this model it was pTau that 
contributed variance, rather than tTau. The ratio of tTau to Afl-1-42 has been 
indicated as a unique predictor of diagnostic group previously (K B Walhovd, AM 
Fjell, Brewer, et al. 201 0), however, in a ratio measurement it is unknown 
whether it is the Afl-1-42 or the tTau driving the predictive value. tTau and pTau 
are typically associated with neuronal and axonal damage, while Afl-1-42 is a 
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reflection of the amyloid burden in the brain. Although CSF measures may be 
useful in identifying individuals at risk for disease progression, they are not as 
useful as MRI or neuropsychological tests at differentiating between the groups 
(Schmand et al. 2011 ). This may be in part because the CSF measures are not 
exclusively brain derived, nor do they provide insight as to the localization of the 
AD-related pathology. 
Multimodal models 
While each modality on its own had some predictive value, we wanted to 
determine whether they were independent measure and to do this we combined 
them to see if this resulted in better models. Indeed, combining modalities 
increased the overall discriminability of the models, with the exception of AD vs. 
normal aging, in which MRI on its own showed higher discriminability index than 
the multimodal model. The addition of CSF variables further increased the c-
statistic in all scenarios, such that multimodal including CSF provided the highest 
degree of discrimination. 
When differentiating normal aging from MCI, both volume and FOG uptake 
in the entorhinal cortex contributed significantly to the model. Correlation analysis 
indicates that the variables were independent factors, likely because the FOG 
PET data had been corrected for atrophy effects, so that any changes in 
metabolism observed are true representations of brain function and are not 
mixed with atrophy results. Although FOG PET showed significant decreases in 
AD compared to both normal aging and FOG PET, no regions provided any 
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additional variance to the model after including MRI and cognitive measures 
suggesting that MRI and neuropsychological test scores on their own could 
adequately distinguish between the groups. 
Limitations 
There are a few limitations of the present study. The first is that there is a 
larger proportion of males to females throughout the entire ADNI sample. This is 
consistent throughout each of the diagnostic groups, however, and was included 
in each of our models to control for this. The other limitation with sample is that 
the ADNI subjects may not be representative of the entire population due to the 
restrictions on subject enrollment. The MCI and normal aging groups in 
particular, might be more diverse in the general population. 
Although ADNI collected genetic information on its participants, we did not 
examine genetic variables, such as ApoE status, which has been shown to 
influence rate of disease progression in a dose-dependent manner. Also, not all 
the subjects in our sample had CSF data, which resulted in a smaller sample for 
the multimodal model including CSF. 
CONCLUSION 
This study shows that combining modalities better differentiates between 
normal aging and MCI subject groups. It is important to be able to distinguish 
individuals with MCI as early as possible. By looking outside the typical a priori 
regions, we may increase the number of individuals identified. These individuals 
105 
should be followed over a longer period of time to determine who declines in 
memory and executive function and the brain regions associated with these 
changes. 
A set of MRI , FOG PET, CSF, and neuropsychological variables that best 
differentiates between normal aging, MCI , and AD subject groups has been 
determined in a large sample from the ADNI database. 
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Table 4.1 Demographic information 
Subjects Age mean Education MMSE 
(male/female) years (std Mean (std dev) 
dev) 
Normal 105 (64/41) 75.81 (4.75) 15.90(3.12) 28.98 (1.12) 
Aging 
MCI 204 (137/67) 75.44 (7.22) 15.80 (2.88) 27.15 (1.71)a 
AD 94 (56/38) 74.91 (7.37) 14.61 (3.21)a,o 23.48 
(2.14)a,b 
a significant difference from normal aging (p < 0.05), 0 significant difference 
from MCI (p < 0.05). 
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Table 4.2. MRI model for differentiating AD and MCI groups. The model provided a c-statitisc of 
0.861. 
Odds Lower Upper 
Unit Ratio Cl Cl p-value 
Ag~ 7.27 0.80 0.57 1.13 0.20 
-- - -
Gender 1.33 0.68 2.60 0.41 
. - -- - --
Education 3.04 0.56 0.40 0.77 0.0005 
-
Le~ I:!!P~~mpu! volume 563.50 0.66 0.43 0.99 0.05 
Left fusiform volume 1278.50 1.44 0.98 2.12 0.06 
- - -- -- ------
- ~--
~eft post~~r:_al surface ~~~ 412.10 0.60 0.42 0.86 0.006 
R_!ght .'!liddl~ tE!_mp_~~~l su_rf~~~ ~E~~ 332.70 0.63 0.43 0.91 0.01 
f3ight latera! occipitaJ surfac~ ! rea 609.60 0.73 0.51 1.03 0.07 
-
L_~ft isthr:t_!US oJ the cingu~te co~~ I thickness 0.26 0.49 0.30 0.78 0.003 
Righ_! entor~.inal cortical !hick!les~ 0.53 0.61 0.41 0.92 0.02 
-·-· ·-· -· -L~ft il]_~e~~ teml?ora~ ~o~ica~ ~hic~ness 0.24 0.39 0.23 0.65 0.0004 
-
Left posteri~r cingulate cortical t!:l~_l_<n~ss 0.19 1.51 0.98 2.31 0.06 
R~ght ~a~s § TS cortic~l .!~ic~ness 0.23 0.58 0.39 0.84 0.004 
Left insula cortical thickness 0.22 1.91 1.23 2.96 0.004 
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Table 4.3. MRI model for differentiating MCI and normal aging groups. The model provided a c-
statitisc of 0.870. 
I Odds Lower Upper 
Unit i Ratio Cl Cl p-value 
Age 6.50 1 0.43 0.62 0.29 <.0001 
~ -
-
Gender 0.46 0.93 0.23 0.03 
Education 2.96 1 0.80 1.10 0.58 0.17 
-
Right hipp~a"!~L:JS v_c>J l_Jme 549.30 ; 0.38 · 0.60 0.24 <.0001 
397.40-: -Righ! ~~dal ~nte~o~ cingulate volume 2.04 2.91 1.43 <.0001 
Left caudal middle frontal volume 1067.30 0.46 0.66 0.31 <.0001 
Left entorhinal volume 445.10 0.64 0.92 0.44 0.02 
- -
-
Right parahippoca_mpus volume 327.30 0.75 1.06 0.54 0.10 
-
Left pericalcarine s_urface area 212.50 1.39 1.97 0.99 0.06 
Right post~rl!_r~l surface area 414.30 1.32 1.94 0.89 0.17 
. 
·-·-- --
Right inferior temporal ~~rfac~ area 390.70 0.66 0.93 0.46 0.02 
- -
Right paracentral ! urface area 190.00 1.42 2.00 1.00 0.05 
Lef! middle tem~or::al co~ical thicknes_s Q..22 1 0.46 0.78 0.27 0.004 
Left rostral middle frontal cortical thickness 0.17 0.51 0.94 0.27 0.03 
-- -- -- -Left medial orbitofrontal cortical thickness 0.21 0.78 1.13 ' 0.54 0.19 
--- --- -
R!ght banks_ STS corti~a~ thJ~kn~s_s 0.22 0.61 0.97 0.39 0.04 
., 
-
~ght suera~~inal corti~l thickness 0.19 0.66 1.21 0.36 0.17 
Right inferio! parietal corti cal tb i~k~~ss Q_. 1 ~:_ 3.37 6.60 1.72 0.0004 
Left superior frontal cortical thickness 0.20 2.76 5.29 1.44 0.002 
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Table 4.4. MRI model for differentiating AD and normal aging groups. The model provided a c-
statitisc of 0.986. 
-oaas Tower Upper 
Unit Ratio Cl Cl p-value 
Age 6.11 0.05 0.36 0.008 0.003 
-· -Gender 0.32 4.03 0.03 0.38 
-- --
- - - -
Education 3.22 · 0.04 0.30 0.004 0.002 
. -
--~ef! hippo~~p~_yolu!!l~ 
.. 
614.50 1 0.003 0.09 <0.001 0.0008 
·--
. 
Right ~u~~~ anterior ping~~~te vol~me 404.20 27.75 251.33 3.06 0.003 
Left rostr~l ~nl!_rior cingt:~late volume 
-
404.50 13.23 83.44 2.10 0.006 
Left entorhinal volume 450.80 , 0.04 0.30 0.005 0.002 
-·-- ------ ..... -.... -----·-
l3ight ~~!'!!<~ ~T~ volume 475~Q. I 0.05 0.37 0.007 0.003 
·-
Left insula volume 680.30 1 15.77 130.46 1.91 0.01 
- . - -·· 
-
Left caudal middle frontal surface area 355.10 0.02 0.18 0.003 0.0003 
-- - - -
- ---
Left ir!eri()r:_ten::tpora~_!urface a~ea 459.30 0.07 0.67 0.008 0.02 
Right cunel!s ~~cal thickness 0.14 0.08 0.62 0.01 0.02 
-
Le!! mi<!dl~ ~_l!lporal cort!~l !h~ckness 0.26 . <0.001 0.02 <0.001 0.0006 
-- - - -
Left lateral occipital cortical thickness 0.16 40.80 436.26 3.82 0.002 
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Table 4.5. MRI model for differentiating between all three groups. The model provided a c-
statitisc of 0.879. 
Odds Lower upper 
Unit Ratio Cl Cl p-value 
Age 6.70 0.52 0.40 0.67 <.0001 
Gender 0.48 1 0.74 0.58 0.93 0.01 
-·-
Education 3.06 1 0.67 0.54 0.84 0.0006 
Left hippocampus surface area 580.50 • 0.42 0.31 0.58 <.0001 
Left caudal middle frontal surface area 1042.70 0.57 0.44 0.75 <.0001 
- - - -Rig~t parahip~mpus s~rface area 331.00 0.80 0.62 1.03 0.09 
Right supramarginal surfa~e area 1324.90 I 1.32 0.99 1.74 0.05 
Left inferior p~rietal surface area 1682.90 0.77 0.58 1.02 0.07 
Right fusiform v~lume 348.00 0.68 0.54 0.87 0.002 
-
Right superior J)~rie_tal co~ical thickn~ss 0.20 2.07 1.34 3.20 0.001 
- -· 
Right isthmus of the cingula~e CErtical thickness 0.26 1.29 0.98 1.71 0.07 
Left temporal pole cortical thickness 0.42 1.37 1.02 1.85 0.04 
Left postcentra) ~ortical thickness 0.16 0.74 0.53 1.03 0.07 
Left middle temp9~1 cortical thj ckness 0.24 1 0.61 0.39 0.95 0.03 
Right entorh!nal corti~l thi_ckness 0.53 · 0.60 0.44 0.82 0.001 
Right rostral middl~ fro.ntal cortical thic~ness 0.1~ i 0.61 0.41 0.91 0.02 
Left inferior tem~ral cor:!ical t~lckness 0.24 1 0.52 0.34 0.81 0.003 
Left medial orbitofrontal cortical thickness 0.21 ' 0.73 0.56 0.97 0.03 
Left lateral oc~ip!~l ~rtical thiEkness 0.16 1.75 1.25 2.47 0.001 
-
Right banks ST~ cortical thickness 0.23 · 0.68 0.50 0.92 0.01 
- -
Right ins~la corti9il thickness 0.23 1.35 0.97 1.88 0.08 
Left pars oe_erc~laris ~rtit:?.SI thickn~ss 0.20 1.55 1.10 2.19 0.01 
Left superior ~C?_ntal cortical t~~ckn~s~ 0.20 1.51 0.99 2.31 0.06 
-
Right lateral orbitofro_n_~ cortical thickness 0.21 1.29 0.91 1.82 0.15 
Right precuneus cortical thickness 0.18 0.44 0.29 0.66 0.0001 
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Table 4.6. FOG PET model for differentiating AD and MCI groups. The model provided a c-
statitisc of 0.726. 
t Odds Lower Upper 
Unlt 1 Ratlo 1 Cl Cl p-value 
Gender 1 ~ 0.716 0.406 1.265 0.25 
Education 3.0423 0.61 0.461 0.808 0.0006 
Age 7.0892 1.085 0.811 1.452 0.5811 
Inferior temporal FOG 1337.9 1 0.552 0.408 0.749 0.0001 
-
-
Postcentral FOG 1564 1.779 1.285 2.463 0.0005 
Putamen FOG 2407.4 1.425 1.043 1.946 0.0262 
112 
Table 4.7. FOG PET model for differentiating MCI and normal aging groups. The model 
provided a c-statitisc of 0.688. 
I Odds Lower Upper 
Unit , Ratio Cl Cl p-value 
Gender 1.00 1.51 ' 0.87 2.61 0.14 
Education 2.96 0.86 0.66 1.12 0.25 
Age 6.48 0.80 0.61 1.04 0.10 
Entorhinal FOG 1349.30 0.55 0.36 0.84 0.005 
Fusiform FOG 1235.90 2.44 1.34 4.43 0.004 
- -
l.nferior i!'mpo! al _FO~ 1301.00 0.58 0.34 0.98 0.04 
- -
Isthmus of the cingulate FOG 2007.90 1 0.59 0.39 0.90 0.01 
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Table 4.8. FOG PET model for differentiating AD and normal aging groups. The model provided 
a c-statitisc of 0.879. 
oaas Lower Upper 
Unit 1 Ratio Cl Cl p-value 
Gender 1.00 ! 1.07 0.45 2.55 0.88 
Education 3.25 0.57 0.38 0.87 0.01 
Age 5.93 1 1.05 0.71 1.57 0.81 
Entorhinal FOG 1508.90 0.10 0.03 0.33 0.0001 
-
Isthmus of the cingulate FOG 2183.60 0.42 0.12 1.50 0.18 
Middle temporal FOG 1686.00 0.23 0.11 0.50 0.0002 
Paracentral FOG 2075.20 2.47 1.02 5.99 0.05 
-
Parahippocampus FOG 1576.20 4.22 1.22 14.58 0.02 
Postcentral FOG 1575.60 3.69 1.46 9.28 0.01 
Precuneus FOG 2083.10 0.33 0.10 1.09 0.07 
Temporal pole FOG 1264.50 3.13 1.13 8.66 0.03 
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Table 4.9. FOG PET model for differentiating between all three groups. The model provided a c 
statitisc of 0.876. 
! Odds Lower Upper 
Unit Ratio Cl Cl p-value 
Gender 1.00 , 1.05 0.69 1.59 0.83 
- -~- . - - - --·-Education 
- 3.01 0.69 0.56 0.85 0.0004 
- -
~e 6.59 , 1.00 0.81 1.23 0.98 •. 
-· 
Entorhinal FOG 1405.30 ' 0.72 0.57 0.91 0.007 
--
. -
-· 
,_ .. _______ 
Inferior J?~rietal _EQG 1761.90 0.60 0.44 0.82 0.002 
--- -· -lsth~!J~ Ef the cing~lat~ FE?G 1974.20 i 0.59 0.43 0.80 0.0008 
----Postcentral FOG 1517.70 2.68 1.99 3.60 <.0001 
. ---- -~ -- - -·~--
Pallidum FOG 710.90 ! 1.23 0.99 1.53 0.06 
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Table 4.10. Neuropsyhological test model for differentiating between AD and MCI. The model 
provided a c-statitisc of 0.876. 
Odds Lower Upper 
Unit Ratio Cl Cl p-value 
~~ 7.26 1.18 0.85 1.65 0.33 
-
-··-~· 
Gender 1.42 0.73 2.75 0.31 
--Education 3.03 . 0.69 0.50 0.95 0.02 1- --~lock d~wi_!lg . 1.15 0.71 0.50 1.01 0.06 
_Di_git spa~ backward 2.16 0.62 0.43 0.89 0.01 
- - ·-
Trails A 30.70 2.29 1.56 3.37 <.0001 
- -- -~'{I. T 30 mlnu)e_ ~-~!aY~. re~ll 3.15 0.18 0.09 0.38 <.0001 
2.56' -
- . 
RAVL T 30 minute delayed recognition errors 1.42 1.05 1.92 0.02 
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Table 4.11. Neuropsyhological test model for differentiating between MCI and normal aging. 
The model provided a c-statitisc of 0.841. 
I Odds Lower Upper 
Unit 1 Ratio Cl Cl p-value 
Ag_e 
... 
6.49 0.70 0.51 0.94 0.02 
0 
- -
.... • -··-u 
- - -
Gender ' 0.95 0.51 1.75 0.86 
' 
- '- - - -Education 2.96 1.32 0.97 1.78 0.08 
- -q~~~~ -~I!'!"ing __ 0.89 ' 0.70 0.50 0.97 0.03 
--- .. --
Qi_git ~~n pac~a_rd _ 2.14 ' 0.69 0.51 0.93 0.02 
-
--·- --
Trails B 63.44 1.50 1.03 2.18 0.03 
- -
.. - Oo 0 
~VL T ~.0 mil!ute d~lay~ r~call _ 4.10 0.36 0.25 0.51 <.0001 
- -· -- -RAVL T 30 minute delayed recognition errors 2.16 1.57 0.98 2.51 0.06 
117 
Table 4.12. Neuropsyhological test model for differentiating between AD and normal aging. The 
model provided a c-statitisc of 0.992. 
Odds Lower Upper 
Unit ' Ratio Cl Cl p-value 
~g~ 6.11 ' 0.63 0.24 1.61 0.33 
- - -·· Gender 0.35 0.05 2.55 0.30 
.. 
-
Education 3.22 0.85 0.31 2.36 0.75 
Cl~dra~!ng 1.23 0.21 0.05 0.88 0.03 
--
Di.git span forward 2.07 0.26 0.10 0.67 0.005 
- -
Trails A 32.71 5.03 0.63 40.24 0.13 
-
-
Trails B 87.58 2.92 0.81 10.50 0.10 
-4.45 : ~VL T 30 minute d~I~Ye<! re~ll 0.01 <0.001 0.07 <.0001 
--
. -
RAVLT 30 minute delayed recognition errors 2.32 1 3.53 1.27 9.84 0.02 
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Table 4.13. Neuropsyhological test model for differentiating between all three groups. The 
model provided a c-statitisc of 0.878. 
Odds Lower Upper 
Unit , Ratio , Cl Cl p-value 
Age 6.70 1 0.88 0.71 1.10 0.25 
.. .... 
·-··- ~ ---
Gender 1.09 0.69 1.72 0.72 
-
Education 3.06 ! 1.01 0.80 1.27 0.94 
.. - 1-.09 ' - -Clock drawil!g 0.71 0.55 0.92 0.009 
Digit span forw~rd 1.99 0.79 0.60 1.02 0.07 
Digit _span b~ckward 2.24 ' 0.72 0.54 0.95 0.02 
-
Trails A 27.~8 . 1.57 1.17 2.11 0.003 
-
Trails B 78.81 ' 1.44 1.08 1.92 0.01 
.. . 
RAVL T 30 minute delayed recall 4.00 0.33 0.23 0.47 <.0001 
13AVL T 30 _minut~ delayed rl!cc:>gnition errors 2.37 1.51 1.18 1.94 0.001 
. -
RAVL T 30 minute delayed recognition 3.97 , 0.77 0.57 1.03 0.08 
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Table 4.14. CSF biomarker model for differentiating between MCI and AD. The model provided 
a c-statitisc of 0.685. 
Odds Lower upper 
Unit , Ratio 1 Cl Cl p-value 
Age 
-
7.25 i 1.13 0.77 1.66 0.52 
Gender 1.00 0.97 0.45 2.11 0.95 
--
Education 3.23 0.62 0.43 0.90 0.01 
aBeta 1-42 51.31 ' 0.68 0.44 1.03 0.07 
·- - - -
Phosphorylated tau 19.47 : 1.44 0.98 2.12 0.06 
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Table 4.15. CSF biomarker model for differentiating between MCI and normal aging. The 
model provided a c-statitisc of 0. 775. 
I Odds Lower Upper 
Unit I Ratio Cl Cl p-value 
Age 6.45 1.04 0.70 1.54 0.84 
Gender 1.00 1.42 0.64 3.19 0.39 
Education 3.01 0.98 0.67 1.41 0.89 
aBeta 1-42 59.43 0.50 0.34 0.74 0.0005 
- -
Total tau 54.52 2.80 1.44 5.46 0.003 
121 
Table 4.16. CSF biomarker model for differentiating between AD and normal aging. The model 
provided a c-statitisc of 0.904. 
I oaas Lower Upper I 
Unit ; Ratio Cl Cl p-value 
Age 6.36 1 1.51 0.86 2.64 0.15 
-l -Gender 1.00 . 1.02 0.31 3.37 0.98 
Education 3.46 ' 0.55 0.31 1.00 0.05 
aBeta 1-42 58.94 ' 0.23 0.12 0.46 <0.0001 
- -
Total tau 56.29 1 4.70 2.00 11.06 0.0004 
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Table 4.17. CSF biomarker model for differentiating between all three groups. The model 
provided a c-statitisc of 0. 753. 
Odds Lower Upper 
Unit • Ratio Cl Cl p-value 
Age 6.73 1.09 0.83 1.44 0.53 
Gender 1.00 1 1.31 0.73 2.36 0.36 
Education 3.21 1 0.73 0.56 0.96 0.03 
aBeta 1-42 57.40 0.45 0.33 0.61 <0.0001 
~ 
Total tau 59.00 1 1.70 1.24 2.35 0.001 
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Table 4.18. Multimodal model without CSF for differentiating between AD and MCI. The model 
provided a c-statitisc of 0.918. 
• I 
Odds Lower Upper 
Umt 1 Ratio Cl Cl p-value 
Gender 1_:9.Q_l __ 1.06 0.48 2.34 0.88 
- _.., -- -
-
-~e 
-
7.23 ! 0.91 0.61 1.36 0.65 
Education 3.04 : 0.59 0.40 0.87 0.008 
---- ---lef!.~ip(?.O~'!l__EUS Y._~~-11!~. -~~~..:40_i _0.5!_, 0.31 0.94 0.03 
_!.eft postcentral surf~~ area 415.70 I 0.67 0.46 0.98 0.04 
-Ehf 10 ~ -- --Righ_! lateral occipital~urf~c~ ar~a 0.57 0.38 0.85 0.006 
-, f3ig~! entori]~~al ~~i~l t~~~k~~-~! . 0.5~_; 0.55 0.34 0.89 0.01 
---- -- -~ft inferiC?_r tern poE~ co~~CC! I th~C_!<!!es_s 0.24 0.45 0.26 0.79 0.005 
- -
Left insula cortical thickness 0._?_? : 2.29 1.34 3.93 0.003 
----- -Clc:>ck_ qrawing 1.14 ' 0.70 0.46 1.05 0.08 
- -· . -
-
p _i_git ~a-~ bac~'!_l"~ __ 
·-2.19 !- 0.50 0.32 0.78 0.002 
. 
- - ----
Trails A 29.73 2.26 1.41 3.62 0.0007 
1- --- -- -
RAVL! _10 '!li_!!ute ~elay~_ rE!~I! --~·~? 1 0.29 0.13 0.63 0.002 
-- -
RAVL T 30 minute delayed recognition errors 2.58 : 1.36 0.96 1.93 0.09 
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Table 4.19. Multimodal model with CSF for differentiating between AD and MCI. The model 
provided a c-statitisc of 0.943. 
s pper 
Unit , Ratio · Cl p-value 
Gender 1.00 0.91 0.24 3.42 0.88 
----- -- ·-
Ag_e 7.27 1 0.99 0.53 1.85 0.98 
··--- -~ 
Education 
. ~-2~ 1 0.48 0.25 0.92 0.03 
---·--· - -
Left hippocameus v~~'!l-~- ~5.5Q. , 0.81 0.35 1.88 0.62 
-
L~ft ~-s!cel!_tr~l _!~rfa~ ar~a 446.40 0.74 0.40 1.36 0.33 
_f3igh~ lateral o~pi~!~urfa_~e a!~~ 616:60 i 0.43 0.21 0.86 0.02 
Right ento_!hinal ~rti~ thickn~ss --:9.5? ~- 0.37 0.17 0.82 0.01 
-
Left inf!ri~r temporal_ corti~l thickness 0.23 1 0.32 0.13 0.77 0.01 
Left insula cortical thickness q.~o ;- 2.48 1.03 5.95 0.04 
' --· ----- ·- -·-- - -Clock draw!ng 1.11 1 0.65 0.34 1.24 0.19 
Dig~ ~pan b~ckward 2.: 1? 1 0.30 0.14 0.63 0.001 
Trails A ~-~.6~ ! 2.63 1.30 5.32 0.007 
-
RAVL! 30 minut~ d!!lax~C! re~l 2.74 1 0.31 0.13 0.78 0.01 
RAYL T 39 min~;Jte -~~lay~ recognition ~n:or:s ··i76 ' 2.37 1.28 4.40 0.006 
aBeta 1-42 51.47 ' 0.41 0.20 0.86 0.02 
1-9.52 I - --
. 
0.63 . 0.32 1.24 0.18 
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Table 4.20. Multimodal model without CSF for differentiating between MCI and normal aging. 
The model provided a c-statitisc of 0.925. 
I OddS Lower Upper 
Unit I Ratio Cl Cl p-value 
Gender 1.00 I 1.33 0.59 2.97 0.49 
-- -- - --- -~~-
~e 6.49 0.33 0.20 0.53 <.0001 
. 
- --Education 2.96 1.20 0.81 1.79 0.37 
~lg_b.t hippocampu~ v~ll!m_e .. 550.-30 ;- 6.3 7 0.21 0.66 0.0007 
. -~----~-· ., .. __ 
~ight ~~d~l ~f!~.ri~r c!!!g~l~!e v~l~m~ 399.10 2.01 1.33 3.03 0.0009 
--
Left caudal middle frontal volume 1071.40 . 0.41 0.26 0.65 0.0001 
- ---- 443.90 ' 
-
Left entorhinal volume 0.57 0.37 0.88 0.01 
- ---- - -· 
Right postcentral ~urf_ace area 415.20 1.49 0.96 2.32 0.08 
Right inferior !eElporal !Urf~_~e area 394.40 0.63 0.41 0.95 0.03 
Left rostral middle frontal cortical thickness 0.17 . 0.53 0.26 1.09 0.08 
-- - --- -- --·-Left medial orbitofrontal cortical thickness 0.20 0.60 0.39 0.94 0.03 
-. 
Left superior frontal cortical thickness 0.19 2.44 1.18 5.05 0.02 
. 
Clock drawing 0.89 0.52 0.34 0.80 0.003 
Digit span backward 2.15 0.56 0.37 0.83 0.004 
RAVL T 30 minute delayed re~ll 4.12 0.45 0.29 0.70 0.0004 
RAVL T 30 mi!:l_u!e delayed recognition errors 2.20 2.01 1.05 3.87 0.04 
Entorhinal FOG 1353.90 0.56 0.37 0.84 0.005 
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Table 4.21. Multimodal model with CSF for differentiating between MCI and normal aging. The 
model provided a c-statitisc of 0.972. 
Gender 
Age 
Education 
f3J.ght hippoc_!I":JPUS. v_ol_ume 
Right ~udal anterior cingulate volur:ne 
Left caudal middle frontal volume 
Left entorhinal volume 
Right postc~ntral surfa~ area 
Right inferior t~mporal surface area 
Left rostral middle frontal cortical thickness 
Left medial orbitofrontal cortical thickness 
- - - -
Left superi~r fro'!tal co_rtical t~ickness 
~lock drawing 
Digit span b_!lc~ard 
~VL T ~0 minut~ d~l~y~ recall 
~VL T 30 mi'}ute d~layed r~~ni~ion err<?r,s 
Entorhinal FOG 
aBeta 1-42 
Total tau 
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1 Odds 
Unit Ratio 
1.00 ' 2.44 . 
6.44 ! 0.52 
3.00 ; 1.36 
557.30 0.54 
387.00 3.41 
1109.80 ' 0.15 
. 
447.90 0.76 
363.70 0.81 
424.50 0.43 
0.17 ! 0.79 
0.20 ' 0.30 
0.20 · 4.58 
0.96 . 0.29 
2.17 i 
4.02 
2.32 
1448.70 :·~ 
- ---- - -
59.92 
0.58 
0.13 
1.35 
0.42 
0.42 
55.48 . 2.98 ; 
Lower Upper 
Cl Cl 
0.40 14.79 
0.22 1.22 
0.61 3.00 
0.19 1.57 
1.41 8.23 
0.05 0.49 
0.34 1.70 
0.36 1.83 
0.18 1.03 
0.16 4.04 
0.13 0.72 
0.99 21.13 
0.12 0.73 
0.26 1.28 
0.04 0.43 
0.33 5.59 
0.19 0.97 
0.17 1.03 
0.94 9.46 
p-value 
0.33 
0.13 
0.45 
0.26 
0.006 
0.002 
0.50 
0.61 
0.06 
0.78 
0.007 
0.05 
0.008 
0.18 
0.0009 
0.68 
0.04 
0.06 
0.06 
Table 4.22. Multimodal model without CSF for differentiating between AD and nonnal aging. 
The model provided a c-statitisc of 0.996. 
Odds Lower Upper 
Unit Ratio Cl Cl p-value 
~e 0.60 1 0.006 0.06 6.27 0.02 
-
Education 3.20 ' 0.06 0.44 3.49 0.42 
Left h_ip~c;:ampus vplume 0.20 . <0.001 0.004 608.50 0.006 
- . 
RAVLT 30 minute delayed recall 0.08 , <0.001 <0.001 4.43 0.004 
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Table 4.23. Multimodal model with CSF for differentiating between AD and normal aging. The 
model provided a c-statitisc of 0.998. 
oaas Lower Upper 
Variable Unit I Ratio Cl Cl p-value 
Age 6.36 0.04 0.002 0.68 0.03 
Education 3.46 0.25 0.02 3.82 0.32 
Left hippocampus volume 608.80 ~ 0.002 <0.001 0.35 0.02 
RAVL T 30 mi.nute delayed recall 4.42 • <0.001 <0.001 0.11 0.01 
aBeta 1-42 58.94 1 0.06 0.003 1.29 0.07 
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Table 4.24. Multimodal model without CSF for differentiating between all three groups. The 
model provided a c-statitisc of 0.928. 
Gender 
~ge 
Education 
Left h!PpoCC!']")PUS v~l~m~ _ 
Left caudal middle frontal volume 
_Right ~perior arietal cortical ~hickness 
-~g-~t is~']")US of the cing~~-t~- cof!i£8_1 t~ick~~ss 
_l:eft temporal pole cortical thickness 
LE!ft postcentral co~i~_thic~r.!_e~s 
~ig~-~ en~_tlinal ~rti~_l_!'ickness _ 
~eft i':lf~or !em~~~! ~orti~t_hick_!)_e~s _ . 
Left medial orbitofrontal cortical thickness 
- ·- -- - -- ,.._ ~ -
Left lateral _~ccipital_ ~..!:_t.!~ l _t!'_igkn_~~s 
R~ght ban~s STS C?rti_E~ t!t!c~~~s 
Rig_ht ii)SUlC!. cortical th!_c.~ne.~~ .. 
Le_!t pars ope~-u~aris ~r!i~l thickness 
!3 i_9~~ P!~c~~u~ ~rtical ~i~kness 
Clock drawing 
D~git ~P~I] forwa~d 
Digit s~r:_~ b~c~ard 
Trails A 
~Y!-T ~0 r:!!i r:!~t~~el~y~ ~~call 
RAVL T ~0 mir]l!t~ ~el~yed rec:.ognition error:s 
~YLT 30 ll)_inu~e delay~ recognition 
l sthmus of th~ cjngulate FOG 
Postcentral FOG 
Pallidum FOG 
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.!:QQ_, 1.44 
6.59 0.59 
3.07 1 0.82 
-~1~ -!0_i 0.40 
1047.10 ! 0.53 
0.20 1 2.21 
0.26 1 1.28 
0.42 1 1.33 
0.16 0.64 
0.53 0.58 
0.24 1 0.50 
0~21 1 - 0.69 
._.._,.. --
0.16 1.76 
6~23 ' 0.72 
0.23i 1.47 
o.g~ l 1.6o 
0.18 0.63 
1.09 1 0.72 
1.97 0.71 
2.25 • 0.65 
27.24 1.77 
4.01 0.44 
2.40 . 1.65 
4.03 ' 0.77 
1971 .50 0.69 
- --1 ~~ 1 .50 :- 1.39 
712.30 ' 1.27 
0.82 
0.43 
0.63 
0.27 
0.38 
1.34 
---0.92 
0.94 
0.44 
0.40 
0.32 
0.51 
1.19 
0.50 
1.03 
1.09 
0.39 
0.52 
0.52 
0.47 
1.26 
0.29 
1.22 
0.55 
0.49 
0.99 
0.98 
pper 
Cl 
2.54 
0.80 
1.08 
0.60 
0.73 
3.62 
1.78 
1.88 
0.93 
0.85 
0.77 
0.95 
2.60 
1.04 
2.11 
2.33 
1.02 
0.98 
0.97 
0.90 
2.49 
0.67 
2.23 
1.09 
0.96 
1.95 
1.64 
p-value 
0.21 
0.0007 
0.16 
<.0001 
0.0001 
0.002 
0.15 
0.10 
0.02 
0.005 
0.002 
0.02 
0.005 
0.08 
0.04 
0.02 
-0.06 
0.04 
0.03 
0.009 
0.001 
0.0001 
0.001 
0.14 
0.03 
0.06 
0.07 
Table 4.25. Multimodal model with CSF for differentiating between all three groups. The model 
provided a c-statitisc of 0.946. 
Variable 
Gender 
Ag~ 
Education 
~eft hi~pocampus v~lu_!!l~ " 
Left caudal middle frontal volume 
~-g~~ !~perio~. P~ri~!SJ. ~~.cal thi~~ne~~ 
~ight i~thmu~ of the ci.r:tg~la"te .~rt~cal thickness 
L_!f.! _!~mpor~! ~~~orti~l tb_i~~r_:l~~s 
Left ~~tce_ny~l c_ortical t'!ic~_r:_l~~s 
Right ~nto~~~l co~ical tl_!ic_!<n~ss 
Left inferi.~r tem~ral co~i£_81 thic.kness 
Left medial orbitofrontal cortical thickness 
Left lateral occipital cortical_ ~icknes~ 
13.ight banks STS cortical tl_! iE_k!_l~ss 
f3ight insul_a cortical thickne~ 
Left pars ope~ulari~ ~rt~ ! t~ic_~ness 
Rig~t pre_Euneus cortical thickn~ss 
Cl~ck d_rawing 
Digit ~pan forw~rd 
Digit span b~ckward 
Trails A 
RAVL T 30 min~:~!~ delay~ r~~all 
RAVL! 30 .f.!linute de!!'y~ re~g~tion errors 
RAVL T 30 minute delay~ recogn~tion 
Isthmus of th~ c_!!lgulate FOG 
Postcentral FOG 
Pallidum FOG 
aBeta 1-42 
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1.00 1 0.97 
6.68 0.69 
3.24 , 0.78 
570:20 ' 0.52 
1079.60 0.65 
0.19 2.25 
0.26 1.20 
0.42 1.87 
0.15 0.48 
0.53 0.53 
0.24 0.45 
0.20 0.64 
0.15 1.62 
0.23 1.12 
0.22 1.20 
-H ··-·-.- -
0.18 1.29 
0.19 0.63 
1.07 0.65 
1.93 . 1.03 
2.25 0.51 
28.21 1.52 
· i 89 ' o.31 
2.61 2.10 
3.78 0.77 
1921.70 ' 0.55 
1549.70 1.22 
597.50 1.25 
------4 
58.13 , 0.58 
0.40 
0.42 
0.51 
0.28 
0.40 
0.98 
0.73 
1.10 
0.25 
0.30 
0.24 
0.40 
0.89 
0.63 
0.68 
0.70 
0.29 
0.41 
0.64 
0.32 
0.91 
0.16 
1.34 
0.46 
0.31 
0.69 
0.78 
0.36 
pper 
Cl 
2.33 
1.12 
1.19 
0.95 
1.08 
5.16 
1.97 
3.18 
0.93 
0.96 
0.87 
1.03 
2.94 
1.99 
2.14 
2.37 
1.35 
1.03 
1.65 
0.82 
2.54 
0.62 
3.30 
1.29 
0.95 
2.15 
1.99 
0.91 
p-value 
0.94 
0.14 
0.25 
0.03 
0.09 
0.06 
0.47 
0.02 
0.03 
0.03 
0.02 
0.07 
0.11 
0.70 
0.53 
0.41 
0.24 
0.06 
0.91 
0.005 
0.11 
0.0009 
0.001 
0.32 
0.03 
0.49 
0.35 
0.02 
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Chapter 5 - Multimodal imaging and CSF biomarkers associated 
with baseline cognitive function and predictive of future 
cognitive decline in normal aging, mild cognitive impairment, 
and Alzheimer's disease 
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INTRODUCTION 
Alzheimer's disease (AD) is characterized by a progressive decline in 
cognitive abilities. Initial symptoms typically present as difficulties with memory 
tasks, where a rapid rate of forgetting is often found, followed by deficits in 
executive function, ultimately affecting visuospatial abilities and attention in the 
later stages of the disease. The cognitive deficits seen throughout mild cognitive 
impairment (MCI) and AD have been shown to correlate with the degree of 
pathology in post-mortem tissue analysis as well as in vivo imaging measures 
(G6mez-lsla et al. 1997; Mufson et al. 2012; K B Walhovd , AM Fjell, AM Dale, 
et al. 201 0; PA et al. 201 0). However, many of these studies only report one or 
two tests in the same subjects, thus we do not have a complete picture as to the 
neural correlates of the wide range of neuropsychological functions in normal 
aging , MCI , and AD. Tests that involve memory, such as delayed recall, have 
been examined to greater depths than simpler tasks, such as Trails A and few 
studies to our knowledge have examine the full extent of cognitive abilities in the 
same subjects. 
Insight into structure-function relationships in the brain can be gained by 
studying multiple tests and their imaging correlates both at baseline and over 
time using measures expressed as average annual change in the same subjects. 
Although tests, such as delayed recall have been extensively studied in AD, the 
brain regions that are predictive of decline and baseline performance are not 
consistent in these reports. Often there are variations reported , which may be the 
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results of the subjects in the sample or the version of the test being used. Thus, 
by studying the same sample of subjects over time using the same measures, we 
will be able to obtain a more cohesive and broad picture of the interaction 
between cognitive functions and imaging variables. In this study we sought to 
identify the MRI morphometric and FOG PET metabolic variables that are 
associated with baseline cognitive performance and those that are able to predict 
future cognitive decline. For this study, cognitive decline was defined as the 
annualized percent change (APC), which was calculated as the total amount of 
change in score divided by the time between the first and last incidences of the 
testing. Linear regression models were used to identify the variables that best 
predicted neuropsychological decline and baseline scores. Thus, we created a 
series of stepwise linear regression models to predict baseline performance and 
APC in a battery of neuropsychological tests in normal aging, MCI, and AD 
groups. We hypothesized that MRI and FOG PET would both be able to predict 
future cognitive performance. We also hypothesized that combining metabolism 
and morphometry would increase the total amount of variance that the models 
accounted for. 
METHODS 
Subjects 
The data for use in this study were chosen from the larger pool of data 
that has been made publically available by the Alzheimer's Disease 
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Neuroimaging Initiative. Data was screened to include all subjects who had both 
PET and MRI scans available for use on the ADNI/LONI website 
(www.loni.ucla.edu/ADNI) at the time this study began. From this screened 
dataset, PET data from 21 subjects was of poor contrast and quality and had to 
be omitted from the analyses undertaken in this study. Three subjects were 
omitted due to missing information. This left us with data from 403 subjects. 
Approximately half of the total subjects from ADNI also underwent lumbar 
puncture to obtain CSF samples. In our subjects, 55 normal aging, 103 MCI, and 
51 AD subjects had CSF sample data. We present demographic information on 
this sample in Table 5.1. 
As part of the ADNI , all subjects completed a battery of 
neuropsychological tests, On the basis of their cognitive status the subjects were 
classified by the ADNI clinical core as: (a) normal controls with normal cognition 
and memory, Clinical Dementia Rating (CDR) 0, and Mini Mental Status Exam 
(MMSE) between 24-30; (b) amnestic MCI with memory complaint verified by a 
study partner, memory loss measured by education-adjusted performance on the 
Logical Memory II subscale of the Wechsler Memory Scale-Revised<Wechsler 1987), 
preserved activities of daily living , CDR 0.5, MMSE between 24 and 30, and 
absence of dementia at time of baseline MRI scan; or (c) probable AD with 
memory complaint validated by an informant, abnormal memory function for age 
and education level, absence of depression, impaired activities of daily living, 
diminished cognition, CDR> 0.5, and MMSE between 20- 26. 
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Alzheimer's Disease Neuroimaging Initiative 
The ADNI was a 5-year non-randomized natural history non-treatment 
study utilizing data from multiple study centers across the United States and 
Canada. One of the main goals of the ADNI was to develop optimized methods 
and uniform standards for the acquisition of multicenter MRI and PET data on 
normal control subjects and patients with MCI and AD in drug/treatment trials. 
For more information about the ADNI please refer to http://www.adni-info.org. 
CSF Sampling 
Detailed CSF collection and processing methods can be found in 
elsewhere (Shaw et al. 2011) . Briefly, CSF samples obtained by lumbar puncture 
were examined for tTau. pTau, and Al3-42 using an immunoassay method. These 
measures were performed by the ADNI Biomarker Core at the University of 
Pennsylvania School of Medicine. 
Neuropsychological testing 
The baseline and subsequent follow-up cognitive scores were utilized as 
our variables of interest. The time each subject was followed varies, thus the 
longitudinal cognitive data was converted to annualized percent change (APC), 
which was calculated as the average change in cognitive score from year to year. 
These values were then z-transformed . The cognitive tests of interest were Trails 
A, Trails B, Clock draw, digit span forward, digit span backward , and RAVL T 30 
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minute delayed recall and recognition. Baseline and APC measurements were 
assessed within each diagnostic group. 
MRI scans 
For this study, we analyzed the T1-weighted MPRAGE baseline MRI 
scans from those acquired by the ADNI on 1.5T scanners from General Electric 
(GE), Philips Medical Systems (Phil ips), and Siemens Medical Solutions 
(Siemens). Specific pulse sequence guidelines can be found at 
http://www.loni.ucla.edu/ADNI/Research/Cores/index.shtml. 
FOG-PET scans 
For this study, we analyzed baseline FOG-PET scans from those acquired 
by the ADNI on GE, Philips, or Siemens scanners. Specific protocols for each 
scanner are available from the ADNI website 
(http://adni.loni.ucla.edu/research/protocols/pet-protocols/). These data were 
corrected for radiation attenuation and scatter using scanner-specific algorithms 
and each image was visually assessed for potential artifacts by the ADNI PET 
core at the University of Michigan. For this study we used the original PET data 
that was not pre-processed by the ADNI PET core so that we could have local 
control of all the processing steps as with the MRI scans. 
Freesurfer Analysis 
All MRI and FOG PET scans were processed with the Freesurfer 5.1.0 
(Dale A.M. et al. 1999; B. Fischl et al. 1999), which is documented and freely 
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available. The processing pipeline has been described in detail elsewhere (Dale 
A.M. et al. 1999; B. Fischl et al. 1999; Bruce Fischl et al. 2002; Bruce Fischl, 
Andre van der Kouwe, et al. 2004; Bruce Fischl, David H Salat, et al. 2004; Bruce 
Fischl & Anders M. Dale 2000). Briefly, for each subject, the 2 DICOM T1-
weighted MRI datasets were motion corrected, averaged , segmented into gray 
matter, white matter, and cerebral spinal fluid (CSF), and intensity normalized. 
Cortical thickness measures were corrected for gray/white matter intensity ratio 
using residuals, as it was previously determined to increase the predictive ability 
of cortical thickness in our sample (in preparation). The gray/white matter 
intensity ratio was calculated as previously described, but will be briefly outlined 
here (D H Salat et al. 2009; D.H. Salat et al. 2011). Gray matter tissue intensities 
were measured 35% through the thickness of the cortical ribbon . White matter 
tissue intensities were measured 1 mm below the gray/white matter boundary, 
into the white matter. The GWIR was calculated by dividing the white matter by 
the gray matter intensity values. The ratios were then projected onto the cortical 
surface and smoothed with a Gaussian kernel with a full width at half maximum 
of 30mm. The cortex was parcellated into regions of interest (ROis) based on 
gyral and sulcal structure using the Desikan/Killiany atlas (Desikan et al. 2006). 
In this study, the isthmus of the cingulate is the portion of the cingulate posterior 
to the marginal ramus. Many studies refer to this region as the posterior 
cingulate. For consistency we will refer to this region as the isthmus throughout 
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and specify posterior cingulate when the hypometabolism extended anterior to 
the marginal ramus. 
PET Processing 
Once the T1-weighted MRI images were processed, the PET images were 
affine spatial transformed into "anatomical space" 1 x1 x1, 256x256x256, which 
was the same resolution as the transformed MRI images. The PET and MRI 
images were then co-registered using an automated Freesurfer boundary based 
application using 6 degrees of freedom (Douglas N Greve & Bruce Fischl 2009), 
such that no skewing or twisting of the data occurred. The resulting coregistration 
was visually assessed for accuracy and adjusted if necessary (approximately 
25% of the datasets). After the two datasets were co-registered , FOG uptake was 
measured in specific ROis according to the cerebral cortex parcellations 
generated on the representative MRI images (Desikan et al. 2006). A total of 82 
cortical and subcortical areas were examined for changes in MRI morphometry 
and FOG uptake related to MCI and AD relative to normal aging. 
To control for individual global variations and to increase sensitivity of the 
method for differentiating between subject groups (Yakushev et al. 2008) , the 
FOG uptake was normalized to regional activity in the cerebellum using 
residuals. The choice of reference region was based on the results from a 
previous study in which we tested which region was best suited for as a 
reference region for normalization in our subjects. Partial volume effects were 
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also corrected for using an adapted gray matter mask (Oaisuke Yanase et al. 
2005). 
Statistical Analysis 
In order to assess the equality of the male-female distribution in the three 
diagnostic groups, x2 tests were performed. AN OVA was used in order to assess 
the age, education, and MMSE distributions in the three diagnostic groups. 
Hemisphere differences for both MRI and PET data were examined with paired t-
tests and correlation analysis. If the t-tests showed no significant differences the 
two hemispheres they were averaged together. Age was correlated with each of 
the morphometric and uptake variables, including cortical surface area, volume, 
cortical thickness, gray/white matter intensity ratio, and FOG uptake. The 
difference in baseline cognitive tests and APC between groups was determined 
using ANOVA with Tukey's post-hoc comparison. 
Linear regression Analyses 
A stepwise linear regression was used to identify the baseline MRI 
morphometry, FOG PET, and CSF sample variables that were associated with 
baseline cognitive performance and predictive of future APC within each 
diagnostic group. To determine which CSF and imaging variables should be 
entered into the linear regression models, we first performed a linear regression 
on each variable individually to ensure that on its own the variable could account 
for a minimum amount of variance in the cognitive test. If the standardized 
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estimate was greater or equal to an absolute value of 0.15, then it was enabled 
as a variable for the stepwise linear regression models. The stepwise linear 
regression models had entry and exit criteria of 0.20. Age, gender, and education 
were included in each of the models to control for the variance that they may 
have contributed to the cognitive variables. To generate multi-modal models, the 
variables that contributed to the individual modality models were entered into 
another stepwise linear regression with the same entry and exit criteria as before. 
Standardized estimates were used to put the predictor variables in the same 
scale, such that holding all other variables constant, a one standard deviation 
change in one predictor variable, results in a one standard deviation change (in 
the direction of the sign) of the dependent cognitive variable. Pearson's 
correlation and variance inflation factor were used to assess collinearity amongst 
the predictor variables of the multimodal models. 
RESULTS 
Age and gender were not significantly different between groups, as 
measured with ANOVA and chi-square, respectively. Education was significantly 
lower in the AD group compared to normal and MCI. As expected , MMSE scores 
were significantly lower in MCI and further decreased in AD. 
Cognitive scores at baseline and decline by diagnostic group 
Baseline scores differed between groups in two main patterns: 1) a 
stepwise significant decrease between normal aging and MCI, and again 
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between MCI and AD, and 2) significant decreases in AD, but no change 
between normal aging and MCI. Trails 8, clock score, digit span backward, and 
the AV 30 minute delay, delay total, and delay errors shared the first pattern, 
whereas Trails A and digit span forward showed the second pattern . The details 
are shown in Table 5.2. 
Differences in APC between groups showed three main patterns: 1) 
significantly increased decline in AD compared to both normal and MCI , as seen 
in clock score, digit span backward, and AV 30 minute delay, 2) significantly 
increased decline in AD compared to normal, but not MCI, as observed in Trails 
8 and digit span forwards, and 3) no significant differences in amount of decline 
between groups, as seen with AV delayed recognition and Trails A. 
Linear Regression Models 
After an initial linear regression on each of the individual morphometric, 
metabolic, and CSF biomarkers, the variables that accounted for enough 
variance of the cognitive tasks on their own were eligible to be entered into the 
stepwise linear regression model for baseline and decline in cognitive 
performance. Age, gender, and education were accounted for in each of the 
models. We will present only the significant contributors in the text. 
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Normal aging 
Baseline clock drawing scores 
MRI accounted for 43% of the variance (R2 = 0.48, Adj . R2 = 0.43, F = 
9.89, p < ,0.0001 ), FOG PET accounted for 32% of the variance (R2 = 0.37, Adj. 
R2 = 0.32, F = 7.66, p < 0.0001), and CSF did not account for any variance. 
Combining imaging modalities increased the prediction accounting for 49% of the 
variance (R2 = 0.54, Adj . R2 = 0.49, F = 10.35, p < 0.0001). Age and education 
showed significant associations with clock drawing. Cuneus hypermetabolism 
and larger cortical thickness of the right pericalcarine and surface area of the left 
caudal middle frontal and left pars triangularis were associated with worse clock 
draw scores. Thinner cortex in the right posterior cingulate and smaller surface 
area of the right lingual gyrus were also associated with worse clock drawing 
scores. The full models can be found in Table 5.3. 
Longitudinal clock drawing scores 
Clock drawing scores increased over time in the normal group by an 
average of 0.11 (sd = 0.83). Because this study focuses on predicting future 
decline, we will not discuss the longitudinal clock drawing models for normal 
aging further. 
Baseline digit span forward 
MRI variables attributed for 36% of the variance (R2 = 0.43, Adj. R2 = 0.36, 
F = 6.34, p < 0.0001 , FOG PET accounted for 10% of the variance (R2 = 0.14, 
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Adj. R2 = 0.1 0, F = 3.80, p = 0.0066), and CSF did not contribute any variance. 
The combination of modalities did not improve upon the adjusted R2 values 
beyond MRI alone (R2 = 0.42, Adj . R2 = 0.36, F = 6.42, p < 0.0001). Larger 
surface area in the right pars orbitalis were significantly associated with shorter 
digit spans, while smaller cortical thickness in the right pericalcarine and smaller 
volume in the right isthmus of the cingulate were significantly associated with 
worse digit spans. The full models can be found in Table 5.4. 
Longitudinal digit span forward change 
For subjects in the normal aging group, the average APC for digit span 
forward was an increase of 0.13 (sd = 0.35). Because this study focuses on 
predicting future decline, we will not discuss the longitudinal digit span forward 
models for normal aging further. 
Baseline digit span backward 
MRI accounted for 31% of the variance (R2 = 0.38, Adj. R2 = 0.31, F = 
5.64, p < 0.0001) and FOG PET accounted for 5% of the variance (R2 = 0.09, 
Adj. R2 = 0.05, F = 2.35, p = 0.06). No CSF variables made it through the cutoff 
steps. Combining MRI morphometry and FOG PET metabolism accounted for 
36% of the variance (R2 = 0.42, Adj. R2 - 0.36, F = 6.98, p < 0.0001 ). In the 
multimodal model, larger cortical thickness in the left entorhinal, larger volumes 
in the right anterior cingulate and right pars triangularis, and larger surface area 
in the right transverse temporal were associated with worse scores on the digit 
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span backward in normal aging. Smaller cortical thickness in the right 
pericalcarine and smaller surface area in the left isthmus of the cingulate were 
also associated with wore sc.ores on the digit span backward. The full models 
can be found in Table 5.5. 
Longitudinal digit span backward 
In the group diagnosed as normal aging at baseline, digit span backward 
score improved an average of 0.13 per year (sd = 0.35). Because this study 
focuses on predicting future decline, we will not discuss the longitudinal digit 
span backward models for normal aging further. 
Baseline Trails A 
MRI accounted for 34% of the variance (R2 = 0.42, Adj. R2 = 0.34, F = 
5.46, p < 0.0001 ), FOG PET accounted for 14% of the variance (R2 = 0.18, Adj. 
R2 = 0.14, F = 4.1 0, p = 0.0021), and CSF variables did not pass the initial cutoff 
values. Combining MRI morphometry and FOG PET metabolism accounted for 
36% of the variance (R2 = 0.45, Adj. R2 = 0.36, F = 5.25, p < 0.0001 ). Older ages 
were associated with longer time to complete for Trails A. Larger volume in the 
right temporal pole, larger surface areas in the left insula and right lateral 
orbitofrontal regions, and hypermetabolism in the insula were associated with 
longer times to complete Trails A in normal aging. Smaller cortical thickness in 
the right transverse temporal, smaller surface area in the left rostral middle 
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frontal, as well as hypometabolism in the frontal pole were associated with longer 
times to complete Trails A The full models can be found in Table 5.6. 
Longitudinal Trails A change 
The average APC for Trails A in normal aging was 0.14 (sd = 0.49), 
indicating that it took more time to complete the test on future visits. This change 
was predicted best from combining MRI and FOG PET (R2 = 0.36, Adj. R2 = 0.29, 
F = 4.91, p < 0.0001). Larger baseline volume in the right temporal pole and 
surface area in the left banks of the superior temporal sulcus were predictive of 
greater decline during follow-up . Smaller baseline cortical thickness in the right 
posterior cingulate, volume in the right thalamus, surface area in the right inferior 
temporal, and hypometabolism of the precentral gyrus were associated with 
greater decline in Trails A at follow-up, as reflected in the positive APC. The full 
models can be found in Table 5.7. 
Baseline Trails B 
MRI accounted for 35% of the variance (R2 = 0.42, Adj. R2 = 0.35, F = 
6.19, p < 0.0001 ). Neither FOG PET nor CSF variables made it through the initial 
cutoff steps. Older age was associated with worse performance. Higher volume 
in the right temporal pole and higher surface area in the right superior temporal 
and right middle temporal areas were associated with longer times (e.g. worse 
performance) to complete Trails B. Smaller volume in the right precentral, and 
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smaller surface area in the right inferior parietal were associated with worse 
performance on Trails B. The full models can be found in Table 5.8. 
Longitudinal Trails B 
Time to complete trails B decreased on average by 0.06 (sd 0.01 ). 
Because this study focuses on predicting future decline, we will not discuss the 
longitudinal Trails B models for normal aging further. 
Baseline A V 30 minute delayed recall (Recall) 
MRI accounted for 40% of the variance (R2 = 0.48, Adj. R2 = 0.40, F = 
5.93, p < 0.0001 ), FDG PET accounted for 7% of the variance (R2 = 0.11, Adj. R2 
= 0.07, F = 2.85, p = 0.03), and CSF accounted for 9% of the variance (R2 = 
0.16, Adj. R2 = 0.09, F = 2.32, p = 0.07). Combining MRI morphometry and FDG 
PET metabolism accounted for 38% of the variance (R2 = 0.46, Adj. R2 = 0.38, F 
= 5.53, p < 0.0001), while combining CSF biomarker concentrations with the 
imaging measures, 40% of the variance in baseline AV 30 minute delayed recall 
was accounted for (R2 = 0.58, Adj. R2 = 0.40, F = 3.13, p = 0.002). Age, gender, 
and education were significantly associated with delayed recall. Larger volume in 
the left thalamus, and right isthmus of the cingulate, larger surface area of the 
right posterior cingulate, and hypermetabolism in the paracentral gyrus were 
associated with worse AV 30 minute delayed recall scores. Smaller surface area 
in the right inferior temporal was associated with worse AV 30 minute delayed 
recall scores. The full models can be found in Table 5.9. 
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Longitudinal A V 30 minute delayed recall (Recall) 
The average APC for AV 30 minute delayed recall was 0.14 (sd = 0.86). 
Because this study focuses on predicting future decline, we will not discuss the 
longitudinal 30 minute RAVL T delayed recall models for normal aging further. 
Baseline A V delayed recognition (Recognition) 
MRI accounted for 42% of the variance (R2 = 0.49, Adj. R2 = 0.42, F = 
6.72, p < 0.0001), FOG PET accounted for 7% of the variance (R2 = 0.12, Adj. R2 
= 0.07, F = 2.52, p = 0.04), and CSF accounted for 10% of the variance (R2 = 
0.17, Adj. R2 = 0.1 0, F = 2.53, p = 0.05). Combing MRI morphometry and FOG 
PET metabolism accounted for 45% of the variance (R2 = 0.53, Adj. R2 = 0.45, F 
= 7.15, p < 0.0001 ), while combining CSF biomarker concentrations with the 
imaging measures accounted for only 37% of the variance (R2 = 0.55, Adj. R2 = 
0.37, F = 3.02, p = 0.003). Age and gender with significantly associated with 
recognition scores. Larger volumes in the left temporal pole and left thalamus, 
larger surface area in the right supramarginal gyrus, and hypermetabolism in the 
hippocampus were associated with poorer recognition scores. Smaller volume in 
the right accumbens, and smaller surface area in the left insula were significantly 
associated with poorer recognition scores in the multimodal model. The full 
models can be found in Table 5.1 0. 
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Longitudinal A V delayed recognition scores (Recognition) 
Subjects categorized as normal aging at baseline declined on average 
0.005 (sd = 1.16). Because this study focuses on predicting future decline, we 
will not further discuss the longitudinal recognition scores for normal aging. 
MCI 
Baseline Clock drawing 
In MCI subjects, MRI accounted for 18% of the variance (R2 = 0.21, Adj. 
R2 = 0.18, F = 6.48, p < 0.0001) and FOG PET accounted for 3% of the variance 
(R2 = 0.05, Adj. R2 = 0.03, F = 2.47, p = 0.05). No CSF variables made it through 
the initial cutoff values. Combining MRI morphometry and FOG PET metabolism 
accounted for 20% of the variance (R2 = 0.24, Adj. R2 = 0.20, F = 6.17, p < 
0.0001 ). Education was significantly associated with clock draw scores. Larger 
surface area in the right transverse temporal was significantly associated with 
lower scores in the multimodal model. Smaller cortical thickness in the right 
isthmus of the cingulate and right caudal middle frontal and surface area in the 
right inferior parietal lobule were significantly associated with lower scores in the 
multimodal model. The full models can be found in Table 5.11. 
Longitudinal Clock drawing 
In subjects diagnosed with MCI at baseline, the average APC in clock 
draw scores was 0.03 (sd = 0.59), thus it increased slightly every year. Because 
153 
this study focuses on predicting future decline, we will not further discuss the 
longitudinal clock drawing models for MCI. 
Baseline Digit span forward 
In MCI , MRI accounted for 5% of the variance (R2 = 0.08, Adj. R2 = 0.05, F 
= 2.66, p = 0.02). Neither FOG PET nor CSF variables made it through the initial 
cutoffs for entry as variables in the stepwise linear regression models. Age was 
significantly associated with baseline digit span forward. Smaller cortical 
thickness in the right pericalcarine and smaller volumes in the left pallidum and 
left were significantly associated with lower digit spans. The full models can be 
found in Table 5.12. 
Longitudinal Digit span forward 
Digit span forward score APC increased on average of 0.004 (sd = 0.59) 
in subjects diagnosed with MCI at baseline. Because this study focuses on 
predicting future decline, we will not further discuss the longitudinal digit span 
forward models for MCI. 
Baseline Digit span backward 
In MCI, MRI accounted for 10% of the variance (R2 = 0.13, Adj. R2 = 0.1 0, 
F = 4.95, p < 0.0001), FOG-PET variables did not make it through the initial 
cutoffs, and CSF biomarker concentrations accounted for 4% of the variance (R2 
= 0.08, Adj . R2 = 0.04, F = 2.05, p = 0.09). Combining MRI morphometry with 
CSF biomarker concentrations, the model accounts for 12% of the variance (R2 = 
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0.18, Adj. R2 = 0.12, F = 2.93, p = 0.008). Gender was significantly associated 
with worse scores. Lower concentration of a~1-42 in the CSF was significantly 
associated with lower scores as was smaller volume in the left frontal pole. The 
full models can be found in Table 5.13. 
Longitudinal digit span backward 
The average APC for digit span backward in MCI was 0.04 (sd = 0.73). 
Because this study focuses on predicting future decline, we will not further 
discuss the longitudinal digit span backward models for MCI. 
Baseline Trails A 
In MCI, MRI accounted for 11% of the variance (R2 = 0.14, Adj. R2 = 0.11 , 
F = 4.68, p < 0.0001 ), FOG PET accounted for 12% of the variance (R2 = 0.15, 
Adj. R2 = 0.12, F = 5.53, p < 0.0001) , but no CSF variables made it into the 
model. Combining FOG PET and MRI accounted for 17% of the variance (R2 = 
0.20, Adj. R2 = 0.17, F = 6.76, p < 0.0001 ). Education was significantly 
associated with baseline Trails A Thinner cortex in the left isthmus of the 
cingulate, smaller surface area in the right supramarginal gyrus, and 
hypometabolism in the precuneus were all significantly associated with longer 
times to complete Trails A in the multimodal model. The full models can be found 
in Table 5.14. 
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Longitudinal Trails A 
In the MCI group, the average APC for Trails A was -0.06 (sd = 0.70) , 
indicating that it required less time to complete at follow-up . Because this study 
focuses on predicting future decline, we will not further discuss the longitudinal 
Trails A models for MCI. 
Baseline Trails B 
MRI accounted for 27% of the variance (R2 = 0.30, Adj. R2 = 0.27, F = 
10.49, p < 0.0001), FOG PET accounted for 17% of the variance (R2 = 0.22, Adj. 
R2 = 0.17, F = 5.02, p < 0.0001 ), and no CSF variables made it through the initial 
cutoff stages. Combining MRI morphometry and FOG PET metabolism 
accounted for 30% of the variance (R2 = 0.34, Adj . R2 = 0.30, F = 1 0.27, p < 
0.0001). Education was significantly associated with Trails B in the MCI group. 
Smaller cortical thickness of the left cingulate, smaller volume of the left inferior 
parietal, smaller surface areas in the right superior frontal, and hypometabolism 
in the supramarginal gyrus were significantly associated with increased times to 
complete Trails Bin MCI at baseline. The full models can be found in Table 5.15. 
Longitudinal Trails B 
In the MCI group, the Trails B APC was -0.03 (sd = 0.50) , indicating less 
time to complete the test at follow-up. Because this study focuses on predicting 
future decline, we will not further discuss the longitudinal Trails B models for MCI. 
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Baseline A V 30 minute delayed recall 
MRI accounted for 31% of the variance (R2 = 0.35, Adj. R2 = 0.31, F = 
9.26, p < 0.0001), FOG PET accounted for 1% of the variance (R2 = 0.03, Adj. R2 
= 0.01, F = 1.61.p = 0.17), and CSF accounted for 4% of the variance (R2 = 0.08, 
Adj. R2 = 0.04, F = 1.99, p = 0.1 0). Combining MRI morphometry accounted for 
30% of the variance (R2 = 0.34, Adj. R2 = 0.30, F = 8.47, p < 0.0001), while 
combining CSF and imaging modalities accounted for 23% of the variance (R2 = 
0.32, Adj. R2 = 0.23, F = 3.48, p = 0.0003). Age and gender were significantly 
associated with baseline recall scores in MCI subjects. Larger cortical thickness 
in the right supramarginal gyrus and larger surface area in the left postcentral 
gyrus were associated with lower scores. Smaller cortical thickness in the right 
superior parietal and left insula and smaller volume in the hippocampus were 
significantly associated with lower scores. The full models can be found in Table 
5.16. 
Longitudinal A V 30 minute delayed recall 
MCI subjects showed an average APC for AV 30 minute delayed recall of 
-0.03 (sd = 0.61). MRI accounted for 26% of the variance (R2 = 0.31, Adj. R2 = 
0.26, F = 96.36, p < 0.0001) , FOG PET accounted for 1% of the variance (R2 = 
0.04, Adj. R2 = 0.01, F = 1.41.p = 0.23). Combining MRI morphometry and FOG 
PET metabolism accounted for 26% of the variance (R2 = 0.31, Adj. R2 = 0.26, F 
= 6.21 , p < 0.0001) , while combing CSF biomarker concentrations with imaging 
markers accounted for 12% of the variance (R2 = 0.26, Adj . R2 = 0.12, F = 1.85, p 
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= 0.07). Older age was significantly predictive of greater change. Larger baseline 
cortical thickness in the left superior parietal, larger baseline volumes in the left 
entorhinal, left posterior cingulate, and left caudate, and larger baseline surface 
areas in the right postcentral and left pars opercularis were predictive of greater 
decline in the multimodal model. The full models can be found in Table 5.17. 
Baseline A V delayed recognition 
MRI accounted for 15'Vo of the variance (R2 = 0.18, Adj. R2 = 0.15, F = 
5.35, p < 0.0001 ), while no FOG PET or CSF biomarker concentration variables 
made it through the initial cutoff steps. Age was a significant predictor of 
recognition scores. Larger surface area in the left postcentral gyrus was 
significantly associated with lower AV delayed recognition scores. Smaller 
cortical thickness in the right middle temporal and volume in the left hippocampus 
were significantly associated with poorer performance on the AV delayed 
recognition. The full models can be found in Table 5.18. 
Longitudinal A V delayed recognition 
MCI subjects showed an average APC for AV delayed recognition score of 
0.05 (sd = 0.50), indicating better performance during follow-up. Because this 
study focuses on predicting future decline, we will not further discuss the 
longitudinal delayed recognition models for MCI. 
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AD 
Baseline Clock drawing 
In AD, MRI accounted for 35% of the variance (R2 = 0.43, Adj . R2 = 0.35, 
F = 5.62, p < 0.0001 ), FOG PET accounted for 6% of the variance (R2 = 0.1 0, 
Adj. R2 = 0.06, F = 2.41, p = 0.06), and CSF accounted for 1% of the variance 
(R2 = 0.09, Adj. R2 = 0.01, F = 1.17, p = 0.34). Combining MRI morphometry and 
FOG PET metabolism accounted for 38% of the variance (R2 = 0.47, Adj. R2 = 
0.38, F = 5.58, p < 0.0001). Adding CSF biomarker concentrations to imaging 
variables accounted for 30% of the variance (R2 = 0.49, Adj . R2 = 0.30, F = 2.53, 
p = 0.02). Larger cortical thickness in the left parahippocampal gyrus and the left 
precuneus and hypermetabolism in the cuneus were significantly associated with 
lower clock draw scores. Smaller cortical thickness in the right temporal pole, and 
left inferior parietal and smaller surface area in the left superior frontal were 
associated with lower clock draw scores. The full models can be found in Table 
5.19. 
Longitudinal Clock drawing 
In the AD group, the average APC was -0.28 (sd = 0.83) for clock draw. 
MRI accounted for 32% of the variance (R2 = 0.41 , Adj. R2 = 0.32, F = 4.53, p < 
0.0001 ). No FOG PET variables made it through the initial cutoff stage. Although 
CSF concentration of pTau made it through the initial cutoff, it did not contribute 
any additional variance beyond that offered by age, gender, and education in the 
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linear regression model. Larger baseline cortical thickness in the right fusiform, 
larger volume in the left paracentral gyrus, and larger baseline surface area of 
the left lateral occipital regions were predictive of higher APC in clock draw in the 
AD group. Smaller baseline cortical thickness in the right pericalcarine and 
smaller baseline surface areas in the left pars triangularis, left entorhinal, and 
right parahippocampus were significantly predictive of greater APC in clock draw. 
The full models can be found in Table 5.20. 
Baseline Digit span forward 
MRI accounted for 36% of the variance (R2 = 0.44, Adj . R2 = 0.36, F = 
5.81, p < 0.0001 ), FOG PET accounted for less than one percent of the variance 
(R2 = 0.04, Adj. R2 = -0.008, F = 0.82, p = 0.52). No CSF variables made it 
through the initial cutoff values. Combining MRI morphometry and FOG PET 
metabolism accounted for 38% R2 = 0.45, Adj . R2 = 0.38, F = 5.83, p < 0.0001 ). 
Education was significantly associated with digit span forward. Larger surface 
areas in the right pars triangularis, left postcentral gyrus, and left entorhinal , and 
hypermetabolism in the precuneus were significantly associated with worse 
performance on the digit span forward task. In addition, smaller volumes in the 
left pars orbitalis and smaller surface area in the right middle temporal were 
significantly associated with worse performance on the baseline digit span 
forward task in the AD subject group. The full models can be found in Table 5.21. 
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Longitudinal digit span forward 
The average APC for the AD group was -0.21 (sd = 0.96). MRI accounted 
for 30% of the variance (R2 = 0.37, Adj. R2 = 0.30, F = 5.45, p < 0.0001 ), no FOG 
PET variables made it through the initial cutoff stages, and CSF accounted for 
14% of the variance (R2 = 0.20, Adj. R2 = 0.14, F = 2.95, p = 0.03). Combining 
MRI morphometry with CSF biomarker concentration accounted for 35% of the 
variance (~ = 0.48, Adj. R2 = 0.35, F = 3.69, p = 0.002). Age was significantly 
predictive of future decline. Larger baseline concentrations of af31-42 in the CSF 
were predictive of greater decline at follow-up, as was larger baseline surface 
area in the left superior frontal in the multimodal model for the AD group. The full 
models can be found in Table 5.22. 
Baseline digit span backward 
MRI accounted for 31% of the variance (R2 = 0.38, Adj. R2 = 0.31, F == 
5.17, p < 0.0001), FOG PET accounted for 6% of the variance (R2 = 0.10, Adj. R2 
= 0.06, F = 2.39, p = 0.06) , and CSF accounted for 5% of the variance (R2 = 
0.13, Adj. R2 = 0.05, F = 1.67, p = 0.17). Combining MRI morphometry and FOG 
PET metabolism accounted for 31% of the variance (R2 = 0.38, Adj. R2 = 0.31, F 
= 4.91 , p < 0.0001 ). Combining CSF biomarker concentration with imaging 
variables accounted for 37% of the variance (R2 = 0.50, Adj. R2 = 0.37, F = 3.70, 
p = 0.002). Larger volume in the left pall idum and larger surface areas in the right 
cuneus, left fusiform were significantly associated with lower scores on the digit 
span backward. Smaller volume in the left inferior parietal and smaller surface 
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areas in the right rostral middle frontal and left precuneus were significantly 
associated with lower scores on the digit span backward. The full models can be 
found in Table 5.23. 
Longitudinal Digit span backward 
The average APC for the AD group was -0.21 (sd = 0.98). MRI accounted 
for 23% of the variance (R2 = 0.31, Adj. R2 = 0.23, F = 4.11, p = 0.0002), FOG 
PET accounted for 8% of the variance (R2 = 0.12, Adj. R2 = 0.08, F = 3.01, p = 
0.02), and No CSF biomarker concentration variables made it through the initial 
cutoffs for entry into the model. Combining MRI morphometric and FOG PET 
metabolic variables increased the variability to 25% (R2 = 0.32, Adj. R2 = 0.25, F 
= 4.27, p = 0.0001). Gender was a significant predictor of decline. Larger 
baseline surface areas in the left isthmus of the cingulate and left caudal middle 
frontal were significantly predictive of greater APC at follow-up for digit span 
backward in AD subjects. Smaller baseline cortical thicknesses in the right 
cuneus and left frontal pole at baseline were significantly predictive of greater 
APC at follow-up. The full models can be found in Table 5.24. 
Baseline Trails A 
MRI accounted for 35% of the variance (R2 = 0.44, Adj. R2 = 0.35, F = 
5.23, p < 0.0001 ), FOG PET accounted for 3% of the variance (R2 = 0.07, Adj. R2 
= 0.03, F = 1. 70, p = 0 .16), and CSF accounted for 17% of the variance (R2 = 
0.24, Adj. R2 = 0.17, F = 3.63, p = 0.01). Combining MRI morphometry and FOG 
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PET metabolism accounted for 30% of the variance (R2 = 0.37, Adj. R2 = 0.30, F 
= 5.86, p < 0.0001). Combining CSF with imaging markers accounted for 49% of 
the variance (R2 = 0.64, Adj. R2 = 0.49, F = 4.18, p = 0.0004) . Smaller cortical 
thickness in the right transverse temporal, smaller volume in the left inferior 
parietal, smaller surface area in the right pars triangularis were significantly 
associated with longer times to complete Trails A. The full models can be found 
in Table 5.25. 
Longitudinal Trails A 
The average APC for the AD group was -0.02 (sd = 0.72), in other words, 
with time, the time to complete Trails A in the AD group decreased. We did not 
include these models in this paper, as we focus on cognitive decline, and the AD 
subject showed improvements in performance over time. 
Baseline trails B 
MRI accounted for 32% of the variance (R2 = 0.40, Adj. R2 = 0.32, F = 
5.02, p < 0.0001), FOG PET accounted for 12% of the variance (R2 = 0.16., Adj. 
R2 = 0.12, F = 3.53, p = 0.006), and CSF accounted for 10% of the variance (R2 
= 0.17,d. ~ = 0.1 0, F = 2.37, p = 0.07). Combining MRI morphometry and FOG 
PET metabolism accounted for 35% of the variance (R2 = 0.43, Adj. R2 = 0.35, F 
= 5.34, p < 0.0001). Combining CSF with imaging variables accounted for 42% of 
the variance (R2 = 0.52 , Adj. R2 = 0.41, F = 4.66, p = 0.0003). Education 
significantly predicted baseline Trails B in AD subjects. Larger surface area in the 
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right isthmus of the cingulate was significantly associated with longer times to 
complete Trails B. Larger concentrations of tTau in the CSF were significantly 
associated with longer times to complete Trails B. Smaller cortical thickness in 
the left precuneus, smaller volumes in the left temporal pole, and smaller surface 
area in the right insula were significantly associated with longer times to 
complete Trails B. The full models can be found in Table 5.26. 
Longitudinal Trails B 
For the AD group, the average APC on Trails B was 0.15 (sd = 1.21 ). MRI 
accounted for 24% of the variance (R2 = 0.32, Adj. R2 = 0.24, F = 3.92 , p = 
0.0002) and FOG PET accounted for 4% of the variance (R2 = 0.08, Adj . R2 = 
0.04, F = 1.82, p = 0.13). No CSF variables made it through the initial cutoffs. 
Combining MRI morphometry with FOG PET metabolism accounted for 25% of 
the variance (R2 = 0.34, Adj. R2 = 0.25, F = 4.0, p = 0.0002). Smaller baseline 
volume in the right lateral orbitofrontal , and smaller baseline surface area in the 
right postcentral gyrus were predictive of greater decline during the follow-up 
period. Larger baseline volumes in the left rostral middle frontal and left 
hippocampus and larger baseline surface areas in the right entorhinal and left 
frontal pole were predictive of greater decline in Trails B during follow-up . The full 
models can be found in Table 5.27. 
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Baseline A V 30 minute delayed recall 
In the AD group, MRI accounted for 29% of the variance (R2 = 0.37, Adj. 
R2 = 0.29, F = 4.74, p < 0.0001) and FOG PET accounted for 7% of the variance 
(R2 = 0.12, Adj . R2 = 0.07, F = 2.32, p = 0.05). No CSF variables made it through 
the initial cutoff. Combining MRI morphometry and FOG PET metabolism 
increased the variance accounted for to 34% (R2 = 0.43, Adj. R2 = 0.34, F = 4.75, 
p < 0.0001). Larger cortical thickness in the right lingual, larger surface areas in 
the right rostral middle frontal and right lateral occipital, and hypermetabolism in 
the supramarginal gyrus were significantly associated with lower scores on AV 
30 minute delayed recall at baseline in the AD group. Smaller cortical thickness 
in the right superior temporal and smaller surface areas in the right paracentral 
gyrus were significantly associated with worse performance on AV 30 minute 
delayed recall at baseline. The full models can be found in Table 5.28. 
Longitudinal A V 30 minute delayed recall 
The average APC for the AD group on AV 30 minute delays scores was-
0.41 (sd = 0.38). MRI accounted for 68% of the variance (R2 = 0.78 , Adj. R2 = 
0.68, F = 7.65, p = 0.0001) and FOG PET accounted for less that one percent of 
the variance (R2 = 0.11, Adj. R2 = -0 .04, F = 0.72, p = 0.59). No CSF biomarker 
variables made it through the initial cutoff. Combining MRI morphometry and 
FOG PET metabolism accounted for 78% of the variance (R2 = 0.86, Adj. R2 = 
0.78, F = 10.40, p < 0.0001). Larger baseline cortical thickness in the 
parahippocampal gyrus and larger baseline surface area in the left pericalcarine 
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were significantly predictive of greater decline during follow-up. Smaller baseline 
volumes in the superior parietal , right frontal pole and smaller baseline surface 
areas in the right inferior parietal were significantly predictive of higher APC 
during the follow-up interval. The full models can be found in Table 5.29. 
Baseline A V delayed recognition 
MRI accounted for 36% of the variance (R2 = 0.42, Adj . R2 = 0.36, F = 
6.89, p < 0.0001) and FOG PET accounted for 11% of the variance (R2 = 0.16, 
Adj. R2 = 0.11 , F = 3.21, p = 0.01). No CSF biomarker concentration variables 
made it through the initial cutoffs. Combining MRI morphometry and FOG PET 
metabolism accounted for 35% of the variance (R2 = 0.42, Adj. R2 = 0.35, F = 
6.34, p < 0.0001 ). Age was significantly associated with delayed recognition 
scores. Larger cortical thickness in the right transverse temporal , larger volumes 
in the left frontal pole and brainstem, and hypermetabolism in the superior 
temporal were significantly associated with lower AD delayed recognition scores. 
In addition , smaller cortical thickness in the left entorhinal and smaller surface 
area in the right superior temporal were significantly associated with lower AV 
delayed recognition scores in the AD subject group at baseline. The ful l models 
can be found in Table 5.30. 
Longitudinal A V delayed recognition 
The average APC was -0.10 (sd = 0.63), thus the group decreased in their 
AV delayed recognition score over time. MRI accounted for 20% of the variance 
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(R2 = 0.28, Adj. R2 = 0.20, F = 3.41, p = 0.0014) and FOG PET accounted for 4% 
of the variance (R2 = 0.09, Adj. R2 = 0.04, F = 1.93, p = 0.11 ). No CSF biomarker 
baseline concentrations made it through the initial cutoffs. Combining MRI 
morphometry and FOG PET metabolism accounted for 23% of the variance (R2 = 
0.30, Adj. R2 = 0.23, F = 4.08, p = 0.0004). Larger baseline cortical thickness in 
the left isthmus of the cingulate and larger baseline volume in the left lingual 
were significantly predictive of increased APC for AV delayed recognitions. In 
addition, smaller baseline volume in the left entorhinal, smaller baseline surface 
areas in the right fusiform, and baseline hypometabolism in the posterior 
cingulate were significantly predictive of increased APC during follow-up. The full 
models can be found in Table 5.31. 
DISCUSSION 
In this study, we identified the baseline morphometric, metabolic, and CSF 
biomarker variables associated with baseline performance and decline in clock 
drawing, trails A and B, digit span forward and backward, and RAVL T delayed 
recall and recognition. We addressed two main hypotheses: MRI and FOG PET 
would independently account for variance in baseline neuropsychological test 
scores; and combining both modalities would improve prediction. In addition, we 
assessed the contribution of CSF biomarker concentrations to account for 
variance in neuropsychological performance at baseline and amount of average 
annualized decline in cognition. The results of this study indicate that MRI 
performs better than FOG PET or CSF measures at accounting for variance in 
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the neuropsychological measures at every stage of disease. Combining 
modalities did not consistently improve the adjusted R2 values, nor did FOG PET 
and CSF alone account for any variance. In many instances, no FOG PET or 
CSF biomarker concentration variables made it through the initial cutoff stages of 
building the models. Each of the tests was associated with measures related to 
widespread regions in the brain, which suggests that each of these tests involves 
a network of neuronal processing for efficient function. In addition, different 
regions were typically predictive of baseline performance and decline within each 
group, and the regions and types of measures varied between groups illustrating 
the complex nature of structure-function relationships and the impact of disease 
upon them. 
A number of imaging variables showed opposite relationships than 
originally anticipated (e.g. larger volumes predicting worse test scores or greater 
decline). While we are still investigating the exact origins of this negative 
relationship, in some cases it is likely the result of interactions between variables 
in the model , such as precentral FOG metabolism in MCI for Trails A. This 
interpretation is supported by the assessment run during the screening process, 
where regression was run using each variable separately and the directionality of 
the relationship was opposite to that found in the final multivariate model. Other 
instances where this may be the case is FOG metabolism of the pericalcarine 
and inferior parietal in baseline normal aging clock score, FOG metabolism in the 
superior temporal, superior frontal, and fusiform for MCI baseline Trails B, 
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cortical thickness in the right supramarginal gyrus for baseline MCI delayed 
recall, left precuneus cortical thickness for baseline AD clock drawing, and FOG 
metabolism for the postcentral gyrus in Trails A normal aging decline. 
For the inverse relationships that are not the result of potential interaction 
effects, one potential explanation is that is represents a compensatory 
mechanism. This phenomenon is not well understood, but has been observed 
previously (Browndyke et al. 2012; Caroli et al. 2010; Clement & Belleville 2010; 
Clement et al. 2012; Guedj et al. 2009; Leyhe et al. 2009; Mufson et al. 2012; Qi 
et al. 201 0) . The underlying premise being that these brain regions are more 
associated with a specific task than wou ld normally be the case to help cope with 
the loss of function in related structures (e.g. the pericalcarine may be 
compensating for decreased visuospatial processing abilities in other brain 
regions). Undoubtedly, this accounts for some of the inverse relationships that 
we observed. Finally, it is feasible that when looking at APC, the relationships 
with directions opposite to that expected are a byproduct of more rapid and 
variable rates of disease progression. More studies are needed for us to better 
understand these complex relationships. 
Clock Drawing 
The clock drawing test utilizes a number of cognitive functions, including 
visuospatial ability, executive function, comprehension, motor ability, and 
semantic memory (Leyhe et al. 2009; Rouleau et al. 1992; Royall et al. 1998; 
Shulman 2000). It has been argued that difficulties in clock drawing mostly reflect 
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impairments of visuospatial ability (Mendez et al. 1992; Sunderland et al. 1989), 
while others have argued that it is more heavily influenced by semantic memory 
and executive function (Libon et al. 1996; Rouleau et al. 1992; Tuokko et al. 
1992). Our results would suggest that multiple cognitive systems are associated 
with performance of the clock drawing test. In all groups frontal, parietal, and 
temporal regions were associated with clock draw scores, although the specific 
regions differed. In normal aging, left surface areas in the caudal middle frontal 
and pars triangularis were predictive of baseline performance, while in MCI the 
cortical thickness in the right caudal middle frontal was associated with baseline 
performance. In AD the frontal regions changed to the left superior frontal and left 
pars orbitalis. These results indicate that poorer performance on the clock 
drawing test may be related to increased levels of frontal lobe damage, agreeing 
with the argument in favour of frontal executive functioning involvement. In 
addition, nearly the entire right occipital lobe was involved with baseline 
performance in normal aging, but these areas were not associated with baseline 
performance in either MCI or AD. The posterior and isthmus of the cingulate 
were predictive of baseline performance in normal aging and MCI , respectively, 
which supports the notion that this test involves some memory component, as 
these regions are heavily connected to the hippocampus and MTL structures. 
Providing further support for a memory component is that the left 
parahippocampal gyrus was predictive of baseline scores in the AD group, 
suggesting that decrease cortical thickness in this region is associated with lower 
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scores on the clock drawing test. Clock drawing scores has previously been 
shown to be inversely related to tangle counts in the parietal lobe and the 
parahippocampal gyrus, as well as to neuronal count in the parahippocampal 
gyrus (Forst! et al. 1993). In addition, evidence suggests that the right 
parahippocampus, which in our case was predictive of APC in the AD group, is 
required for spatial memory and for accurate schematic spatial representations of 
familiar environments (Bohbot et al. 1998; Bohbot et al. 2000; Johnsrude et al. 
1999; Moscovitch et al. 2005; Owen et al. 1996). Perhaps in normal aging and 
MCI, the spatial memory and representations are not impaired enough to see 
associations with the parahippocampal gyrus. Also, the switch from left to right 
hemisphere in association with baseline and decline in the AD group suggests 
that perhaps the left hemisphere is affected first, followed by the right 
hemisphere. Visual information is processed in two streams, the dorsal , or 
where, and the ventral, or what, pathways. Because MCI and AD affect 
structures in both of these streams (e.g. parietal and temporal) , one might expect 
to see associations between both parietal and temporal structures with clock 
drawing performance. In fact, we observed increasing involvement of both the 
parietal and temporal regions with increasing disease severity. In addition , more 
temporal structures were predictive of future APC than parietal structures. It has 
previously been shown that the right posterior temporal lobe is associated with 
semantic knowledge about the clock's minute hand (Leyhe et al. 2009) , while the 
parietal lobe plays more of a role in detecting spatial relationships among 
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objects, which might be important for proper numbering of the clock (Ungerleider 
& Haxby 1994). The parietal lobe has also been associated with spatial 
construction ability and figure design ability, as damage to this area causes 
impairment on spatial reconstruction ability (Takahashi et al. 2008). In our 
subjects, the parietal lobe was increasingly involved with clock drawing abilities 
as the disease progressed . In addition, the types of variables involved reflects 
the idea that glucose metabolism is affected prior to structural changes in AD, 
with changes in FOG associated with baseline performance in normal aging and 
structural MRI measures associated with baseline performance in both MCI and 
AD groups. Interestingly, it was the inferior parietal lobule that showed this 
pattern. 
Trails A 
The neural correlates of Trails A are not well identified and it has not been 
well characterized on its own in normal aging, MCI, and AD, as it tends to be 
used in conjunction with Trails B. We examined both tests individually, rather 
than taking the ratio of the two, because with ratios, it is unknown whether it is 
the numerator or denominator that is the driving force behind the relationship . 
Trails A is thought to reflect abilities in visual scanning, graphomotor and 
psychomotor speed , and attention , as such, we would expect to see associations 
with the occipital areas, precentral gyrus, and regions critical to attention . Indeed, 
our results support each of these roles of Trails A. At baseline, visual regions 
were left lateralized and were observed in the lateral occipital and lingual areas in 
172 
normal aging and AD, respectively. In the MCI group, the left lateral occipital 
volume was predictive of decline, while the baseline left cortical thickness of the 
pericalcarine was predictive of decline in AD. The occipital cortex has previously 
been implicated in object-based attention (Hou & Liu 2012) , in agreement with 
our results . Reflecting the motor component of Trails A, baseline scores were 
associated with the precentral gyrus in normal aging and MCI groups. Baseline 
FOG uptake in the precentral and postcentral gyri was predictive of APC in the 
normal aging group, while surface area of the left paracentral gyrus was 
predictive of APC in the MCI group, confirming the role of brain regions 
controlling motor function in Trails A. Attention has also been implicated in Trails 
A. There are various forms of attention that may be more closely linked with 
distinct brain regions. Selective attention , whereby attention is focused on a 
single stimulus, while ignoring irrelevant information , is modulated by posterior 
parietal systems. These areas are important for orienting and shifting attention 
and may be modulated by basal ganglia structures (R. J. Perry & Hodges 1999). 
According to the Posner model , the intraparietal sulcus/superior parietal lobe and 
the temporoparietal junction are involved orienting attention to the appropriate 
location along with the frontal eye fields and inferior frontal gyrus (Steven E 
Petersen & Michael I Posner 2012; M I Posner & S E Petersen 1990). We 
observed supramarginal and inferior parietal associations in baseline 
performance of Trails A in MRI and AD subject groups. In addition , the pars 
triangularis portion of the inferior frontal was associated with baseline Trails A in 
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the AD group. This region along with the pars orbitalis was also predictive of APC 
in AD. In our subjects, Trails A was not predicted by the frontal eye fields, which 
are located in the caudal middle frontal gyrus (Blanke et al. 2000), but rather by 
the rostral middle frontal gyrus at baseline and APC. Thus, our results support 
the attention component of Trails A. We observed a significant increase in time to 
complete Trails A in the AD group as baseline. This may be the result of poor 
working memory, as reflected by increased involvement of memory structures in 
the model, or decreased attentional capacity, as indicated by greater involvement 
of attentional structures. In MCI and AD, as disease severity increased, more 
temporal and parietal regions were associated with Trails A, indicating that 
completion of the task relied more heavily on the memory network. This is also 
supported by the influence of baseline cortical thickness of the right isthmus of 
the cingulate on APC in MCI and AD groups. Similarly, the temporal lobe at 
baseline was predictive of APC in all three groups, particularly in the inferior 
temporal and banks of the superior temporal sulcus. Based on this we can 
conclude that our data-driven approach successfully identified neural correlates 
of Trails A components in our three subject groups and that MRI was able to 
predict baseline and APC performance better than FOG PET. 
Trails 8 
Similar to Trails A, Trails B also involves visual scanning, graphomotor 
and psychomotor speed and attention. However, because the test requires the 
switching between numbers and letters, there are components of cognitive 
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flexibility and set shifting, both of which are typically thought of as part of the 
executive function domain, which is mainly thought to be the realm of the frontal 
lobes. Thus, we might expect to observe involvement from the frontal lobe, 
reflecting set shifting abilities, the medial temporal and cingulate regions , 
reflecting working memory abilities required to keep track of where one is in the 
sequence of numbers/letters, and perhaps occipital regions reflecting the visual 
processing component of the test. Previous studies using fMRI have shown 
increased activation compared to Trails A in the left middle frontal gyrus, 
precentral gyrus, cingulate , superior frontal , medial frontal, insula, paracentral , 
and middle and superior temporal areas (Zakzanis et al. 2005) . In addition, 
previous studies have suggested that the strongest predictor of Trails 8 
performance is atrophy of the medial temporal lobe (Oosterman et al. 201 0) . The 
same study also cited correlations between performance on Trails 8 and working 
memory, executive function , speed, attention , and episodic memory, thus the 
regions critical to each of these skills may very likely be associated with Trails 8 
baseline performance or APC. In fact, Pa and colleagues (PA et al. 201 0) 
reported widespread correlations with trails 8 switch performance, involving gray 
matter of the frontal , parietal , temporal , and occipital lobes. Our results show that 
there is increasing involvement of frontal regions and decreased involvement of 
temporal regions in MCI and AD compared to normal aging. In addition, temporal 
and frontal regions tended to be the most predictive of APC, reflecting the roles 
of memory and executive processing in Trails B. 
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Digit Span Forward 
Digit span forward is thought to be a measure of attention (Cohen & Jr 
1993). It may be associated more with the left hemisphere than the right 
hemisphere, as brain injury to the left hemisphere can lead to an impaired digit 
span (F. W. Black 1986). Although our results showed about equal 
representation of the left and right hemispheres at baseline, we did observe an 
increased representation of the left hemisphere when predicting APC. In this 
case, 6 of the regions were in the right hemisphere, while 12 were in the left 
hemisphere. In the AD group, the variables most highly associated with digit 
span forward were the right middle temporal, left postcentral gyrus, left pars 
orbitalis, and the left entorhinal cortex. In MCI, the left hippocampus and right 
pericalcarine were most highly associated with digit span forward, while in normal 
aging, it was the right pars orbitalis, right pericalcarine, and right rostral middle 
frontal. There is a noticeable shift as the disease progresses to involve more 
memory structures, such as the hippocampus and entorhinal cortex, which 
indicates that the task becomes less of an attention task and more of a memory 
task as memory function worsens. It is not surprising that the pars orbitalis is 
involved, as it plays a role in speech production, what is interesting is the shift 
from the right hemisphere to the left hemisphere in normal aging and AD, 
respectively. The left pars orbitalis is the location of Broca's area and is typically 
thought to be involved in speech production, while the right pars orbitalis has 
been implicated in error inhibition on verbal tasks (Geva et al. 2012), inhibitory 
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control (Poirel et al. 2012). The middle temporal gyrus is involved in a number of 
cognitive processes, one of which is language processing (Cabeza & Nyberg 
2000). Thus, our results indicate that as the AD progresses from normal aging 
through MCI, the brain regions involved are those subserving memory and 
language processing regions. 
Digit Span Backward 
Digit span backward is thought to be a measure of the capacity of verbal 
working memory (R. Li et al. 2012). It involves storage and maintenance of the 
numbers in working memory as well as transformation of the data to reorder the 
numbers into reverse sequence. The highest predictors of baseline performance 
in normal aging were the right pericalcarine, right rostral middle frontal, left 
isthmus of the cingulate, and metabolism in the paracentral gyrus. In MCI 
subjects, MRI morphometry in the left frontal pole and left paracentral gyrus and, 
in AD subjects, the right rostral middle frontal , left inferior parietal, left pallidum, 
and right cuneus were most highly associated with digit span backward. The 
dorsolateral prefrontal cortex and inferior parietal lobule have previously been 
associated with digit span backward performance in neurodegenerative disorders 
(Amici et al. 2007). Involvement of the isthmus of the cingulate hints at the 
memory component of the task. This region was also predictive of APC in the 
normal and AD groups, while the caudal anterior cingulate was predictive of 
decline in MCI subjects. 
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RA VL T Delayed Recall 
Baseline recall scores in normal aging were most highly associated with 
paracentral metabolism and MRI morphometry in the right isthmus of the 
cingulate, right inferior temporal , and right caudal middle frontal regions. Recall 
score in MCI were most highly associated with right superior parietal , right 
supramarginal, and left hippocampal morphometry. Scores in AD were most 
associated with MRI morphometry in the right superior temporal , right lingual, 
and right rostral middle frontal regions, along with metabolism in the entorhinal 
and supramarginal gyrus. Hippocampal associations with recall in the MCI group 
provide support for the thought that there may be a connection between episodic 
memory and NFT pathology in the medial temporal lobes. The associations 
between frontal and parietal regions with recall scores is not surprising , as these 
regions have been shown to subserve working memory ability (Champed & 
Michael Petrides 2007). The posterior/isthmus of the cingulate as well as the 
precuneus and prefrontal regions are highly interconnected with the medial 
temporal lobes and have previously been shown to play a role in memory 
function . The prefrontal cortex contributes to encoding and retrieval of accurate 
memory (M. P. Alexander et al. 2009; Blumenfeld & Ranganath 2007), with the 
left ventrolateral prefrontal cortex being critical to semantic access at memory 
encoding (Logan et al. 2002; Otten et al. 2001). In our study, surface area in the 
right posterior cingulate and metabolism in the isthmus of the cingulate were 
predictive of recall score in normal aging and MCI , respectively. In a study 
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examining the correlations between baseline FOG metabolism and subsequent 
decline in verbal memory in pre-MCI individuals, the posterior cingulate, bilateral 
parietal, and left prefrontal were all correlated with higher rates of decline. 
Interestingly, in the same study, those who did not decline, but remained in the 
normal aging category at follow-up, showed significant correlations in the 
posterior and mid-cingulate regions with verbal memory decline. This indicates 
that it may be increased involvement of the parietal and frontal lobes that is 
predictive of future decline, more than the cingulate, as the cingulate was 
involved with verbal memory in both those who did not decline and those who did 
(Caselli et al. 2008). Interestingly, in a study with AD subjects examining various 
stages of recall based on the immediate recall trials and delayed recall and 
recognition trials of the RAVL T, different brain regions were implicated at 
different stages of recall. In the early immediate recall trials (e.g. trials 1 through 
3), the scores were correlated with cortical thickness of the inferior parietal, 
middle frontal, temporal pole, and supramarginal gyrus. Later immediate recall 
trials (e.g. 5 plus) were correlated with the medial temporal lobe and temporal 
pole. In delayed recall, the hippocampus correlated with performance (Wolk & 
Dickerson 2011). In our study, the hippocampus did not predict recall scores in 
the AD population. We did observe, however, associations with the entorhinal, 
rostral middle frontal, superior temporal , and the supramarginal gyrus, which 
were associated with earlier recall trials in the Wolk study (Wolk & Dickerson 
2011) . The hippocampus was implicated in the MCI group for recall , which would 
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suggest that in our method , the hippocampus is more sensitive to early rather 
than late deficits in recall. 
One difficulty in assessing the impact of deficits in recall is that it may 
represent problems in either learning or in retention, since both would affect the 
ability to recall information after delays. Although the present study did not 
separate the results into retention and learning, a previous study in MCI subjects 
examined high vs. low retainers and learners (Chang et al. 201 0). They observed 
that both learning and retention were significantly correlated with cortical 
thickness in the lateral and medial frontal cortex, lateral temporal, medial 
temporal , anterior temporal, parietal, and anterior and posterior cingulate 
cortices. Meanwhile, retention on its own, after removing the effects of learning, 
showed correlations with the anterior, medial, and ventral temporal lobe, 
entorhinal, parahippocampus, temporal pole, fusiform , and hippocampus. Thus, 
retention tended to involve more medial structures, while learning was more 
widespread. When this is applied to our results, we can conclude based on the 
regions predictive of recall scores, that in normal aging, recall is mainly affected 
by difficulties with retention, as predominantly temporal regions were involved. In 
our MCI and AD subjects, we observed more widespread changes, involving 
temporal as well as frontal and parietal regions, suggesting that as memory 
deficits progress, there becomes more difficulties in both learning and retention. 
It is also possible that as medial temporal regions become increasingly atrophic, 
that they are no longer able to mediate memory function and other brain regions 
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are recruited. This has been observed in functional imaging studies that show the 
compensatory involvement of a number of regions including the frontal (Clement 
& Belleville 201 0; Clement & Belleville 2012; Clement et al. 2012) and cingulate 
cortices (Caroli et al. 201 0; Clement et al. 2012). Of note, in the AD group we 
observed involvement of the medial orbitofrontal regions with recall scores. The 
medial orbitofrontal cortex is associated with the ability to inhibit irrelevant 
information (Happaney et al. 2004; D. T. Stuss & M. P. Alexander 2007), this 
suggests that in AD, the subjects are not able to inhibit the incorrect information 
to correctly identify which words to recall (e.g. the test words, rather than the 
interference words) . 
RA VL T Delayed Recognition 
Recall requires the generation of the mental representation of the original 
stimuli , whereas in the recognition condition , the original stimuli are presented 
again intermixed with distracter stimuli. Previous studies have shown that in AD, 
recognition more is heavily dependent on perirhinal and entorhinal cortices, 
rather than the hippocampus, which is implicated in delayed recall( Kerchner et 
al. 2012; Wolk & Dickerson 2011). In our subjects, the hippocampus was 
predictive of baseline performance in MCI and normal aging , while the entorhinal 
cortex was predictive of baseline performance in AD. In addition , the entorhinal 
cortex was predictive of APC in the AD group. This supports the theory that 
recognition relies on the entorhinal cortex in AD, but it also suggests that the 
hippocampus is more predictive of recognition at earlier stages of dementia. Our 
181 
results conflict to some degree with a recent study by Walhovd (K B Walhovd, A 
M Fjell, A M Dale, et al. 201 0), in which entorhinal metabolism accounted for 
15% of the variance in recognition scores in normal aging, while the 
parahippocampal gyrus accounted for the most variance in the MCI group and 
genetic variables, rather than imaging variables, predicted AD recognition scores. 
In our study, the parahippocampal gyrus did not predict baseline of APC in any 
group, which may be the result of differences in post-processing or other 
methodological differences. In addition, our FOG PET data was more strictly 
corrected for partial volume effects, which likely contributed to some of the 
discrepancies as well. The medial temporal lobes are thought to be associated 
with memories that are automatically retrieved given the appropriate cues, 
whereas memory that involves strategies and context (Strategic, explicit 
memory) , may involve more prefrontal areas. Along these line, we observed 
greater temporal and cingulate involvement than prefrontal involvement in 
baseline performance, but when predicting future change in MCI and AD, there 
were a number of inferior frontal regions that contributed to the model. Given that 
the task is auditory, it is not surprising that a number of auditory processing 
areas, such as the middle and superior temporal gyri are associated with 
recognition scores on the RAVL T. 
CONCLUSION 
At baseline, we observed progressively worse scores on 
neuropsychological tests of visuospatial abilities, attention, executive function , 
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delayed recall, recognition, and working memory in MCI and AD at baseline. 
However, over time, the MCI group declined mainly on delayed recall, whereas 
the AD group declined on everything but Trails A We generated statistical 
models for predicting baseline performance and future decline within MCI and AD 
of scores from a number of neuropsychological tests, which address specific 
cognitive functions. Overall, the models indicate that MRI was better able to 
predict baseline scores and future decline than either FOG PET of CSF 
biomarker concentrations. The brain regions that were associated with each 
tasks highlighted the types of cognitive skills required for successful completion 
of the test and also highlighted that these regions, when damaged, can result in 
poor memory, executive function, and visuospatial abilities. 
The results of this study provide insight into which types of cognitive 
functions might be best used in clinical trials as indices of disease severity and 
amount of decline. As increasing number of drug trials fail in later stages of 
testing , it is imperative to reanalyze the types of markers used to measure the 
success or failure of the treatments. The results of this study suggest that the 
imaging and CSF biomarkers most telling of disease severity and decline may be 
outside the medial temporal lobes and that perhaps it is these other regions, 
such as the frontal, parietal, and cingulate cortices that may be more telling 
clinical end points. 
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Table 5.1 Demographic information 
Baseline Age mean Education MMSE 
Subjects (m/f) years (std Mean (std dev) 
dev) 
Normal 105 (64/41) 75.81 (4.75) 15.90(3.12) 28.98 (1.12) 
Aging 
MCI 204 (137/67) 75.44 (7.22) 15.80 (2.88) 27.15 (1.71)a 
AD 94 (56/38) 74.91 (7.37) 14.61 (3.21 )a,o 23.48 
(2.14)a,b 
a significant difference from normal aging (p < 0.05), o significant difference 
from MCI (p < 0.05). 
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Table 5.2a. Baseline ANOVA results showing mean (sd) scores from each of the neuropsychological and cognitive tests for 
normal aging, MCI, and AD. Tukey's post-hoc results are presented in the last three columns, whereby a change in letter 
between groups indicates a significant change. 
Mean 
normal Mean MCI 'Normal 
df aging (sd) (sd) Mean AD (sd) F-value P-value Aglng !MCI AD 
CDR Memory 2 0 (0) 0.57 (0.1 9) 1.03 (0.34) 586.87 · <.0001 c b a 
CDR judgement and problem 
so!ving 2 0.03 (0.13) 0.37 (0.:.25) 0.86 (0.36) 262.05 <.0001 c b a 
. 
CDB_global 2 0 (0) 
·- _Q.:.~_(O) .. -· ~!30 (0.25) 1169.73 <.0001 c . b , a 
·- - -- - ' 
MMSE 2 28.98 (1 .1.?) 27.15 (1.71)' . ~~.48(2.14) 272.07 <.0001 a b c 
-
Clock draw 2 4.58 _(0.76) 4._?~ <~:~3) 3.33 (1.31) 42.45 <.0001 a b c 
-
. 
-
.. 
-
DJgitspan forward 2 8.~_8 (2.03_ -~· 1_0_(1.9J ) 1·~ (1.83)_ 15.05 <.0001 a a b 
-
- - --
Dig_it ~pan !>a~~i!rd 2 7.17 (2.1_?) I 6.1 ~_(2.0?) 4.:_~6 (2.0~) 36.97 <.0001 a b c 
-· - -·- - -
Trails A 2 t 93.36 (44.79) 1125.86 (6f!.6J) .1 .9_? .2~_(~-!: 1~) I 49.81 <.0001 b l b a 
- -
Trails B 2 37.36 (13.40) I 43.37 (21 .50) 70.24 (38.73) ' 50.75 <.0001 c b a 
- -
RAVL T 30 minute delayed recall 2 7.31 (3.83) 3.07 (3.44) 0.61 (1 .33) 114.9 <.0001 a b c 
RAVLT 30 minute d-elayed -
recognition 2 12.51 (2.93) 10.00 (3.59) 7.31 (3.98) I 53.96 <.0001 a b c 
RAVLT 30 minute delayed I 
recognition errors 2 0.82 (1.14) 2.00 (2.44) 3.19 (2.64) 28.14 <.0001 c b a 
Table 5.2b. Annual percent change (APC) AN OVA results showing mean (sd) APC from each of the neuropsychological and 
cognitive tests for normal aging, MCI, and AD during follow-up. Tukey's post-hoc results are presented in the last three 
columns, whereby a change in letter between groups indicates a significant change. 
MeanAPC 
' MeanAPC · MeanAPC 
df 
normal 
aging (sd) MCI (sd) l AD (sd) · F-value 1 
.Normal 
P-value Aging · MCI AD 
Clock draw 
Q_igit_span !orw~_rd 
Digit s~nba~kward 
Trails A 
Trails B 
-·- -·-
- .. . .. 
RAVL T 30 minute delayed recall 
RAVLT 30mi11ute de layed -·· - ---
recognition 
2 ' 
2 
2 
2 · 
2 
2 
0.11 (0.83) 
-- 0.12_(0.55t 
Q.13J<!:_35) 
_9.14 (0.49) 
_ -~:96 (O.q_1) 
0.14 (Q.86) 
2 -0.005 (1.16) • 
0.03 (0.?9) ' 
0.0~ (0.5~)J 
O.Q..4 (0.7~) ; 
-0.06 (0. 70) i 
-o.o3 .. (o.5o>' i 
-o~_Q3 ·(o:61.) ' 
0.05 (0.50) 
-0.28 (0.83) 8.3 , 0.0003 
-.-<!.:.15 (0.~8) 3.98 0.02 
~0 .. 2~ (0.96L: 6.21 -0.002 
-0.02 (0.72) . - 3.27 .. 0.04 
o .. !~J 1.~ ~ > i .. 2.86 ' o.o6 
-:0.41 (0.38) 7.12 ' O.O,Q_1 
' 
-0.10 (0.63) , 1.25 0.29 
a 
a 
--
a 
a 
b . 
-· 
--~--
a 
-
a 
a · 
ab 
a 
.. 
a 
ab 
-
a 
a 
-
b 
b 
b 
a 
a 
b 
a 
Table 5.3. Models predicting baseline clock drawing in normal aging subjects. The MRI model accounted for 43% of the variance, FOG PET 
accounted for 32% of the variance, and combining modalities accounted for 49% of the variance. 
MRIMODEL FOG PET MODEL MULTIMODAL MODEL 
Parameter Standardized Parameter Standardized Parameter Standardized 
Estimate p-value Estimate Estimate p-value Estimate Estimate · p-value Estimate 
Age -0.06 <.0001 -0.35 -0.05 0.001 -0.31 -0.06 <.0001 -0.36 
-
.. 
Gender -0.14 0.26 -0.09 -0.05 0.72 -0.03 -0.06 0.63 -0.04 
Education 0.07 0.001 0.30 0.08 0.0002 0.34 0.07 0.0003 0.30 
--Right pericalcarine cortical 
thickness -2.05 0.003 -0.23 - - - -1 .88 0.01 -0.21 
Right posterior cingulate cortical 
thickness 1.49 0.0002 0.31 
- - --
1.45 ' 0.0003 0.30 
Left caud ai middle frontal surface 
area -0.0003 0.09 -0.13 - - - -0.0003 0.05 -0.15 
Left pars triangularis surface area -0.001 <.0001 -0.34 - - - -0.001 ' 0.0002 -0.31 
Right temporal pole su~ace area 0.002 0.13 0.12 
- - -
0.002 0.08 · 0.13 
Right lingual surface area 0.0004 0.02 1 0.19 - - - 0.0004 0.05 0.16 
Cuneus FOG PET - - - -0.0002 0.01 -0.58 -0.0001 0.01 -0.22 
-
Inferior parietal FOG P_ET - - - 0.0001 0.19 0.22 - - -
Lateral occipital FOG PET - - - -0.0001 0.06 -0.25 - - -
Pericalcarine FOG PET - i - - 0.0001 0.06 0.31 - - -
Table 5.4. Models predicting baseline digit span forward in normal aging subjects. The MRI model accounted for 36% of the variance, FOG PET 
accounted for 10% of the variance, and combining modalities accounted for 36% of the variance. 
MRIMODEL FDG PET MODEL MULTIMODAL MODEL 
Parameter · Standardized Parameter Standardized Parameter I Standardized 
Estimate p-value Estimate Estimate 1 p-value Estimate Estimate i p-value Estimate 
Age -0.07 0.05 -0.17 -0.07 0.07 -0.18 -0.05 0.20 -0.12 
Gender -0.39 0.30 -0.09 -0.03 0.94 -0.01 -0.37 0.33 -0.09 
-
Education 0.11 0.05 0.17 0.15 0.03 0.23 0.13 0.03 0.21 
.. 
Rright pericalcarine cortical 
thickness 6.12 0.003 0.26 - - - 5.71 0.01 0.25 
- -
Left fusiform cortical thickness -1 .59 0.16 -0.14 - - - -2.50 ' 0.01 -0.22 
Right rostral middle frontal Cortical -
... 
thickness -2.39 0.06 . -0.20 - - - - - --
Right isthmus of the cingulate - - -- ~· I 
volume 0.001 0.04 0.18 - - - 0.001 0.02 0.21 
Right superior parietal surface --
.... 
--
.. 
---- -
-- --
area 0.0004 0.18 ' 0.12 - - - -- --
-
- .. 
-· - - ·-Left superior temporal surface 
area 0.001 0.17 0.13 - - - 0.001 0.12 0.15 
Right pars orbitalis surface area -0.01 0.0003 -0.34 - - - -0.01 0.003 -0.28 
-
Left inferior pa~etal surface area 0.001 0.06 0.16 - - - 0.001 0.04 0.18 
Pallidum FOG PET - - - -0.001 0.06 -0.19 -0.001 0.03 -0.19 
...... 
CX> 
co 
Table 5.5. Models predicting baseline digit span backward in normal aging subjects. The MRI model accounted for 31 o/o of the variance, FOG PET 
accounted for 5% of the variance, and combining modalities accounted for 36% of the variance. 
MRIMODEL FOG PET MODEL MULTIMODAL MODEL 
Parameter : Standardized Parameter 'Standardized Parameter Standardized 
Estimate ' p-value Estimate Estimate p-value Estimate Estimate 1 p-value Estimate 
Age -0.07 0.06 -0.17 -0.04 0.36 -0.09 -0.07 0.07 -0.15 
Gender -0.37 0.34 -0.09 -0.26 0.57 -0.06 -0.28 0.46 -0.07 
Education 0.08 0.20 0.1 2 0.09 0.18 ' 0.14 0.09 0.14 0.14 
Right pericalcarine cortical - -. -
thickness 10.72 <.0001 0.44 - - - 10.62 j <.0001 0.44 
-
-
i -
-
Left entorhinal cortical thickness -0.71 0.15 -0.13 - -- - -0.79 0.12 -0.14 
Right rostral middle frontal cortical 
- . 
_,_ 
thickness -2.81 0.02 -0.22 
- - -- -- - -
Right rost ral anterior clngulate ·- -- I -
volume -0.001 0.06 · -0.16 -
- · 
- -0.001 0.91 , -0.21 
-
- -··-
- . - - - . 
Right pars triangularis volume -0.0004 0.14 -0.13 - I - - -0.001 0.05 -0.18 
Left isthmus of the cingulate -
surface area 0.004 0.02 0.20 - - - 0.004 0.02 0.20 
Right transverse temporal surface 
area -0.01 0.03 -0.20 - - - -0.01 0.01 -0.24 
- -
Paracentral FOG PET - - - 0.0002 0.02 0.23 - -- -
....... 
(.0 
0 
Table 5.6. Models predicting baseline Trails A in normal aging subjects. The MRI model accounted for 34% of the variance, FOG PET accounted for 
14% of the variance, and combining modalities accounted for 36% of the variance. 
MRIMODEL FDG PET MODEL MULTIMODAL MODEL 
Parameter Standardized Parameter 1 Standardized Parameter Standardized 
Estimate p-value Estimate Estimate , p-value . Estimate Estimate I p-value Estimate 
Gender 2.06 0.43 0.08 -2.24 0.43 -0.08 0.12 0.96 · 0.004 
Education 0.36 0.36 0.08 -0.09 0.84 -0.02 0.19 0.63 · 0.04 
Left caudal anterior cingulate 
cortical thickness -4.67 0.18 -0.12 
- - - - - -
Right transverse temporal cOrtical -
thickness -9.49 0.03 -0.20 - - - -10.83 0.02 -0.22 
·-
Right temporal pole volume 0.01 0.002 0.27 - - I - 0.01 0.01 0.23 
-
_Left lateral occipital voh~_me -0.002 0.04 -0.18 - - - -0.001 0.07 -0.16 
- - - -- -
·- -
Right caudate volume -0.01 0.02 -0.21 - - - -0.01 0.06 -0.17 
I eft.rostralm iddie frontal surface -- ·- - ·- - -
.. 
-
.. .. 
-
--· _.... ~ . 
area -0.01 0.01 -0.28 - - - -0.01 0.004 , -0.30 
- ·-·- - -~-- . 
Left insula surface area 0.02 0.01 0.26 - - - 0.02 0.09 0.17 
-
' Right precentral surface area -0.01 0.03 -0.23 - - - -0.01 0.06 -0.20 
Right lateral oibitofrontal surface 
.. 
- -
I 
area 0.02 0.004 0.27 - - - 0.02 0.01 0.26 
. 
-- -- - -- - -- - - -
Franta! pole._ FOG P!=T - - - -0.002 0.001 -0.39 -0.001 0.04 -0.21 
-
Insula FOG PET - - - 0.003 0.002 0.34 0.002 0.01 0.24 
Table 5.7. Models predicting APC of Trails A in normal aging subjects. The MRI model accounted for 22% of the variance, FOG PET accounted for 
8% of the variance, and combining modalities accounted for 29% of the variance. 
MRIMODEL FOG PET MODEL MULTIMODAL MODEL 
Parameter Standardized Parameter ! Standardized Parameter Standardized 
Estimate p-value 1 Estimate Estimate ; p-value Estimate Estimate , p-value Estimate 
Age -0.01 0.29 ' -0.10 -0.004 0.68 -0.04 -0.01 0.24 -0.11 
.. 
-
Gender 0.09 0.37 0.09 0.10 0.36 · 0.10 0.15 0.13 0.15 
-
Education 0.02 0.32 0.10 0.04 0.02 , 0.25 0.02 0.20 0.12 
-Right posterior cingulate cortical - - -
•. 
...... 
c.o 
...... 
thickness -0.79 0.01 -0.26 - - ' - -0.66 0.02 -0.21 
-- - -
Right te'!lporal po~~C?Iume 0.001 0.002 ' 0.30 - - - 0.001 ' 0.001 0.31 
.. 
- --- - -
.. 
··- -. -
.. 
-
Right pars orbitalis ~ol~me -0.0002 0.20 -0.12 - - - -0.0003 0.07 -0.17 
- --
- -- - -· 
Right thalamus volume -0.0002 . 0.04 -0.19 - - - -0.0002 ' 0.02 . -0.21 
Right rostral middle frontal surface· --- -- ·-· -- -· 
--~- -··-
__. ··--- -- -
.. 
-
area -0.0001 0.14 -0.14 - - - - - -
Right inferior temporaisurface - - -- ·- -----
.. 
·--- -
-
- --
.. --~ -
--- -
.. -
- --- - --
area -0.0003 0.01 -0.25 - - - -0.0003 0.01 -0.24 
-
. -
--
- -
.. 
-
.. 
-
Left banks STS surface area 0.001 0.01 0.24 - - - 0.001 0.01 0.26 
-
... 
.. -- - -· . 
. -
-
Postcentral FOG PET - - - 0.0001 0.11 . 0.39 - - -
- -
. -
--
·-- -- - -- - --
Precentral FOG PET - - - -0.0002 0.01 -0.62 -0.0001 0.001 -0.31 
Table 5.8. Model predicting baseline Trails B in normal aging subjects. 
The MRI model accounted for 35% of the variance. 
MRI MODEL 
Parameter Standardized 
Estimate p-value Estimate 
Age 1.76 0.04 0.19 
~ 
-Gender 0.90 0.91 0.01 
- -
Education -2.29 0.07 -0.16 
-
Right temporal pole volume 0.04 
-
0.003 0.26 
~ight pr~central volume -0.01 0.001 -0.32 
-~eft pallid_um v<!!_~mE! -0.04 0.08 -0.15 
-
Righ! accumbens volume -0.08 0.08 -0.15 
--Right superior temporal surface 
area 0.04 0.004 0.28 
- -
Right midtemporal surface area 0.03 0.005 0.26 
Left-pa-rahippoeariipal surface ; 
area 0.08 0.10 0.14 
-
Right inferior parietal surface area -0.02 0.02 -0.21 
192 
Table 5.9. Models predicting baseline RAVL T 30 minute delayed recall in normal aging subjects. The MRI model accounted for 40% of the variance, 
FOG PET accounted for 7% of the variance, and CSF accounted for 9% of the variance. Combining imaging modalities accounted for 38% of the 
variance, while combining all modaliites accounted for 40% of the variance. Param. Est. = Parameter Estimate, Std. Est. = Standardized Estimate. 
MRI MODEL FOG PET MODEL CSF MODEL MODEL MULTIMODAL MODEL 
Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. 
Est. . value Est. Est. value Est. Est. l value Est. Est. • value Est. Est. value Est. 
Age -0.23 1 0.001 -0.28 -0.14 0.07 -0.19 -0.12 0.24 -0.16 -0.24 0.001 -0.31 -0.28 i 0.01 1 -0.40 
- -
--
- -
- --
. 
Gender 1.08 0.11 0.14 0.90 0.27 0.12 0.73 0.50 0.10 1.04 0.14 0.13 2.27 , 0.04 · 0.31 
Education 0.13 0.22 0.11 0.25 0.05 0.21 0.39 0.02 0.34 0.21 0.06 0.17 0.48 · 0.002 0.43 
Left superior 
parietal volume -0.0005 0.03 -0.21 - - - - - - -0.001 0.01 -0.25 -0.0003 0.36 -0.13 
Right i sthmus of - - -· I 
the cingulate 
volume -0.003 0.02 -0.23 
- - - - - --
-0.004 0.004 -0.30 -0.01 1 0.003 -0.48 
Right pericalcarine 
volume 0.002 0.03 0.20 -- - - - - - 0.002 0.08 0.16 0.0002 0.92 0.02 
Right laterai - -·· - ·- -
-
occipital volume -0.0004 0.07 -0.17 - -- - - -- -- - - - 0.0002 : 0.64 0.07 
Left· thalamus 
. - - -
' -
.. 
-
volume -0.001 0.04 -0.17 - - - - - - -0.002 0.02 -0.20 -0.002 ' 0.03 -0.27 
Left transverse - --- "·- -- ·- - - - - ··-- - - ··- --
temporal surface I 
area -0.01 ' 0.07 ' -0.15 - - - -- -- -0.01 ' 0.05 -0.17 -0.01 ! 0.07 -0.24 
Right caudal 
. - -
... 
-
- -- -
·~~ .. 
-
.. 
- - - -
. -
' 
... ... 
- ·- .. -
.. 
I 
middle frontal 
surface area 0.002 · 0.01 0.24 
- - -- - - -
0.002 O.Q1 , 0.24 0.001 0.46 0.10 
.. 
--
.. 
·-·· 
-
-- ·- --Left fusifonn 
surface area -0.002 0.02 -0.20 - - -- - -- - -0.001 0.16 -0.13 0.0004 0.78 0.04 
Left entOrhinal - - - - - - - -
surface area 0.01 0.10 0.13 -- - - - - - - - - 0.002 t 0.68 0.05 
Right -inferior - -
temporal surface 
area 0.002 0.01 0.22 - - - - - -- 0.002 0.02 0.20 0.003 0.04 0.26 
Right posterior 
cingulate surface 
area -0.004 0.07 -0.15 - - - - - -- -0.004 0.11 -0.14 -0.01 0.05 -0.24 
Paracentral FOG 
PET - - - -0.0004 0.02 -0.23 - -- - -0.0002 0.14 -0.13 -0.0004 0.13 -0.21 
Phosphorylated tau - - - - - - -0.04 0.19 -0.18 - - - -0.05 0.09 -0.22 
Table 5.10. Models predicting baseline RAVLT 30 minute delayed recognition in normal aging subjects. The MRI model accounted for 42% of the 
variance, FOG PET accounted for 7% of the variance, and CSF accounted for 10% of the variance. Combining imaging modalities accounted for 
45% of the variance, while combining all modaliites accounted for 37% of the variance. Param. Est. = Parameter Estimate, Std. Est. = Standardized 
Estimate 
MRI MODEL FOG PET MODEL CSFMODEL MODEL MULTIMODAL MODEL 
Param. p- • Std. Param. p- Std. Param. p- Std. Param. p- Std. Param. , p- Std. 
Est. value Est. Est. value Est. Est. value Est. Est. value Est. Est. value Est. 
Age -0.10 I 0.07 1 ~0.16 -0.06 0.34 -0.10 -0.14 0.05 -0.27 -0.11 0.05 -0.17 -0.28 0.01 -0.40 
'> 
Gender 1.35 0.01 ' 0.23 1.21 0.06 0.20 1.22 0.11 0.23 1.24 0.02 0.20 2.27 • 0.04 0.31 
Education -0.06 . 0.47 -0.06 -0.12 0.24 -0.12 0.04 0.72 0.05 -0.06 0.44 -0.06 0.48 • 0.002 0.43 
-· 
-· 
-Right banks STS 
cortical thickness -1.80 ' 0.12 -0.13 -- - - - - - -2.18 0.07 -0.16 -0.0003 0.36 -0.13 
Left isthmus of the 
cingulate volume -0.002 0.03 -0.19 - - - - - - -0.001 0.12 -0.13 -0.01 0.003 -0.48 
--··-Left temporal pole 
volume -0.003 1 0.0001 -0.31 - - - - - - -0.003 0.0002 -0.32 0.0002 0.92 0.02 
- - -· -
- - -Right lateral 
occipital volume -0.0004 0.03 -0.19 - - - - -- - -0.0003 0.06 -0.16 0.0002 0.64 0.07 
Left thalamus - - -
-
volume -0.001 0.07 -0.15 - - - - · - - -0.001 0.04 -0.18 -0.002 0.03 -0.27 
- - - -Right accumbens 
volume 0.01 ! 0.02 0.19 - - - - - - 0.01 0.002 0.27 -0.01 0.07 -0.24 
Right cuneus " - - - -
- -
surface area 0.002 0.19 0.11 -- - - - - - - - - 0.001 0.46 0.10 
RI~Jhl fusiform 1- " 
surface area 0.001 0.07 . 0.16 - - - - - - - - - 0.0004 0.78 0.04 
Left insula surface 
area 0.004 0.02 1 0.21 - - - - - - 0.01 0.0004 0.30 0.002 0.68 0.05 
Right 
supramarginal 
surface area -0.002 0.01 -0.23 - - - - - - -0.002 0.02 -0.20 0.003 0.04 0.26 
Hippocampus 
FOG PET - - - -0.0004 0.09 -0.18 - - - -0.0004 0.06 -0.16 -0.01 0.05 -0.24 
Thalamus FOG 
PET - - - -0.0004 0.08 -0.18 - - - -0.0003 0.17 -0.12 -0.0004 0.13 -0.21 
Phosphorylated tau - - - - - - 0.03 0.03 0.31 - - - -0.05 0.09 -0.22 
Table 5.11. Models predicting baseline clock drawing in MCI subjects. The MRI model accounted for 18% of the variance, FOG PET accounted for 
3% of the variance, and combining modalities accounted for 20% of the variance. 
MRIMODEL FOG PET MODEL MULTIMODAL MODEL 
Parameter ; Standardized Parameter Standardized Parameter 
. 
1 Standardized 
Estimate , p-value Estimate Estimate · p-value Estimate Estimate 1 p-value Estimate 
~ge -0.0004 0.96 -0.003 -0.01 0.37 -0.07 -0.0003 . 0.98 -0.002 
- - -
--. 
- -- -· --· - - - -- - - --~ -
Gender -0.05 0.69 -0.03 -0.03 0.84 -0.01 -0.03 0.82 -0.02 
..... 
- --· - - - -
Education 0.04 0.08 0.12 0.05 0.05 , 0.14 0.04 • 0.05 · 0.13 
Right isthmus of the cingulate --- -
-· 
-- --
I 
cortical thickness 0.56 0.03 0.16 
- - -
0.52 0.05 ' 0.15 
Right caudal middle frontal - - - i 
cortical thickness 0.86 , 0.02 0.17 - - - 0.85 0.02 • 0.18 
. - -· --· - - - --· - -·· - ---- -
- .. ~· 
Right banks STS volume 0.0003 1 0.10 1 0.11 -- - · - 0.0003 0.12 1 0.11 
-. 
Right transverse temporal surface 
area -0.004 0.001 -0.22 - - - -0.004 0.002 -0.21 
Righ~infe~or pari~tal surface area 0.0003 ' 0.01 0.17 - - - 0.0003 0.002 0.22 
-
Inferior temporal FOG PET - - - 0.0001 0.04 0.15 0.0001 0.17 ' 0.09 
Table 5.12. Model predicting baseline digit span forward in MCI 
subjects. The MRI model accounted for 5% of the variance. 
MRIMODEL 
Parameter Standardized 
Estimate p-value Estimate 
Ag_e -0.04 ; 0.03 -0.17 
·-
Gender -0.07 ' 0.81 -0.02 
-
- - -
Education 0.02 0.70 0.03 
-Right pericalcarine cortical 
thickness -2.89 0.04 -0.15 
-- -
Left pallidum volume -0.001 0.07 -0.13 
Left hippocampus volume -0.001 0.04 -0.16 
196 
Table 5.13. Models predicting baseline digit span backward in MCI subjects. The MRI model accounted for 10% of the variance, CSF biomarkers 
accounted for 4% of the variance, and combining modalities accounted for 12% of the variance. 
MRI MODEL CSF MODEL MULTIMODAL MODEL 
Parameter Standardized Parameter Standardized Parameter Standardized 
Estimate p-value Estimate Estimate p-value Estimate Estimate , p-value Estimate 
Age 0.001 0.96 0.003 -0.02 0.49 -0.07 -0.01 0.74 -0.03 
-
.. 
- . - -
Gender 0.50 0.09 0.11 0.88 0.05 0.20 0.95 . 0.03 0.21 
-
-· Education 0.03 0.50 0.05 0.05 0.45 0.08 0.04 0.61 0.05 
Left isthmus of the cingulate - ' I 
volume 0.001 0.09 ' 0.12 - - - 0.0002 t 0.74 0.03 
-
--
--
.. 
-
Left frontal pole volume 0.004 0.001 ' 0.23 _ , -- - 0.004 0.01 0.28 
-
Left paracentral su_rface area 0.002 0.01 0.18 
- -- -
0.001 0.26 0.11 
ABETA142 - -- - 0.01 0.04 0.20 0.01 0.03 0.21 
...... 
CD 
00 
Table 5.14. Models predicting baseline Trails A in MCI subjects. The MRI model accounted for 11 o/o of the variance, FOG PET accounted for 12% of 
the variance, and combining modalities accounted for 17% of the variance. 
MRIMODEL FOG PET MODEL MULTIMODAL MODEL 
Parameter Standardized Parameter Standardized Parameter Standardized 
Estimate p-value Estimate Estimate · p-value Estimate Estimate p-value Estimate 
Age -0.26 0.21 -0.09 -0.03 ' 0.88 -0.01 -0.15 0.46 -0.05 
.. ~ 
Gender 2.04 0.51 0.04 -0.04 0.99 -0.001 2.11 0.48 0.05 
-
-Education -0.79 . 0.12 -0.11 -1.15 0.02 -0.16 -0.99 0.04 -0.14 
Left isthmus of the cingulate-
cortical thickness -12.38 0.07 -0.14 
- - -
-16.20 0.01 -0.19 
Right precuneus cortical thickness -27.92 0.003 -0.23 - - - -14.16 0.12 -0.12 
Right inferior temporal surt'ace - -
' area -0.01 0.09 -0.12 - - -- -- ' - -
-
-
Right supramarginal surface area -0.01 0.04 -0.14 - - - -0.01 0.03 -0.14 
Inferior parietal FOG PET - - - -0.002 0.13 -0.19 - - -
- -
Precentral FOG PET - - - 0.003 0.03 0.23 - - -
Precuneus FOG PET - - - -0.003 0.03 -0.30 -0.003 0.001 -0.25 
Table 5.15. Models predicting baseline Trails B in MCI subjects. The MRI model accounted for 27% of the variance, FOG PET accounted for 17% 
of the variance, and combining modalities accounted for 30% of the variance. 
MRIMODEL FDG PET MODEL MULTIMODAL MODEL 
Parameter Standardized Parameter . 1 Standardized Parameter Standardized 
Estimate p-value Estimate Estimate p-value Estimate Estimate p-value Estimate 
Age -0.29 0.63 -0.03 0.68 0.33 0.07 -0.58 0.36 -0.06 
.. 
Gender 7.54 0.41 0.05 -1.03 0.92 -0.01 6.81 0.46 0.05 
Education -4.61 0.002 -0.19 -4.46 0.01 -0.18 -4.45 0.004 -0.18 
--Left isthmus of the cingulate 
cortical thickness -81 .26 <.0001 -0.28 
- - -
-74.24 ' 0.0002 . -0.26 
Left fron~l e<>le corti~l thickness -29.55 0.04 -0.13 - - -- -23.77 0.11 -0.11 
. 
-
Left inferior_parietal volume -0.01 0.002 -0.20 - - - -0.01 0.003 -0.19 
-
... 
-
Right cuneus surface area 
.. 
-0.03 0.11 -0.10 
- - -
-0.03 0.08 -0.11 
Right superior frontal surface .. area -0.02 0.00 -0.20 - - - -O.Q2 ' 0.001 -0.21 
.. 
Banks STS FOG PET - - - -0.01 0.01 -0.37 - ' - -
Fusiform FOG PET - - - 0.01 0.06 0.26 - - -
-
-
lnferi_or temporal FOG PET - - - -0.02 0.001 -0.42 - - -
-
Superior ~tal FOG PET - - - 0.01 0.03 0.25 - - -
Superior temporal FOG PET - - - 0.03 0.001 0.57 - - -
-
. 
Supramarginal FOG PET - - - -0.02 0.01 -0.47 -0.01 0.01 -0.18 
Caudate FOG PET - - - -0.01 0.07 -0.17 - - -
"' 0 
0 
Table 5.16. Models predicting baseline RAVlT 30 minute delayed recall in MCI subjects. The MRI model accounted for 31% of the variance, FOG 
PET accounted for 1% of the variance, and CSF accounted for 4% of the variance. Combining imaging modalities accounted for 30% of the variance, 
while combining all modaliites accounted for 23% of the variance. Param. Est. = Parameter Estimate, Std. Estimate = Standardized Estimate. 
MRIMODEL FOG PET MODEL CSF MODEL MODEL MULTIMODAL MODEL 
Param. p- Std. Param. P· Std. Param. p- Std. Param. P· Std. Param. p- Std. 
Est. value Est. Est. value Est. Est. •value Est. Est. value Est. Est. value Est. 
Age 0.08 0.01 0.16 -0.01 0.83 -0.02 -0.002 0.96 -0.005 0.07 0.03 . 0.14 0.09 0.05 0.21 
- -
Gender 0.91 0.04 · 0.12 0.50 · 0.34 0.07 0.34 0.60 0.05 0.97 0.04 0.13 0.75 , 0.22 0.12 
. . 
Education 0.12 , 0.11 0.10 0.08 0.37 0.07 0.01 0.94 0.01 0.09 0.23 0.08 -0.01 0.95 -0.01 
--
Right superior 
parietal cortical 
thickness 5.08 · 0.001 0.28 - - - - - - 5.06 0.001 0.28 4.17 0.04 0.27 
. -
-
left entorhinal 
cortical thickness 0.75 0.15 0.12 - - - - - - 0.83 0.12 0.13 0.96 0.15 0.17 
left pars orbitalis 
.. 
-
cortical thickness 1.47 0.11 0.11 
- - - - - -
1.52 , 0.11 0.12 1.26 0.32 0.11 
-
- . -
- .. 
--- -
left insula cortical 
thickness 3.67 0.00 0.22 - - - - - - 3.94 0.002 . 0.24 2.83 0.08 0.19 
- -
.. ... 
Right f I ! 
supramarginal 
cortical thickness -5.39 0.002 -0.31 - - -- - - - -5.87 1 0.001 -0.33 -4.65 0.05 -0.30 
left hippocampus 
volume 0.002 0.0001 0.32 - -- - - - - 0.002 0.0003 0.30 0.001 0.09 0.21 
Left postcentral 
- -
surface area -0.001 0.04 -0.13 - - - -- - - -0.001 0.03 -0.14 -0.001 0.34 -0.09 
left banks STS I 
surface area 0.002 0.13 0.09 - - - - - - 0.002 0.19 0.08 0.002 0.13 0.14 
Isthmus of the 
cingulate FOG 
PET - - - 0.0003 0.04 0.15 -- - - -- -- -
Phosphorylated tau - - - - - - -0.05 0,01 -0.28 -- -- -- -0.03 0.07 -0.18 
1\.) 
0 
...... 
.. 
Table 5.17. Models predicting APC of RAVLT 30 minute delayed recall in MCI subjects. The MRI model accounted for 26% of the variance, FOG PET 
accounted for 1% of the variance, and CSF accounted for 1% of the variance. Combining imaging modalities accounted for 26% of the variance, 
while combining all modaliites accounted for 12% of the variance. Param. Est. = Parameter Estimate, Std. Estimate= Standardied Estimate. 
MRIMODEL FOG PET MODEL CSFMODEL MODEL MULTIMODAL MODEL 
Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. 
Est. , value Est. Est. value Est. Est. lvalue Est. Est. 1 value 1 Est. Est. i value . Est. 
Age 0.02 1 0.002 0.27 0.004 0.60 0.05 0.005 1 0.59 · 0.07 0.02 1 0.002 0.27 0.02 : 0.06 0.29 
·-
Gender -0.09 0.36 -0.07 -0.14 0.25 -0.10 -0.08 0.58 -0.07 -0.08 0.42 -0.06 -0.09 ' 0.54 -0.08 
-. 
Education -0.02 0.31 -0.08 -0.02 0.40 -0.07 0.01 0.58 0.07 -0.02 0.21 -0.10 0.01 0.50 0.08 
- -· -Left superior 
parietal cortical 
thickness 0.60 0.02 0.19 - - - - - - 0.55 0.04 0.17 0.29 1 0.39 0.12 
Left entOrhinal -
volume 0.0003 1 0.01 0.21 - - - - - - 0.0003 0.01 ; 0.22 0.0003 0.09 0.22 
Left posterior - - -· - - -- -· -
I 
cingulate volume 0.0003 1 0.02 0.19 - - -- - -- - 0.0003 0.04 0.17 0.0003 0.07 . 0.24 
Left caudate- - ·- -
. 
-·. 
-
···-· - - - . 
volume 0.0002 0.03 0.17 - - - - - - 0.0002 0.03 0.18 0.0003 1 0.13 0.19 
Right postcentral - -
.. 
- - -
surface area 0.0004 I 0.0002 0.29 - - - -- - - 0.0004 0.0003 1 0.29 0.0001 0.48 0.09 
-
. 
-Left pars 
opercularis 
surface area 0.0005 0.002 0.24 - - - - - - 0.001 0.003 0.24 0.0005 ' 0.07 0.24 
Postcentral -FOG 
PET - - - -0.0001 0.16 -0.13 - - - - - - - - --
Phosphorylated tau - - - - - - -0.01 0.06 -0.24 - - - -0.01 0.16 -0.18 
Table 5.18. Model predicting baseline RAVLT 30 minute delayed 
recognition in MCI subjects. The MRI model accounted for 15% of the 
variance. 
MRJMODEL 
Parameter ! Standardized 
Estimate , p-value Estimate 
Ag_e 0.13 0.001 0.25 
- - - -
Gender 0.70 0.16 0.09 
Education 0.1 1 0.21 0.08 
Left pericalcarine cortical 
thickness 4.24 0.09 0.12 
Right middle temporal cortical - . -
thickness 3.15 . 0.01 0.19 
Left isthmus of the cingulate 
volume 0.002 0.06 0.13 
Left hipp<>campus volume 0.001 0.01 0.18 
-
Left postcentral surface area -0.001 0.05 -0.14 
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Table 5.19. Models predicting baseline clock drawing in AD subjects. The MRI model accounted for 35% of the variance, FOG PET accounted for 
6% of the variance, and CSF accounted for 1% of the variance. Combining imaging modalities accounted for 38% of the variance, while combining 
all modaliites accounted for 30% of the variance. Param. Est. = Parameter Estimate, Std. Est. = Standardized Estimate. 
MRI MODEL FDG PET MODEL CSFMODEL MODEL MULTIMODAL MODEL 
-
Param. p- Std. Param. p- Std. Param. p- Std. Param. P" l Std. Param. p- Std. 
Est. value Est. Est. value Est. Est. 1value Est. Est. value , Est. Est. value Est. 
Age 0.001 0.98 0.003 0.03 0.11 0.17 0.001 0.97 0.01 0.004 0.82 0.02 -0.01 1 0.62 -0.07 
.. 
- -· - -
.•. ... .. 
Gender -0.20 ' 0.40 -0.08 0.04 0:88 , 0.02 -0.05 0.88 -0.02 -0.25 0.31 -0.09 -0.28 · 0.41 -0.11 
-
. -
--
.. 
--
.. 
- -
.. 
Education -0.004 0.92 · -0.01 -0.04 0.39 1 -0.09 -0.02 0.67 -0.06 -0.02 0.60 ' -0.05 -0.03 0.55 -0.08 
Right superior 
parietal cortical 
thickness 1.33 0.08 0.23 - - - - - - 1.24 0.10 . 0.21 -0.85 0.52 -0.15 
-
-
Right temporal pole 
0.69 ' cortical thickness 0.65 O.Q1 0.24 - - - - - - 0.67 0.01 0.26 0.05 0.30 
Left pars orbitalis 
cortical thickness 0.84 ' 0.04 · 0.20 - - · - - - - 0.77 0.07 0.18 0.48 • 0.44 0.12 
teft --- - ·-···- - -· 
-- .... 
para hippocampus 
cortical thickness -1.14 0.001 -0.32 
-
_ , 
- - - -
-1.24 I 0.0004 1 -0.34 -1.35 1 0.003 • -0.44 
- - ···-
-. -
-
- -- -·--
·- -- -
Left inferior parietal 
cortical thickness 2. 79 I 0.002 ' 0.49 - - - - - - 2.70 0.003 0.48 2.29 0.08 0.41 
Left precuneus 
cortical thickness -2.29 0.01 -0.38 - - - - - - -1.97 0.04 . -0.33 -0.25 0.85 -0.05 
Left pallidum 
volume -0.002 0.01 -0.23 - - - - - - -0.001 0.09 -0.17 -0.001 0.52 -0.10 
-
Left superior frontal 
surface area 0.0004 0.02 0.20 - - - - - - 0.0004 0.02 0.20 0.0001 0.67 0.06 
Cuneus FOG PET 
- - -
-0.0001 0.02 -0.24 - - - -0.0001 0.05 -0.19 -0.0001 0.41 -0.12 
Total tau - - - - - , - -0.01 0.06 -0.29 - -- - -0.004 0.12 -0.23 
Table 5.20. Model predicting APC of clock drawing in AD subjects. The 
MRI model accounted for 32% of the variance. 
MRIMODEL 
Parameter · Standardized 
Estimate 1 p-value Estimate 
-
Age 0.01 1 0.45 0.08 1-. 
Gender -0.08 0.60 -0.05 
- .. 
-- --
Education -0.002 0.92 -0.01 
1 Right pericalcarine cortical ---- -
thickness -2.26 0.01 -0.26 
- --~ig~-~ ~sifo~-~~i~ ~i9_<ne~s 0.75 0.04 ' 0.21 
- --- 4·--
l:_e_rt parace!!tr~ ~~~":l.~ 0.000 0.01 0.26 
---- -
Left pars triangularis surface area -0.001 0.01 -0.24 
1- - - -··--- 0.0004 I Left ~os_!c~ntral ~rfa?! area 0.07 0.17 
-·- -
Left entorhinal surface area -0.002 0.02 -0.22 
. - -
. 
- - -- -- ·-
Right pars orbitali~ ~urface area 0.001 0.17 0.12 
-
Left lateral occipital surface area 0.0004 0.02 0.24 
Right -parahippO(impus surface 
area -0.004 0.001 -0.31 
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Table 5.21. Models predicting baseline digit span forward in AD subjects. The MRI model accounted for 35% of the variance, FOG PET accounted 
for <1% of the variance, and combining modalities accounted for 35% of the variance. 
MRIMODEL FDG PET MODEL MULTIMODAL MODEL 
Parameter , Standardized Parameter ·Standardized Parameter Standardized 
Estimate p-value Estimate Estimate p-value Estimate Estimate · p-value Estimate 
Age 0.02 0.38 0.09 0.02 0.44 0.08 0.02 0.52 0.06 
Gender -0.46 0.17 -0.12 -0.10 0.81 -0.03 -0.47 0.18 -0.12 
- -
Education 0.09 0.09 0.15 0.04 0.56 0.06 0.10 0.06 · 0.17 
- -
Left entorhinal volume -0.001 0.01 -0.25 - - - -0.001 0.01 -0.23 
~ 
Left PC!rs orbitalis volume 0.001 0.05 0.19 - - - 0.001 0.10 0.16 
- -
Right thalamus volume -0.0004 0.17 -0.13 - - - -0.0004 0.15 -0.13 
Right parstiiangularis surfrace - - - -I 
area -0.002 0.01 -0.23 - - - -0.002 0.01 -0.24 
··~- - 1- .. -
-0.002 1 o.ooo2 Left postcentral surface area -0.002 0.0004 -0.35 - - - -0.39 
Left superior temporal su-rface -· - - - -· - - -- 1- - --
area 0.001 0.05 0.19 - - - 0.001 0.03 0.22 I-;;;. - -- ..... 
Right middle temporal surface 
area 0.002 0.002 0.33 - - - 0.002 0.003 0.32 
- - -- - -
Left in!~or parietal surface area 0.001 0.09 0.17 - - - 0.001 0.08 0.18 
Precuneus FOG PET - - - -0.0001 0.18 -0.15 -- - -
N 
0 (J) 
Table 5.22. Models predicting APC of digit span forward in AD subjects. The MRI model accounted for 30% of the variance, CSF biomarkers 
accounted for 14% of the variance, and combining modalities accounted for 35% of the variance. 
MRIMODEL CSF MODEL MULTIMODAL MODEL 
Parameter 1 Standardized Parameter j Standardized Parameter Standardized 
Estimate p..value Estimate Estimate 1 p-value Estimate Estimate . p..value Estimate 
Age 0.01 0.27 0.11 0.04 0.03 0.32 0.04 0.02 0.31 
Gender 0.16 0.38 0.08 -0.11 0.68 -0.06 0.07 0.79 0.03 
-- -
1-- - - --- - '--1 ~--- -
Education 0.02 0.62 0.05 0.002 0.95 0.01 0.02 0.51 0.10 
- I-
Right ~upramar-Qinal volume 0.0003 i 0.0003 . 0.41 - - - 0.0001 0.46 0.14 
- - - - - -
Right p_!lrs opercularis volume -0.001 0.001 1 -0.35 
- - -
-0.00003 1 0.92 . -0.02 
-
-
- -
Right ac~umbens volume -0.002 0.07 ' -0.17 - - - -0.001 1 0.59 -0.07 
-
Left temporal pole surface area -0.004 0.02 ! -0.23 - -- - -0.001 1 0.71 -0.05 
-
Left f~o~tal ~le surf~ce area -0.01 0.02 -0.23 - - - -0.002 0.52 -0.08 
- - - -
Left s~perior_ frontal surface area 0.0004 0.004 0.27 - - - 0.001 0.0002 0.50 
- - -
ABETA142 - - - 0.01 0.06 0.26 0.01 0.05 0.27 
N 
0 
-....J 
Table 5.23. Models predicting baseline digit span backward in AD subjects. The MRI model accounted for 31% of the variance, FOG PET 
accounted for 6% of the variance, and CSF accounted for 5% of the variance. Combining imaging modalities accounted for 31% of the variance, 
while combining all modaliites accounted for 37% of the variance. Param. Est. = Parameter Estimate, Std. Est. = Standardized Estimate. 
MRIMODEL FOG PET MODEL CSF MODEL IMAGING MODEL MULTIMODAL MODEL 
Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. 
Est. value Est. Est. value Est. Est • . value Est. Est. value Est. Est. :value Est. 
Age -0.003 0.92 -0.01 0.07 0.03 0.24 0.04 0.28 0.16 0.01 . 0.79 0.03 0.01 1 0.85 0.03 
-
Gender -0.03 1 0.93 -0.01 0.18 0.67 0.04 0.28 0.60 0.08 -0.09 0.81 -0.02 -0.26 0.59 -0.07 
-
----
-
Education 0.06 0.33 0.09 -0.03 0.71 -0.04 0.02 0.79 0.04 0.06 0.35 0.09 0.15 0.02 0.32 
Left inferior parieta-l - -
volume 0.0004 0.004 0.28 - - - - - - 0.0003 0.01 0.27 0.0003 0.03 0.29 
--
. 
-
. 
-- -Left pallidum 
volume -0.003 0.01 -0.26 - - - - - - -0.002 0.01 -0.25 -0.002 0.10 -0.23 
..... - -Rughtcuneus 
surface area -0.003 0.01 -0.26 - - - - , - -0.002 0.02 -0.25 -0.003 0.01 -0.38 
Left fusiform -- - · -- - - - --
. 
-
. 
-··-·· 
--
surface area -0.002 0.002 -0.30 - - - - - - -0.001 0.01 -0.28 -0.002 0.01 -0.39 
Left pars - --- - - - - - -·- -- - - -- -·· - --
triangularis surface 
area -0.002 0.06 -0.17 - - - - - - -0.002 0.07 -0.17 0.00004 0.97 0.005 
Right rostral middle 
frontal surface area 0.001 0.001 0.32 - - - - - - 0.001 0.003 0.31 0.002 0.002 0.48 
--Left precuneus 
surface area 0.001 0.17 0.14 - - - - - - 0.001 0.13 0.16 0.001 0.05 0.31 
Pericalcarine- FOG 
PET - - - -0.0001 0.16 -0.16 - - - - - - - - -
Total tau - - - - - - -0.01 0.06 -0.28 - - - - - -
"' 0 (X) 
Table 5.24. Models predicting APC of digit span backward in AD subjects. The MRI model accounted for 23% of the variance, FOG PET accounted 
for 8% of the variance, and combining modalities accounted for 25% of the variance. 
MRIMODEL FDG PET MODEL MULTIMODAL MODEL 
Parameter ·Standardized Parameter Standardized Parameter Standardized 
Estimate p-value Estimate Estimate p-value Estimate Estimate p-value Estimate 
Age 0.04 0.01 0.27 0.01 0.33 0.10 0.03 0.08 0.18 
Gender 0.44 0.03 0.23 0.32 0.12 0.16 0.44 0.03 0.22 
Education 0.01 0.67 0.04 -0.03 0.41 -0.09 0.01 0.81 0.03 
Right cuneus cortical thickness -0.95 0.17 -0.14 
- - - -- - -
-
Left frontal pole cortical thickness -0.58 0.06 -0.19 - - - -0.71 0.02 ' -0.23 
-
-
Right parahippocampus volume 0.001 0.07 0.18 - - - 0.0005 , 0.13 0.15 
Left isthmus of the cingulate ·-
surface area 0.002 0.04 0.20 - - - 0.002 0.03 0.21 
Left caudal middle frontal surface 
area 0.001 0.04 0.21 - - - 0.001 0.04 0.21 
- -Right pars triangularis surface 
area -0.001 0.11 -0.16 - - - -0.001 0.10 -0.16 
- - -
.. 
Pericalcarine FOG PET - - - -0.0001 0.01 -0.28 -0.0001 0.16 -0.15 
N 
0 
CD 
Table 5.25. Models predicting baseline Trails A in AD subjects. The MRI model accounted for 35% of the variance, FOG PET accounted for 3% of 
the variance, and CSF accounted for 17% of the variance. Combining imaging modalities accounted for 30% of the variance, while combining all 
modaliites accounted for 49% of the variance. Param. Est. = Parameter Estimate, Std. Est. = Standardized Estimate. 
MRI MODEL FOG PET MODEL CSF MODEL IMAGING MODEL MULTIMODAL MODEL 
-
Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. 
Est. value Est. Est. •value Est. Est. value Est. Est. i value • Est. Est. Jvalue Est. 
Age -0.19 0.73 -0.04 -0.20 0.74 -0.04 -0.83 0.25 -0.16 -O.Q7 l 0.91 -0.01 -1.52 ' 0.05 -0.30 
-
Gender 2.42 0.74 0.03 8.88 0.30 0.12 -7.48 ! 0.49 -0.09 4.25 0.56 0.06 -15.94 0.14 -0.20 
- - -
--
-
Education 1.46 0.17 0.12 1.62 0.20 0.14 3.32 ' 0.02 0.31 0.87 0.42 0.07 0.98 0.45 0.10 
Right transverse 
. -
-- -
.... -
temporal cortical 
thickness -26.97 0,01 -0.24 - - - - - - -32.06 0.00 -0.28 -41.22 0.02 -0.35 
Right entorhinal 
volume 0.01 0.09 · 0.16 - - - - - - 0.02 0.01 0.26 0.04 0.003 0.42 
- - ·-- -Left inferior parietal 
volume -0.01 0,01 -0.27 
- - I - _ , - - -0.01 : 0.002 -0.32 -0.003 0.47 -0.10 
- -- ----
·-
Brainstem volume 0.004 0.06 0.18 - - - - - - 0.003 0.09 0.16 0.004 0.20 0.18 
- - - - --- - -Right pars 
' 
traingularis surface 
area -0.03 ' 0.04 -0.18 - - - - - - -- - - -0.004 0.85 -0.02 
··-·- -Right superior 
temporal surface 
area 0.02 0.09 0.16 - - - - - - - -- - 0.003 ! 0.87 0.02 
Right inferior --
temporal surface 
area -0.02 0.07 · -0.17 - - - - - - -0.02 0.07 -0.17 -0.034 t 0.06 -0.33 
Right 
para hippocampal 
surface area 0.07 0.14 0.13 - - - - - - - -- -- -0.12 0.12 -0.23 
Left lingual surface 
arrea -0.01 0.18 -0.12 - - - -- - - -- -- - -0.01 0.58 -0.07 
Inferior parietal 
FDGPET - - - -0.004 0.06 -0.21 - - - - -- -- 0.001 0.79 0.03 
Total tau - - - - - - 0.15 0.06 0.26 -- - - 0.14 0.06 0.24 
Table 5.26. Models predicting baseline Trails B in AD subjects. The MRI model accounted for 32% of the variance, FOG PET accounted for 12% of 
the variance, and CSF accounted for 10% of the variance. Combining imaging modalities accounted for 25% of the variance, while combining all 
modaliites accounted for 42% of the variance. Param. Est. = Parameter Estimate, Std. Est. = Standardized Estimate. 
MRIMODEL FOG PET MODEL CSFMODEL IMAGING MODEL MULTIMODAL MODEL 
Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. Param. p- Std. 
Est. value Est. Est. 1value Est. Est. value · Est. Est. 'value Est. Est. value Est. 
Age -0.86 0.47 -0.07 -0.01 0.99 O.QC? 1.62 0.36 0.13 0.12 0.92 ' 0.01 2.12 ! 0.17 0.17 
- ·-
Gender -8.50 0.62 -0.04 10.09 1 0.62 1 0.05 -25.05 , 0.35 -0.13 -10.58 0.54 ' -0.06 -27.57 ' 0.22 -0.14 
·- --
Education -8.26 0.005 -0.28 -8.74 0.004 -0.30 -7.91 0.03 -0.32 -8.90 0.002 -0.31 -9.97 1 0.003 ' -0.40 
Left precuneus 
cortical thickness -64.36 0.14 -0.15 - - - - - - -75.69 0.08 -0.18 -120.56 : 0.02 -0.29 
Left temporal pole 
volume -0.06 0.01 -0.25 - - - - - - -0.05 0.04 -0.20 -0.07 0.03 -0.28 
Right frontal pole 
volume -0.12 0.04 -0.19 
- - - - - -
-0.12 0.04 -0.19 -0.11 0.13 -0.20 
- -Right superior 
frontal volume -0.01 0.16 · -0.14 
- - - - - -
-0.01 0.19 -0.13 
- -- -
Right isthmus of 
the cingulate 
surface area 0.16 0.05 0.18 
- - - - - -
0.17 1 0.04 0.19 0.27 0.03 0.28 
I 
Left caudal middle 
frontal surface area 0.05 0.09 0.16 - - - - - - 0.05 0.05 0.18 - - -
Right insula 
' 
surface area -0.14 O.o1 -0.26 - - - - - - -0.15 0.004 -0.29 -0.14 0.04 -0.27 
-Right inferior 
parietal surface 
area 0.02 0.17 0.13 - - - - - - 0.02 0.16 0.13 - - -
Temporal pole FOG 
PET - - - -0.02 0.01 -0.27 - - - - -- -- - -- --
Total tau - - - - -- - 0.40 0.05 0.28 - - -- 0.36 0.05 0.25 
Table 5.27. Models predicting APC of Trails B in AD subjects. The MRI model accounted for 24% of the variance, FOG PET accounted for 4% of 
the variance, and combining modalities accounted for 25% of the variance. 
MRIMODEL FOG PET MODEL MULTIMODAL MODEL 
-
Parameter , Standardized Parameter . Standardized Parameter Standardized 
Estimate 1 p.value Estimate Estimate p-value Estimate Estimate I p-vaiue Estimate 
Age 0.02 0.25 0.13 -0.01 0.66 -0.05 0.02 0.31 0.12 
Gender 0.21 0.38 ' 0.08 
- 0.23 I_ _ _2:~- 0.09 0.19 0.44 0.08 
-·- -
--
--
- -
Education 0.01 0.84 0.0~ 0.08 · 0.05 0.21 0.01 0.81 0.03 
Right banks STS .cortical -
thickness -1.13 J 0.04 -0.23 - - -- -1.11 0.05 -0.22 
-
.. 
- - -
- ' - -
-·-
-- --
- -
- . 
. 
Left rostral middle frontal volume 0.0001 0.06 0.22 - - - 0.0002 i 0.05 0.23 
- --- -- -
--- - - - '·. ·-
-
Right lateral «_?rbitofrontal v~lu~~ -0.0004 0.02 -0.27 - - - -0.0005 0.01 -0.31 
·- -· - ~ ·-· ~ -·- ·- -· -- - . ~-··· ···- 0.001 : 
~ - -· .. ·~·· .. 
L~ft hippocamf?~~ v~l~me 0.001 0.03 0.24 - - -- 0.02 0.26 
--
-· 
... 
- -
-- - -
Right f!<>St~nt~al SIJrf~e._ _are._a -0.001 0.002 -0.33 - - -- -0.001 0.002 -0.33 
-- ·- --
- - -· - -· 
Right ento~i~al_surface are._a 0.004 0.03 0.24 - - - 0.004 0.04 ' 0.23 
-- 0.01-, - ···~ - - -Left frontal pole surface area 0.03 0.22 - - - 0.01 0.03 , 0.22 
-
Paracentral FOG PET _ , - - 0.0001 ' 0.11 0.17 - ' - --
Table 5.28. Models predicting baseline RAVLT 30 minute delayed recall in AD subjects. The MRI model accounted for 29% of the variance, FOG 
PET accounted for 7% of the variance, and combining modalities accounted for 34% of the variance. 
MRI MODEL FDG PET MODEL MULTIMODAL MODEL 
Parameter ! Standardized Parameter Standardized Parameter t Standardized 
Estimate 1 p-value Estimate Estimate p-value Estimate Estimate 1 p-value , Estimate 
Age -0.01 0.77 1 -0.03 -0.02 0.44 -0.08 0.003 0.90 0.01 
- . ·-
-
.. 
-
-- -· - - -· 
.. 
-
Gender -0.28 0.27 -0.11 0.13 0.67 0.05 -0.23 • 0.39 -0.08 
-
Education -0.04 0.31 -0.10 0,01 , 0.90 0.01 -0.04 0.31 . -0.10 
Right superior temporal cortieai 
.. -. 
- -· 
. -
-
thickness 2.06 0.001 0.35 
- - -
1.92 1 0.005 0.33 
N 
...... 
. -
- - -
.....----- --- ---- -- - -- ..,_ -- --- -·- -- - ---- o .01·-- -Right lingual cortical thickness -3.65 0.001 -0.34 - - - -2.80 -0.26 
N Ri ght superior parietal surface - -l 
area 0.0004 · 0.11 0.15 - - - 0.0004 . 0.12 0.15 
Right rostral middle frontal surtace - -- - - -- .. ··- - - --- -- - ·- ---- -- -· -- - -·---
-
-
--
I 
area -0.001 0.01 -0.28 - - - -0.001 1 0.003 : -0.32 
Left -m8dial orbiiOtrootal surface~ -- --- --- - - --···- -· - . ... ·- ---·- . - -- ·-- - - -- ----·-·- -- -·-- - -------~-I 
area 0.002 0.07 0.20 - - - 0.002 · 0.08 0.20 
- --· ····~- - .. _ --~· 
____ ,_ 
-
.. 
--
Right lateral ~~~ital surface are~ -0.001 i 0.003 -0.28 - - - -0.001 0.001 -0.30 
- - --- - --
-~ 
·- - - --
Righ! p_!!ra~m!!_al ~~a~ area 0.002 0.02 0.23 - - - 0.002 0.03 0.20 
- - -
Entorhinai FOG PET - - - 0.0002 0.02 1 0.26 0.0002 0.10 0.17 
- -
Supramarginal FOG PET - - - -0.0002 1 0.01 -0.28 -0.0002 0.03 -0.22 
Table 5.29. Models predicting APC of RAVLT 30 minute delayed recall in AD subjects. The MRI model accounted for 68% of the variance, FOG 
PET accounted for <1% of the variance, and combining modalities accounted for 78% of the variance. 
MRIMODEL FDG PET MODEL MULTIMODAL MODEL 
Parameter standardized Parameter Standardized Parameter Standardized 
Estimate p-value Estimate Estimate p-value Estimate Estimate 'p-value Estimate 
Age -0.01 0.30 -0.15 -0.01 0.58 -0.13 -0.004 0.52 -0.08 
-
Gender -0.04 0.73 -0.05 -0.10 0.57 -0.13 -0.15 0.13 -0.19 
- ·- -·· - -
Education -0.01 0.59 -0.07 0.01 , 0.70 , 0.08 -0.01 0.45 -0.10 
Left parahlppocamus cortical - --
thickness 0.38 0.005 0.38 - - - 0.46 0.0003 0.48 
- - - -
.. 
. -
- -
.. 
Rig~t superior p~rietal V?lume -0.0001 0.01 -0.38 - - - -0.0001 . 0.001 -0.41 
- - --
-
- - -- -·-- - - - -
Rig!lt _!ron~ ~01! V~U"!_e -0.001 0.01 -0.36 - - -0.001 0.005 · -0.33 
. - --
-
~- -· - -· .... .. -- - -- - -
Left pericalcarine surface area 0.001 0.01 0.40 - - - 0.001 0.03 ' 0.32_ 
Right posterior cingulate surface - --
area -0.001 . 0.08 -0.25 - - - -0.0005 0.14 -0.18 
··-. -· 
Right_!nferi~ e_arieta~_surf~c~ ~e~ -0.0003 0.01 -0.39 - - - -0.0003 0.005 -0.35 
- ··- ·- --- -
Inferior parietal FOG PET - - - 0.0001 ' 0.12 0.39 0.00003 1 0.18 0.20 
Table 5.30. Models predicting baseline RAVLT 30 minute delayed recognition in AD subjects. The MRI model accounted for 36% of the variance, 
FOG PET accounted for 11% of the variance, and combining modalities accounted for 35% of the variance. 
MRIMODEL FOG PET MODEL MULTIMODAL MODEL 
-·- - - Parameter Standardized Parameter Standardized Parameter Standardized 
Estimate j p-value Estimate Estimate , p-value 1 Estimate Estimate ~ p-value Estimate 
Age -0.14 i 0.01 -0.26 -0.08, 0.16 -0.15 -0.13 0.02 -0.23 
-
.. 
-
Gender -0.92 . 0.20 -0.11 -1.37 0.11 } -0.17 -0.89 0.23 -0.11 
-
- - -. - . -
' 
- - - . -
- . 
- -
Education -0.04 0.71 -0.03 -0.10 0.43 -0.08 -0.06 , 0.6? i -0.05 
Right transverse temporal cortical ·- -
.. 
.. -
··- - -- - -
thickness -3.50 ' 
_9_.002 , -0.30 - - -- -3.54 , 0.003 -0.30 
.. -. - -
- . -· - ------ I . - ···- --- ·- - -· Left entorhinal cortical thickness 2.68 0.0001 0.36 
-- - - 2.71 ' 0.0002 0.37 
.. 
0.01 ! Left frontal pole vol~:~~e -0.01 -0.22 - - -- -0.01 ' 0.02 -0.22 
-
Brainstem volume o.ooo ' 0.02 , -0.20 
-- - --
-0.0004 1 0.02 ' -0.21 
Right superior te-mporal surface 
..• 
... --
-
0 
area 0.002 , 0.04 0.19 - - -- 0.002 0.06 0.17 
. .. 
-
Left lingual surface area 0.002 0.07 • 0.16 - _ , - 0.002 0.08 0.16 
Entorhinal FOG PET 
-· 
- - 0.001 ' O.Q1 0.30 - - --
.. 
- -
Superior temporal FOG PET - -- - -0.001 1 O.Q1 -0.31 - -- --
Table 5.31. Models predicting APC of RAVLT 30 minute delayed recognition in AD subjects. The MRI model accounted for 20% of the variance, 
FOG PET accounted for 4% of the variance, and combining modalities accounted for 23% of the variance. 
MRIMODEL FOG PET MODEL MULTIMODAL MODEL 
Parameter Standardized Parameter , Standardized Parameter • Standardized 
Estimate • p-value Estimate Estimate p-value Estimate Estimate · p-value Estimate 
Age -0.01 0.30 -0.15 -0.01 0.58 -0.13 -0.004 0.52 -0.08 
.. 
-
Gender -0.04 0.73 , -0.05 -0.10 0.57 -0.13 -0.15 0.13 -0.19 
- --· -
Education -0.01 0.59 -0.07 0.01 0.70 0.08 -0.01 0.45 -0.10 
l.efi parahippocamus cortical --
... 
thickness 0.38 0.005 0.38 
- - -
0.46 0.0003 0.48 
- - ·-
.. 
--- -
Right su~ri~~ pa~etal ~olume_ -0.0001 0.01 -0.38 - - - -0.0001 0.001 -0.41 
·- -
·-
- - -· --
-~_ht fn>!!tal p~le ~olume_ -0.001 . 0.01 -0.36 - - - -0.001 0.005 ' -0.33 
- - -
.. 
- -
--
----
- ---Left pericalcarine surface area 0.001 0.01 0.40 - - - 0.001 ' 0.03 0.32 
Right post enor clngulate surface -
.. - . 
- ·- ·-
.. 
area -0.001 0.08 -0.25 - - I - -0.0005 · 0.14 -0.18 
-- -
- . 
-- - -
,. - - .... 
-
Right inf! rior parietal surface area -0.0003 0.01 -0.39 - - - -0.0003 0.005 -0.35 
- - - -
Inferior parietal FOG PET - - - 0.0001 ' 0.12 1 0.39 0.00003 0.18 0.20 
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Chapter 6 -Overall discussion 
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OVERALL DISCUSSION 
The overall goal of this study was to utilize a data-driven multimodal 
approach to examine structural, functional, neuropsychological , and pathological 
markers of MCI and AD. The specific aims of this study were examined in four 
studies. The first of these compared partial volume correction techniques and 
appropriate normalization reference regions for FOG PET post processing. In this 
study, the effects of two partial volume correction methods were compared, 
namely using a gray matter mask and taking residuals of cortical thickness and 
subcortical volume. In addition, this study examined which reference region for 
normalization provided the best discrimination between normal aging, MCI , and 
AD. The brainstem, cerebellum, precentral gyrus, postcentral gyrus, and 
thalamus were the candidate regions assessed. FOG metabolism in the brain 
was normalized using statistical residuals, effectively removing the individual 
variation in uptake from the PET scans. In both parts of this study, stepwise 
logistic regression was used to establish the discriminability of FOG PET 
metabolism under the various partial volume correction and normalization region 
conditions. Based on the c-statistic, a measure of discriminability, normalization 
to the cerebellum with gray matter mask partial volume correction provided the 
most meaningful means for FOG PET post-processing. 
The second study's aim addressed changes in gray/white matter intensity 
ratio (GWIR) and its use as a correction factor for cortical thickness in normal 
aging, MCI, and AD. Recent studies have suggested that brain changes that 
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occur in normal aging and as a result of accumulation of pathology in MCI and 
AD may result in blurring of the gray/white matter boundary. Because this 
boundary is used to calculate cortical thickness values, it is possible that the 
potential age- and/or disease-related changes in the gray/white matter intensity 
ratio may influence the cortical thickness measurements. This chapter addressed 
four hypotheses: 1) GWIR correlates positively with age in normal aging subjects, 
2) GWIR decreases progressively between normal aging, MCI, and AD subject 
groups, 3) adjusting cortical thickness measurements for GWIR improves the 
ability to differentiate between normal aging, MCI, and AD subjects using 
statistical models, and 4) the effect size of cortical thickness increases after 
adjusting for GWIR. The results show that there were no significant correlations 
between GWIR and age in the normal aging population we studied. We did not 
observe any significant differences in GWIR between the disease groups, nor 
was GWIR able to differentiate between the groups in a meaningful way, though 
adjusting cortical thickness for GWIR did slightly improve the ability to 
differentiate between groups. The effect size of cortical thickness increased after 
correcting for GWIR, though it is not certain if this increase represents a real 
phenomenon or merely provides a means for reducing the variance in the data. 
The results of this study provide support for adjusting cortical thickness for 
variations in GWIR, although it does not support the use of GWIR on its own for 
discriminating between normal aging, MCI, and AD, nor does this study provide 
evidence in favor of age-related changes in the elderly. 
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The third study examined which combination of FOG metabolism, MRI 
morphometry, neuropsychological, and CSF biomarker concentration data best 
discriminated between normal aging, MCI, and AD. We used stepwise logistic 
regressipn to determine which variables contributed unique variance to the model 
with each modality individually and then in combination. MRI morphometric 
measures and neuropsychological test scores produced better discriminated than 
FOG PET or CSF biomarker concentration measures. Combining modalities 
increased the c-statistic in all instances. These findings provide support for the 
use of multiple modalities in comparing groups. 
The fourth study identified the baseline CSF biomarker concentration, 
FOG metabolic, and MRI morphometric variables that predict baseline 
neuropsychological test scores and future cognitive decline in normal aging, MCI, 
and AD subject groups. We used stepwise linear regression to determine which 
imaging and CSF biomarker concentration variables contribute variance to the 
models predicting clock drawing, Trails A, Trails B, digit span forward, digit span 
backward, and RAVL T 30 minute delayed recall and recognition baseline score 
and subsequent decline. MRI measures predicted both baseline and decline for 
all tests better than FOG metabolism or CSF biomarker concentration measures. 
Normal aging subjects declined only on Trails A, while MCI subjects declined 
only on delayed recall. AD subjects showed decline across all tests with the 
exception of Trails A. 
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The first two studies were more technical in nature and were used to 
determine how to best treat the data from two of the modalities (FOG PET and 
cortical thickness) in the third and fourth studies. The results of the third and 
fourth studies provide insight into the current models of disease progression and 
the modalities that best distinguish between disease stages and predict cognitive 
decline. Recent hypothetical models suggest that there is an order in which 
different modalities are most telling of AD pathology. In this model CSF variables 
are thought to change first, followed by FOG metabolism measures, MRI 
morphometric measures, and then neuropsychological test scores. According to 
the model postulated by Jack et al (Jack Jr et al. 201 0), CSF concentrations of 
aBeta or PET amyloid imaging provide the earliest indicators of incipient AD, 
followed by CSF tau concentrations and FOG PET, which target Tau-mediated 
neuronal injury and dysfunction. As pathology continues to build up in the brain, 
neuronal integrity begins to change, resulting in atrophy, which is detectable with 
MRI morphometry. Eventually the neuronal loss and changes in glucose 
metabolism result in cognitive impairment, which may be the last modality to 
detect AD. Unfortunately for most individuals, it isn't until memory or other 
cognitive domains show deficits that they present to clinics for further study, by 
which point many underlying brain changes have likely occurred. The results of 
our study do not fully support this dynamic biomarkers model, as it was MRI and 
neuropsychological tests, rather than the purported more sensitive FOG PET and 
CSF biomarkers concentrations, that best differentiated between groups. It may 
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be that in our subjects, FOG PET and CSF biomarker concentrations change 
prior to a definitive diagnosis of MCI or AD. We do not think that this is the case 
because if FOG PET and CSF biomarkers changed prior to MCI (e.g. in normal 
aging), we might expect these two markers to be more sensitive to future 
cognitive decline in our fourth study. This was not what we observed , suggesting 
that perhaps this dynamic biomarker model cannot be applied to all subject 
groups. There is great debate in the literature as to which imaging modality (FOG 
PET or MRI morphometry) provides the best index for determining current 
disease state and potential to decline in the future. There are studies supporting 
both sides of the debate, with MRI outperforming FOG PET (K B Walhovd et al. 
2009) and conversely, FOG PET outperforming MRI (De Santi S. et al. 2001 ; 
Matsunari et al. 2007; Kawachi et al. 2006) . Our results provide support for MRI. 
Another aspect of the dynamic biomarker model of AD is that within each 
modality, different features within that modality (e.g. brain regions for imaging, 
CSF biomarker types, etc) contribute to differentiating between disease stages 
earlier than others. In MRI , medial temporal atrophy is followed by lateral 
temporal and finally frontal atrophy, whereas in FOG PET, metabolism decreases 
initially in the posterior cingulate cortex, followed by the lateral temporal and 
frontal lobes (Jack Jr et al. 201 0) . Based on this model , we would expect medial 
and lateral temporal atrophy and posterior cingulate hypometabolism to 
discriminate normal aging from MCI and frontal atrophy and hypometabolism to 
discriminate MCI from AD. Our models suggest that the brain regions that best 
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discriminate groups are not necessarily in the order that we would expect. The 
variables that contributed the highest variance for differentiating MCI from normal 
aging tended to be localized to the medial temporal lobes, cingulate cortex, and 
frontal lobes. Because the frontal lobes are hypothesized to be affected later in 
the disease progression, it is possible that our MCI subjects have progressed 
further along the AD spectrum than initially anticipated . The regions that best 
differentiated between MCI and AD were localized to the medial temporal , lateral 
temporal , insula, and occipital regions . The occipital lobe is not involved in AD 
pathology until late in the disease, thus it is surprising that this region may be 
useful in differentiating MCI from early AD. So far as the progression of CSF 
variables from aBeta to tau, our CSF biomarker concentration models suggest 
that both types of pathology are useful for discriminating normal aging, MCI , and 
AD when using CSF alone. When CSF markers were combined with the other 
modalities, however, aBeta was more sensitive than tau at differentiating MCI 
and normal aging, while both aBeta and pTau were useful for differentiating MCI 
and AD . This suggests that there may be an earlier build up of aBeta in the CSF 
than there is a decrease in tau. 
The results from the fourth study, determining which imaging variables are 
most highly associated with baseline neuropsychological function and best 
predict future cognitive decline, indicate that MRI outperformed FOG PET again. 
The brain regions that were associated with each tasks highlighted the types of 
cognitive skills required for successful completion of the test and also highlighted 
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that these regions, when damaged, can result in poor memory, executive 
function, and visuospatial abilities. 
The findings of this study can be applied to future research in MCI and AD 
in a number of ways. The first two chapters outline important post-processing 
steps in both MRI and FOG PET data that may improve the accuracy of the 
measures, which may in turn increase the likelihood of detecting changes due to 
treatment effects or disease progression. The third chapter highlights which brain 
regions, neuropsychological tests, and CSF biomarker concentrations should be 
targeted as biomarkers, which may be useful indicators of disease staging in 
clinical trials. The fourth chapter highlights which brain regions are associated 
with various types of cognitive impairments and those that are indicative of future 
cognitive decline. Morphometric features and metabolism characteristics in these 
areas may be useful endpoints for clinical trials for MCI to slow down the rate of 
disease progression and cognitive decline. 
This study did not examine longitudinal change in MRI morphometry or 
FOG metabolism. These two areas may add insight into the prediction of future 
decline and underlying brain changes. Our results showed a number of 
unexpected brain regions associated with discriminating disease groups, 
baseline neuropsychological tests, or predicting future cognitive decline. Future 
studies ought to look into these regions further and identify whether their 
involvement is due to true disease effects or is a by-product of the statistical 
methods employed. In regression models, the variables that change most with 
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the disease may not contribute enough independent variance to enter into the 
model, or stay in it once other variables are entered. 
There is still so much about MCI and AD that is unknown. Each piece of 
information that is gained through studies such as this one may hopefully one 
day culminate in the development of an effective prevention regimen and 
treatment plan that can limit the huge impact of AD and MCI on our society. 
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